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ABSTRACT 
Eosinophil recruitment is a predominant feature of atopic inflammatory diseases, including 
asthma, rhinitis and dermatitis. Numerous studies have highlighted the strong correlation 
between eosinophilic inflammation, pathophysiological changes and disease severity. 
Eosinophil chemotaxis occurs in response to specific chemokines, lipid mediators and 
complement factors. The functional and structural mechanisms underlying the directed 
migration of eosinophils to the site of antigen provocation still remained to be elucidated. In 
particular, the role of CCR-3 and downstream signalling mediators in the induction and 
maintenance of eosinophil chemotactic responses. In these studies, the murine eosinophil 
was employed with the intention of translating observations on cellular function to in-vivo 
systems of cell migration in murine allergic disease. 
The importance of G-protein coupled receptors (GPCR), such as CCR-3, in cell migration is 
well documented. The Gi-proteins associated with ligand-induced CCR-3 chemotaxis were 
characterised. mRNA studies revealed the expression of Gia2 and Gia3, but not Gia. 
Western blot analysis confirmed translation of Gia2 and Gia3, and the co-immunoprecipitation 
of CCR-3 with Gia2 in response to eotaxin stimulation. In association with cellular studies on 
G-protein, the role of the Gz-protein in leukocyte motility and in the pathophysiology of disease 
was studied. The most striking result was a pronounced elevation in airways responsiveness 
in both basal (non-sensitised, non-provocated) and Ova-sensitised/Ova-provocated BalbC and 
C56BL/6 mice following ~-methacholine treatment. A reduction in PBE in the BalbC, a trend 
reversed in the C56BL/6 mice, highlighted the importance of genetic variation in the analysis of 
experimental parameters. In the absence of further significant changes to leukocyte 
parameters and standard histology, electron microscopic (EM) analysis revealed an elevation 
in surfactant production (SP) in basal C56BL/6 mice. The Gz-protein was identified as an 
important regulator of airways responsiveness to methacholine, potentially through the 
alteration in SP production and composition. 
An eosinophil-specific protocol was developed to allow the visualisation of cell-surface and 
intracellular dynamics of this granulocyte. Of particular interest was the characterisation of the 
spatial and temporal localisation of CCR-3 and the IL-5R in response to both priming and 
chemoattractant stimulation. Short-term exposure of eosinophils towards a shallow gradient of 
eotaxin resulted in the strong polarisation of cells, the asymmetrical distribution of CCR-3 
towards the leading edge and tyrosine phosphorylation of the receptor. IL-5Ra remained 
evenly distributed around the peripheral membrane in response to IL-5, but eotaxin stimulation 
induced polarisation towards both the leading edge and uropod of the cell. Following initial 
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leading edge aggregation, desensitised CCR-3 was found to internalise via distinct intracellular 
"tracks" towards the clear zone, an area housing both the microtubular organising centre 
(MTOC) and golgi complex of the cell. Biochemical analysis suggested that IL-5 priming 
reduced the rate of CCR-3 internalisation and the association of the receptor with 
microdomain-linked glycosphingolipid-cholesterol-enriched complexes (DIG's). IL-5Ra 
internalisation was cytoplasmic and consistent with endosomal localisation. The aggregation 
of these receptors at the site of cell-membrane microdomains provides the proximity necessary 
for protein interaction and the subsequent generation of cellular responses. 
In light of the functional observations made, structural responses of eosinophils to chemotactic 
stimuli were investigated. In eosinophils, the polymerised actin cytoskeleton (F-actin) was 
characterised by a tight dot like formation, typical of podosomal or focal complex formation. 
Upon eotaxin stimulation, actin became polarised and arranged along pronounced intracellular 
"tracks". Chemotactic stimulation induced strong microtubular polymerisation, a distinct 
MTOC-based astral formation and the extension of microtubules towards the leading edge. 
Leading pseudopodia were distinguished by the co-localisation of F-actin contacts on extended 
microtubules and ~-tubulin rich aggregates, with a small proportion of F-actin localised 
adjacent to the MTOC. 
lmmunohistochemical observations of ligand-induced internalisation of CCR-3 suggested a 
role for the microtubule and actin filament systems in the trafficking of this receptor. 
Biochemical investigations revealed the direct co-immunoprecipitation of CCR-3 with ~-tubulin 
in both control and eotaxin stimulated eosinophils. Subsequent immunohistochemical detection 
of CCR-3 and ~-tubulin, following eotaxin stimulation, revealed a strong association at the 
leading edge and the "tracking" of internalised receptor along microtubule filaments from the 
leading pseudopod to a site adjacent to the MTOC. CCR-3 localisation at the "clear zone" 
suggests the direct trafficking of internalised receptor to the golgi complex prior to recycling to 
the peripheral membrane. Although CCR-3/actin association studies were limited, the lack of 
CCR-3 internalisation to the "clear zone" in nocodazole and cytocholasin C treated cells 
highlighted the interplay of these two filament systems in the trafficking of this receptor. A brief 
investigation into microdomain expression in eosinophils identified caveolin localisation at the 
cell-membrane. EM analysis revealed distinct invaginations in association with vacuole 
formation along the entire plasma membrane, suggesting a role for caveolae-based 
microdomains in the aggregation and internalisation of signalling mediators. 
The potential crosstalk of the chemokine and integrin signalling pathways was investigated . 
Biochemical analysis revealed CCR-3 was found to co-immunoprecipitate with FAK upon 
eotaxin stimulation. Localisation studies confirmed this association, with co-localisation of 
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CCR-3 and FAK at the leading edge and focal complexes located at the ventral surface of the 
cell. Co-localisation of FAK with the microtubular network further highlighted the interplay of 
functional and structural signals involved in cell adhesion and motility. 
The inhibition of eosinophil migration was investigated, both through the use of specific 
signalling inhibitors and by directly blocking CCR-3 signalling. In-vitro treatment of eotaxin-
stimulated eosinophils with wortmannin and rapamycin, inhibitors of Pl3K and P70S6K 
respectively, confirmed the role of these two signalling pathways in chemotactic signals 
mediated by this chemokine. The prevention of eosinophil recruitment by the blockade of 
ligand/CCR-3 interaction was illustrated with the CCR-3mAb (19-4). Following Ova-
sensitisation and Ova-provocation, eosinophilia, mucus production and associated airways 
pathophysiology was almost totally abolished in mAb treated mice. In-vivo ablation of 
eosinophil recruitment through the use of CCR-3 mAb (19-4) substantiated the potential of 
humanised CCR-3 antibodies in providing specific clinical intervention in allergic airways 
disease. 
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CHAPTER 1: 
General Introduction 
1 
1.1 INTRODUCTION 
The elemental role that specific leukocyte subsets play in the pathophysiology of allergic 
diseases has focused attention on identifying the molecules that selectively regulate the 
migration of these cells to sites of inflammation. In allergic inflammation, CD4+ helper type-
2 lymphocytes (TH2 cells), mast cells and eosinophils appear to be primarily effector cells 
that underlie the clinical manifestations of disease (Kay AB, 1989). The cellular and 
molecular mechanisms that specifically regulate the recruitment of these inflammatory cells 
from the blood to sites of inflammation are complex. However, cellular migration appears to 
be modulated by two fundamental processes: cell-adhesion systems located in the vascular 
endothelium and signals elicited through cytokine and chemokine ( chemoattractant 
cytokines) receptors (reviewed in: Wardlaw et al., 1995; Hogan and Foster, 1997; 
Rothenberg et al., 1998). In particular, specific cytokine and chemokine signalling systems 
form networks that are elegantly coordinated to orchestrate the inflammatory response. 
At the initiation of inflammation, cytokines and chemokines play elemental roles in 
propagating the inflammatory response by eliciting signals that promote antigen processing, 
T-cell selection, antibody production, and the maturation and mobilisation of haemopoietic 
cells (reviewed in: Wardlaw et al., 1995; Giembycz and Lindsay, 1999). Cytokine and 
chemokine signalling systems also cooperate in the latter events of the allergic inflammatory 
cascade by promoting the selective mobilisation, attachment and recruitment of specific 
leukocyte subsets to the site of allergen deposition (reviewed in: Koenderman et al., 1996; 
Hogan and Foster, 1997). Thus, specific cytokines and chemokines are intimately involved 
in directing the immune response by activating the molecular networks that modulate the 
trafficking and activation of specific leukocyte subsets to the site of inflammation. 
Atopic asthma is characterised by chronic airways inflammation, reversible airways 
obstruction due to increased mucus production and airways hyperreactivity to inhaled 
spasmogens (Bochner et al., 1994). The allergic inflammatory response in the lung can be 
divided into early- and late-phases, both of which are classified by the influx of specific 
inflammatory cells. The early-phase in asthma is characterised by the presence of activated 
mast cells and basophils, while a pronounced influx of THrcells and eosinophils is observed 
in the late-phase response (Kay AB, 1989). Specific cytokines, chemokines and 
chemoattractants produced in the early-phase in response to a particular inflammatory 
stimulus are intimately involved in directing the late-phase response, through the activation 
of the extra- and intra-cellular signals that modulate the trafficking and activation of 
eosinophils to the site of inflammation (Marone G, 1997). 
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1.2 EOSINOPHILS- KEY PLAYERS IN ATOPIC DISEASE 
Eosinophil recruitment is a predominant feature of atopic inflammatory diseases, including 
asthma, rhinitis and dermatitis (Fowler JI and Lowell VC, 1966; Olaru et al., 1967; Weiss A, 
1968). Although the role of eosinophilic inflammation in the pathophysiological changes 
associated with these diseases has recently been questioned (Leckie et al., 2000), the 
evidence supporting eosinophilic inflammation as a major determinant of pathogenesis is 
well documented (Reed, 1994; de Vries, 1994; Oddera et al., 1996). Numerous studies in 
human clinical trials and animal models of asthma have highlighted the strong correlation 
between eosinophilic inflammation, pathophysiological changes (Wardlaw et al., 1994; 
Martin et al., 1996) and disease severity (Bradley et al., 1991; Elwood et al., 1991). 
Although the eosinophil has been linked to disease severity, some clinical and experimental 
studies have found no direct correlation between the level of this granulocyte in 
bronchoalveolar lavage fluid (BALF) and airways hyperreactivity (Djunkanovic et al., 1990; 
Ishida et al., 1990; Banner et al., 1996). Recently, a clinical trial utilising a humanised IL-5 
monoclonal antibody (mAb), which inhibited blood and tissue eosinophilia in response to 
allergen provocation, had only a limited effect on late-phase responses and airways 
hyperreactivity (Leckie et al., 2000). 
1.2.1 The role of eosinophils in the pathogenesis of allergic disease 
Eosinophils have been shown to produce and secrete a range of proinflammatory mediators 
(Giembycz and Lindsay, 1999), including: the cytokines interleukin (IL)-3, granulocyte 
macrophage colony stimulating factor (GM-CSF; Kita et al., 1991 ), IL-4 (Bandeira-Melo et 
al., 2001), IL-6 (Lacy et al, 1998), IL-8 (Braun et al., 1993), IL-16 (Lim et al., 1996); the 
chemokines eotaxin-1 (Nakajima et al., 1998), regulated on activation, normal T-expressed 
and secreted (RANTES; Ying et al., 1996), macrophage inflammatory protein alpha (MIP-
1 a; Costa et al., 1993), monocyte chemotactic protein (MCP-1; Izumi et al.,, 1997); lipid 
mediators including platelet activating factor (PAF; Miyamasu et al., 1995) and leukotrienes 
(Owen et al., 1987); and cationic proteins [major basic protein (MBP; Gleich et al., 1976); 
eosinophil peroxidase (EPO; Carlson et al., 1985); eosinophil cationic protein (ECP; Dahl R 
and Venge P, 1978); and eosinophil-derived neurotoxin (EON; Fredens et al., 1982). 
The role of many of these eosinophil-derived mediators is to facilitate further leukocyte 
recruitment and activation, resulting in the release of additional proinflammatory mediators 
from infiltrating resident cells. The cationic proteins, found in the cytoplasmic granules of 
the eosinophil (Dunn and Spicer, 1969), can be released through either "piece-meal" 
degranulation or cytolysis of the activated eosinophil. These cytotoxic proteins can directly 
induce tissue damage and dysfunction (Ayars et al., 1989; Motojima et al., 1989), and have 
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also been linked to the induction of airways hyperreactivity (Coyle et al., 1993). In guinea 
pig studies, MBP and EPO have been found to directly enhance vagal mediated 
bronchoconstriction by acting as allosteric inhibitors of muscarinic M2 receptors (Gleich et 
al., 1995). The role of eosinophil derived mediators in mouse models of asthma has been 
highly controversial due to the apparent lack of MBP and EPO release. However, findings in 
our laboratory have confirmed both the in-vivo and in-vitro release of these cytotoxic 
mediators upon eosinophil activation (Mould et al., 1997; Clark et al, in publication). 
Furthermore, in the allergic lung eosinophils may modulate inflammation by the release of 
other proinflammatory molecules and through direct interactions with THrcells (Shi et al., 
2000; MacKenzie et al, 2001 ). 
1.2.2 Eosinophil chemotaxis (polarisation) and chemokinesis (motility) 
Leukocyte migration in response to chemoattractants is defined as inducing either a 
chemotactic or chemokinetic response. Eosinophil chemotaxis or the directed migration of 
cells in response to concentration gradients of chemoattractant molecules, occurs in 
response to specific chemokines, lipid mediators and complement factors (Wilkinson et al., 
1976). This process appears to be regulated by the ability of a cell to polarise towards a 
chemoattractant, the extent of chemotaxis being dictated by the expression and aggregation 
of specific receptors and signalling molecules towards the site of polarisation (Gilbert et al., 
1976). In contrast, eosinophil specific cytokines (signalling through receptors of the cytokine 
superfamily), some lipid mediators and neurogenic mediators appear to prime eosinophil 
responses to chemoattractants (Coeffier et al., 1991 ). Priming molecules or processes, 
rather than initiating unique intracellular pathways, increase a cell's overall responsiveness 
to other extracellular stimuli, including such changes as tyrosine phosphorylation, receptor 
retention and aggregation. In terms of eosinophil migration, priming results in an increase in 
chemokinetic behaviour or random motility of the cell, distinguished in-vitro from classical 
chemotactic migration by the lack of directional focus (Wilkinson et al., 1976). 
The mechanism by which chemoattractants produce local chemotactic gradients has yet to 
be fully elucidated. A model has been proposed suggesting that chemokines produced 
within a given tissue, rather than remaining in solution, are preferentially immobilised 
through low affinity binding to heparin-bearing proteoglycans on the vascular endothelial cell 
barrier or to extracellular matrix proteins within the extravascular tissues (Taub et al., 1996). 
Hence, the extracellular matrix may play a vital role in the dynamics of chemoattractant 
gradient formation (Kaplan et al., 1998). 
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1.3 MEDIATORS INVOLVED IN EOSINOPHIL MIGRATION 
1.3.1 The role of cytokines in eosinophil priming: chemokinetic stimuli 
The recruitment of eosinophils to sites of allergic inflammation is a complex process that 
potentially may be regulated by inflammatory cytokines IL-1 ~, IL-3, IL-4, IL-5, IL-16, GM-
CSF and tumour necrosis factor (TNF)-a (Table 1 ). Cytokines generated in the early-phase 
of the allergic response, potentially by THrcells, mast cells, local fibroblasts, the 
endothelium and epithelium, as well as eosinophils themselves, provide the cellular sources 
of cytokines and chemoattractants involved in subsequent eosinophil recruitment in the late-
phase. 
Eosinophils are primed by cytokines, resulting in the phosphorylation and activation of 
receptors and signalling molecules, enhanced responsiveness to specific chemotactic 
factors and increased motility (Kaplan et al., 1998). Eosinophils derived from the peripheral 
blood of allergic asthmatic patients show enhanced migratory responses in-vitro, 
demonstrating the in-vivo primed phenotype of these cells (Warringa et al., 1992). Cytokine 
priming is essential for eosinophil chemotaxis toward formylmethionyl-leucyl-phenylalanine 
(fMLP) and IL-8 (Warringa et al., 1991 ). Interestingly, in contrast to chemotactic migration, 
cytokine priming of eosinophils appears to be Ca2+ independent. Optimal priming 
concentrations of GM-CSF, IL-3 and IL-5 do not appear to induce a rise in intracellular free 
Ca2+ and Ca2+-depleted eosinophils are still primed after preincubation with these cytokines 
(van der Bruggen et al., 1993). However, the use of more sensitive visual imaging systems, 
such as confocal microscopy and Ca2+ specific flurophores may reveal the potential role of 
Ca2+ signalling in the priming of eosinophil migratory responses. 
Although IL-3, IL-5 and GM-CSF have been found to induce primed responses in 
eosinophils (Sanderson et al., 1992), the eosinophil-specific cytokine IL-5, is the most 
characterised chemokinetic mediator (Table 1 ). Importantly, the cytokine IL-5 has been 
shown to play a role in the growth, differentiation and activation of eosinophils and provides 
an essential signal for the induction of eosinophilia during the late-phase of allergic 
inflammation (Sanderson et al., 1992; Schweizer et al., 1996; Koenderman et al., 1996; 
Leckie et al., 2000). The central role of IL-5 in eosinophil recruitment in the late-phase 
response has been demonstrated by investigations employing IL-5-deficient (IL-5_1_) mice. 
Deficiency of this cytokine leads to a marked reduction of eosinophils released from the 
bone marrow into the peripheral blood, resulting in the abolishment of eosinophilia 
associated with allergic airways disease (Foster et al., 1996; Matthaei et al., 1997). 
Interestingly, eosinophil progenitors from IL-s-1- mice still maintain the capacity to 
differentiate in-vitro in response to exogenous IL-5, suggesting IL-5 receptor (R) expression 
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and function is maintained (Takamoto et al., 1997). Conversely, studies on transgenic mice 
have shown that overproduction of IL-5 leads to persistent eosinophilia (Dent et al., 1990). 
However, studies on wild-type mice have found that intradermal injection of IL-5 does not 
induce a significant eosinophil accumulation in the absence of other chemoattractants 
(Mould et al., 1997). 
IL-16 appears to be uniquely distinguished from other cytokines with respect to its chemical 
and biological functions. This cytokine utilizes the CD4+ molecule as it's receptor and has 
subsequently been shown to be a potent chemoattractant for human eosinophils 
(Cruikshank et al., 1998). However, a recent study in a mouse model of allergic asthma 
concluded that IL-16 played no significant role in eosinophil migration and accumulation 
(Hessel et al., 1998). Further investigations will need to be made to clarify the potential and 
possibly unique role of IL-16 as an eosinophil chemoattractant. 
The use of differential display polymerase chain reaction (DDPCR) analysis has enabled 
several groups to identify unique genes expressed in primed eosinophils. Priming of human 
eosinophils with GM-CSF greatly enhances the ability of these cells to be activated by 
subsequent exposure to opsonised particles (Nagata et al., 1995). DDPCR analysis of GM-
CSF stimulated and allergen sensitised human eosinophils identified the upregulation in 
expression of both 5-lipoxygenase, a known eosinophil chemoattractant, and 5-
lipoxygenase activating protein (FLAP) (Kilty et al., 1999). Characterisation of novel genes 
involved in the activation of inflammatory signals from eosinophils will enable the 
development of more specific therapeutic strategies. 
1.3.2 Chemokines and their role in eosinophil chemotaxis 
Since the cloning of IL-8 in 1989 (Matsushima et al., 1989), over 40 unique cytokines have 
been identified as members of the chemokine superfamily. These homologous, small (8-10 
kDa) peptides are subdivided into families based on the relative position of their two 
cysteine residues. Generally, chemokines act on more than one type of leukocyte, and in-
vitro responses include chemotaxis, shape change through cytoskeletal rearrangement, 
enzyme release from intracellular stores, oxygen radical formation, generation of lipid 
mediators and induction of adhesion to endothelium or extracellular matrix proteins 
(Baggiolini eta!., 1997; Rollins eta/., 1997; Luster eta/. , 1998). 
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Table 1: Mediators Involved in Eosinophil Chemotaxis and Chemokinesis 
--- --------------------------------------------------------------
Type Effectiveness Comments 
--------------------- -- ----------------------------------------------------------------------------
Cytokine 
IL-5 Low 
IL-3, GM-CSF Low 
Chemokines 
C-C family 
Eotaxin-1 -2 -3 
' ' 
RANTES 
MIP-1a 
MCP-3 
C-X-C family 
IL-8 
Lipids 
PAF 
High 
High 
Mod 
High 
Low 
High 
L T84 Low Nonselective 
L TE4 Low Nonselective 
Selective, priming agent, mainly chemokinetic 
Nonselective, priming agent, mainly chemokinetic 
Selective, active in-vivo and in-vitro 
Nonselective, active in-vivo and in-vitro 
Nonselective 
Nonselective 
Nonselective, active on primed cells 
Nonselective 
Small Molecular Weight (MW) peptides 
C5a High Nonselective 
fMLP Low Nonselective 
----------------------------------------------------------------------------------------------------------------
Only a few chemokines have been found to be chemotactic towards eosinophils, the C-C 
chemokines RANTES, MCP-3, MIP-1 a and eotaxin-1, -2 and -3 and the C-X-C chemokine 
IL-8. MCP-3 is primarily synthesized by monocytes (Van Damme et al. , 1992), while the 
other eosinophil-recruiting chemokines are produced in the early-phase by tissue cells and 
infiltrating leukocytes at the site of allergen challenge, as well as eosinophils themselves. 
RANTES, MCP-3 and MIP-1 a have been found to induce signals through both the 
chemokine receptors that are expressed on eosinophils, CCR-1 and CCR-3, while eotaxin-1 
and -2 signal exclusively through CCR-3 (Post et al., 1995). 
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Human studies investigating the kinetics of cellular infiltration suggest that MCP-3 is 
involved in the initial phase of eosinophil recruitment (Ying et al. , 1995). An increase in the 
mRNA expression of RANTES and MCP-3 has been shown to correlate with eosinophil 
accumulation at the site of allergen challenge in atopics (Ying et al., 1995), while 
antagonism of RANTES function with neutralising mAbs against RANTES receptors 
significantly decreases eosinophil infiltration (Gonzalo et al., 1998). 
Table 2 
---------------------------------------------------------------------------------------------------------------
Cellular origin of chemokines in allergic asthma - human model 
Cell Type 
Epithelial Cell 
Lung fibroblast 
Smooth muscle cell 
Endothelial cell 
Alveolar macrophage 
Eosinophil 
Lymphocyte 
Chemokine 
IL-8, MCP-1, MCP-3, MCP-4, RANTES, eotaxin 
eotaxin, MCP-1 
RANTES, eotaxin, MDC 
eotaxin 
eotaxin, MDC, MCP-1, IL-8, MIP-1a 
MCP-1, RANTES, eotaxin 
eotaxin 
---------------------------------------------------------------------------------------------------------------
1.3.2.1 The eotaxin family of chemoattractants 
Members of the eotaxin family, eotaxin-1 (Jose et al., 1994), -2 (Forssmann et al., 1997) 
and -3 (Shinkai et al., 1999; Kitaura et al., 1999) are, to date, the most potent eosinophil 
chemoattractants characterised, with their chemotactic activity being highly selective for 
eosinophils (Jose et al, 1994). All three signal exclusively through the CC chemokine 
receptor CCR-3, so it is not surprising that CCR-3 expression has been found to be high on 
both human (Daugherty et al., 1996; Ponath et al., 1996) and murine (Post et al. , 1995) 
eosinophils. In contrast to their similar functional role as specific eosinophil 
chemoattractants, the overall sequence identity of these three members is only 34-38% 
(Bandeira-Melo et al., 2001 ). 
Eotaxin-1 exclusively attracts eosinophils when applied in-vivo (Ponath et al., 1996), and its 
expression is enhanced in animal models of allergic inflammation (Jose et al., 1994; Collins 
et al., 1995), and in local tissue at sites of eosinophil accumulation (Jose et al., 1994). In 
the skin, eosinophils. begin to accumulate 30 minutes after eotaxin-1 exposure, with 
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migration peaking between 3 and 6 hours (Jose et al., 1994). Although eotaxin-1 is 
expressed basally (Matthews et al., 1998), allergen challenge leads to an early increase in 
its production and eosinophil recruitment (Garcia-Zepeda et al., 1996; Humbles et al., 1997; 
Lamkhioued et al., 1997). TH1-type cytokines IFN-y, TNF-a and IL-1 p generated during the 
early phase response may regulate eotaxin-1 production from both epithelial and endothelial 
cells (Cook et al., 1998; Rothenberg et al., 1995), subsequently promoting blood and tissue 
eosinophilia in the late-phase response. 
Although there are many similarities between the expression and activities of the eotaxins, 
their differential roles in eosinophil recruitment are slowly emerging. Both eotaxin-1 and 
eotaxin-2 are co-expressed in human lungs at baseline and are upregulated by 1 hour 
following allergen challenge and peak between 3 hours (mouse; Lilly et al., 1997) and 24 
hours (humans; Brown et al., 1998). Eotaxin-3 expression is upregulated 24 hours after 
allergen challenge (human; Berkman et al., 2001 ). These results suggest that eotaxin-1 
and -2 are involved in the initial recruitment of eosinophils in the early stages of the late-
phase response, while eotaxin-3 promotes prolonged recruitment in the late-phase. 
However, these initial mRNA expression studies will need to be supported by eotaxin-3 
protein assays to confirm functional divergence. Recent work in gastrointestinal (GI) 
allergies has shown that although eotaxin-1 is expressed ubiquitously in the GI tract, 
eotaxin-2 is predominantly expressed in the jejunum (Zimmermann et al., 2000). Studies 
within our laboratory indicate that there is indeed a divergence between the role in eotaxin-1 
and eotaxin-2, as illustrated by changes in the expression and localisation of these 
chemoattractants during the course of allergen exposure in the mouse (unpublished data, 
Ming et al., 2001 ). 
Due to their preferential and strong action on eosinophils, the role of the eotaxins in the 
pathophysiology of allergic conditions such as asthma is an area of intense investigation. In 
particular, the ability of chemokinetic mediators to prime for the chemotactic activity of these 
chemokines, enhancing cell polarity and subsequent migration is of considerable interest. 
However, the interplay between factors that specifically promote chemokinetic (eg: IL-5) and 
chemotactic ( eg: eotaxin) responses of the eosinophil itself, have largely been left 
unexplored. 
1.3.3 Neurogenic chemoattractant activity 
Sensory neuropeptides, such as substance P, calcitonin gene-related peptide (CGRP), 
vasoactive intestinal peptide (VIP) and secretoneurin, produced in the central and peripheral 
nervous systems, are found in primary afferent nerve fibers involved in neurogenic 
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inflammation. Localised in secretory vesicles, these neuropeptides have been identified as 
potent mediators of inflammation, including vasodilation, vascular leakage and smooth 
muscle contraction (Payan et al, 1988). However, the potential neuroregulatory role of 
these mediators in eosinophil migration and accumulation is yet to be fully defined. 
The most characterised neuropeptide involved in allergic inflammation, the tachykinin 
substance P, has been shown to have a higher baseline expression in nasal lavage taken 
from atopic compared to nonatopic individuals, and allergen challenge elevates these levels 
even further in atopics (Nieber et al., 1992). Studies have confirmed the role of substance P 
in eosinophil chemotaxis and chemokinesis (Wiedermann et al., 1993). More recently, this 
neuropeptide was found to produce a synergistic effect on PAF-induced chemotaxis, while 
no change was observed on IL-5-induced chemokinesis. This chemotaxis-specific 
synergism was abolished by an NK-1 receptor antagonist (EI-Shazly, 1996). 
Conflicting data has been reported for the role of CGRP as an eosinophil chemoattractant. 
Studies by Numao on human eosinophils (Numao et al., 1992) found no direct chemotactic 
role, whereas, PAF-induced eosinophil chemotaxis was enhanced by initial priming with 
CGRP. Other research groups have identified a strong chemoattractant potential for both 
human and rat eosinophils by this neuropeptide (Bellibas et al., 1996; Dunzendorfer et al., 
1998), as well as confirming its role in priming for chemotaxis. 
Secretoneurin is a recently discovered neuropeptide that co-localises with substance-P and 
CGRP. Studies by Dunzendorfer (1998) found that secretoneurin produced an eosinophil 
chemoattractant activity comparable to IL-8. Vasoactive intestinal peptide (VIP), known as 
a classical neurotransmitter and vasodilator, appears to have a priming role on eosinophil 
migration, stimulating chemotaxis via activation of the VIP receptor type 1 (Dunzendorfer et 
al., 1998). 
Nerve growth factor (NGF) is a neurotrophic polypeptide essential for the development, 
survival and the maintenance of certain neuronal populations (Thoenen et al., 1995). 
Interest has recently focused on the role NGF plays in asthma, following preliminary studies 
indicating that circulating levels of NGF are increased in inflammatory diseases and allergy 
(Bonini et al., 1996). When applied to mast cells from the rat model, NGF induces 
hypertrophy and in-vitro degranulation resulting in the release of mast cell mediators 
(Marshal et al., 1990), and acts as a potent chemoattractant towards these leukocytes 
(Sawada et al., 2000) and macrophages (Gilad and Gilad, 1995). NGF also induces the 
activation of human eosinophils in-vivo, resulting in the non-cytotoxic release of EPO 
(Solomon et al., 1998). However, its possible role as an eosinophil chemoattractant has yet 
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to be investigated. NGF is also found preformed in both eosinophils and mast cells, 
suggesting an autocrine mechanism for NGF release (Solomon et al., 1998), suggesting a 
role for this mediator in neurogenic regulated inflammation. 
1.3.4 Lipid mediators and low molecular weight proteins 
A number of soluble mediators produced in the early-phase of allergic inflammation by local 
tissues and infiltrating mast cells have been shown to induce eosinophil migration. These 
include lipid mediators, such as PAF and the eicosinoids prostaglandin E (PGE2) and 
leukotriene 84 (L T84), bacterial derived peptides (e.g. f-met-leu-phe, fMLP), activated serum 
components (e.g. C5a), endotoxin and neuroendocrine hormones (Wardlaw et al., 1995). 
High-affinity PAF receptors have also been detected on eosinophils (Agrawal et al., 1992). 
In-vivo, PAF was shown to induce the recruitment of eosinophils to the site of allergen 
challenge in animal models (Sanjar et al., 1990), while the use of PAF antagonists inhibited 
eosinophil infiltration (Coyle et al., 1988). 
Further studies have indicated that PAF may induce permissive changes in epithelial cells 
that favour eosinophil migration, possibly by altering cell-cell adhesion (Liu et al., 1998). 
PAF also appears to have the ability to prime eosinophil chemotactic responses, inducing a 
synergistic increase in eosinophil transmigration toward RANTES, C5a and L TB4 (Liu et al., 
1998), indicating that PAF activates a divergent signalling pathway. Interestingly, studies 
using the commonly administered anti-inflammatory corticosteroid, dexamethasone, found 
no effect on PAF induced eosinophil chemotaxis (Kurihara et al., 1989). 
The arachidonic acid metabolite L TB4 is a potent chemoattractant and chemokinetic agent 
for eosinophils (Sala et al., 1998). L TB4 antagonists attenuate eosinophil accumulation into 
the lungs of sensitized guinea pigs (Richards et al., 1989) and inflammation at the site of 
dermal allergen challenge (Fretland et al., 1995). Recently, the murine receptor for L T84 
was identified and found to be highly expressed on eosinophils (Huang et al., 1998). 
However, the role of L TB4 in allergic inflammatory processes is yet to be fully elucidated. 
During allergic inflammation, complement activation results in the generation of the 
anaphylatoxins, which are highly active pro-inflammatory mediators, the most potent of 
which is C5a. Among its many pro-inflammatory functions, C5a is known to induce 
intracellular calcium flux and act as a chemotaxin for eosinophils (Warringa et al., 1991 ). 
C5a has also been shown to prime for chemotactic responses in-vitro, chemokinetically 
stimulating migration to RANTES and MCP-3 (Kitayama et al., 1997). Recent studies 
indicate that the C5a receptor is expressed homogenously on eosinophils from both atopic 
and non-atopic donors. In the mouse, the C5a gene has bee proposed as a susceptibility 
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locus for AHR (Karp et al., 2000) and C3a has been functionally linked to AHR in the allergic 
lung (Humbles et al., 2000). 
1.3.5 Eosinophil derived chemoattractants 
In addition to their role as effector cells in inflammation, eosinophils have the potential to 
produce and secrete a number of potent chemotactic and chemokinetic mediators. This 
autocrine function gives them a powerful immunomodulatory role, particularly in maintaining 
late-phase responses. Freshly isolated eosinophils have been shown to store several 
chemokinetic cytokines, including IL-5, IL-3 and GM-CSF (Kita et al., 1991 ), that are 
secreted upon the induction of a calcium flux. The production of autocrine chemokinetic 
factors would serve to prime the chemotactic signal for local and circulating eosinophils, 
inducing an amplified eosinophilic response. 
As mentioned previously, the chemokines MIP-1 a (Olszewska-Pazdrak et al., 1998), 
RANTES (Ying et al., 1995; Lim et al., 1996), IL-8 (Braun et al., 1993) and eotaxin 
(Nakajima et al., 1998) are also expressed and secreted by eosinophils. 
lmmunohistochemical studies on eosinophil-derived eotaxin suggest this chemokine is 
granule associated (Nakajima et al., 1998), as may be the case with both RANTES and 
MIP-1 a. The lymphocyte chemoattractant, IL-16, is also produced and secreted by 
eosinophils (Lim et al., 1996). Eosinophil derived chemokines could enhance the 
recruitment of additional eosinophils and THrcells in the late-phase inflammatory response. 
The involvement of neurogernc mediators in the eosinophilic response has initiated 
investigations into their autocrine production by eosinophils. Both substance P and VIP are 
localised within secretory granules of mucosal human eosinophils, and secreted upon cell 
activation (Metwali et al., 1994). Further investigations are required to elucidate the 
endogenous production of other neurogenic peptides or analogs in eosinophils, and their 
role in the autocrine regulation of eosinophilia. 
Eosinophils also have the ability to synthesize and store IL-4 (Moqbel et al., 1995; Bjerke et 
al., 1996). Following IL-5 priming and eotaxin stimulation, release of preformed IL-4 occurs 
rapidly via a vesicular transport mechanism (Bandeira-Melo et al., 2001 ), potentially 
resulting in enhanced IL-4 dependant mucous secretion (Cohn et al., 1999) and further 
eotaxin generation (Mochizuki et al, 1998). Furthermore, trafficking of airway eosinophils, 
as antigen presenting cells (APC's) back to lymph nodes (Shi et al., 2000) and thymus 
(Throsby et al., 2000), results in local IL-4 release and subsequent modulation of CD4+ T 
cells responses (Bandeira-Melo et al., 2001 ). 
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1.3.6 Synergy between priming molecules and chemoattractants 
IL-3, IL-5 and GM-CSF are effective in priming eosinophils in-vitro for enhanced 
chemotactic responses to suboptimal concentrations of lipid (PAF and L TB4) and low-
molecular-weight chemoattractants (C5a and fMLP), that are otherwise weakly active on 
unprimed normal eosinophils (Koenderman et al., 1996). IL-5 also primes eosinophils for 
enhanced responsiveness to the chemokines RANTES, MCP-3 and eotaxin. The 
neuropeptides, such as SP, neurokinin A, calcitonin gene related peptide and 
cholecystokinin octapeptide, have similar modulatory effects on PAF and L TB4 induced 
eosinophil chemotaxis (Numao et al., 1992). The most characterised of these unique 
synergies for the promotion of eosinophilia is the interaction between the IL-5 receptors and 
the chemokines that operate through CCR-3. 
The specific role of IL-5 and eotaxin in the regulation of eosinophil trafficking has initiated 
investigations into the mechanisms of co-operation between these two molecules. In-vivo 
and in-vitro studies have identified eotaxin as a colony stimulating factor for granulocytes 
(Peled et al., 1998), with the ability to mobilise eosinophils and their progenitors from the 
bone marrow in synergy with IL-5 (Palframan et al., 1997). In naive wild-type mice, IL-5 
and eotaxin act co-operatively to recruit eosinophils in tissue (Collins et al., 1995; Mould et 
al., 1997). 
The potentiation of tissue eosinophilia by IL-5 is believed to result from the "priming" of 
eosinophils, enhancing the chemotactic response to eotaxin (Koenderman et al., 1996). 
Previous studies have shown that IL-5 and eotaxin co-operatively regulate adhesion 
pathways utilised by eosinophils (Walsh et al., 1991; Lundahl et al., 1998). IL-5 enhances 
the adhesion of eosinophils to the vascular endothelium by up-regulating the CD11/CD18 
integrin pathway (Walsh et al., 1991). Eotaxin also up-regulates the expression of 
CD11b/CD18 on IL-5 primed human eosinophils, but not on resting or fMLP pre-incubated 
eosinophils (Lundahl et al., 1998). Collectively, these investigations show that although 
eotaxin can act independently of IL-5, both molecules co-operatively interact to regulate 
bone marrow, blood and tissue levels of eosinophils. Due to the specificity of these 
cytokines on eosinophils, investigation into the intracellular signalling pathways operated by 
both molecules may provide a key to future therapeutic targets to inhibit eosinophilic 
inflammation associated with allergic disease. 
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1.4 EXTRA-CELLULAR PROCESSES IN EOSINOPHIL MIGRATION 
1.4.1 Eosinophil trafficking from bone marrow to the airway lumen 
In the absence of allergy, eosinophils comprise 2-3% of the circulating leukocyte population, 
a population which increases dramatically in the allergic state (reviewed in: Rothenberg ME, 
1998). After antigen exposure, the levels of bone marrow derived mediators, namely stem 
cell factor (SCF), and pro-inflammatory cytokines and chemokines produced in the early 
phase, including IL-5, GM-CSF and eotaxin are increased. These mediators in0uce CD34+ 
progenitors to preferentially differentiate to the eosinophil linage (Gaspar Elsas et al. , 1997; 
Ohkawara et al., 1997; Peled et al., 1998). The lgE receptor, CCR-3 and the IL-SR are 
expressed at a relatively early stage in differentiation, and IL-5 itself is implicated as the 
potential regulator of IL-5 receptor expression (Denburg et al., 1998). 
The signals regulating eosinophil-progenitor emigration from the bone marrow to the lung 
are not fully characterised. However, eotaxin has been shown to induce eosinophil 
mobilisation from the bone marrow to the blood (a mixture of both fully mature cells and 
eosinophil committed progenitors) (Palframan et al., 1998). These IL-5-responsive cells 
then migrate to the lung, where they are thought to fully differentiate into mature effector 
cells in response to cytokines elaborated from the site of inflammation (Denburg et al., 
1997; Denburg et al., 1999). 
The sequence of events that allows eosinophils and eosinophil progenitors to traffic to the 
airways follows a defined process known as the multistep paradigm of leukocyte recruitment 
(Springer et al., 1994). This process involves the margination and capturing of free-flowing 
leukocytes, rolling, activation, firm adhesion, spreading, transendothelial diapedesis and 
chemotactic migration of cells to the site of inflammation (see Figure 1.1 ). The prerequisite 
for all these steps is the activation of the endothelial cell monolayer by cell- and tissue-
derived signals that induce the expression of cell-surface adhesion molecules and trigger 
the secretion of inflammatory mediators by these cells (Walzog et al. , 2000 In the 
circulation, eosinophils travel axially, as with all leukocytes, and the signals inducing radial 
displacement, allowing proximity to the blood vessel endothelium, are as yet unknown 
(Springer et al., 1994). However, cell-cell contact is mediated by adhesion molecules on the 
endothelium and selectins on the eosinophil cell surface (Ebisawa et al., 1992). Once 
captured, the eosinophil rolls along the vessel wall , supported by transient contacts between 
endothelium and cell. This process slows the eosinophil and fully exposes the cell to 
inflammatory mediators, inducing firm adherence and spreading of the cell via adhesion 
molecule/integrin interactions. Transendothelial migration is initiated through the 
intercellular junctions of endothelial cells, once again inducing cell-cell contact via adhesion 
molecules of the epithelial layer and integrins on the eosinophil cell surface (Kobayashi et 
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Figure 1.1. Eosinophil trafficking from the vascular to airways lumen. 
Although the process of eosinophil margination is not fully characterised, cell contact and 
selectin-mediated rolling along the vascular endothelium is regulated by THr (IL-4 and IL-
5) and mast cell activated endothelial cells [IL-3, IL-5 and granulocyte-macrophage 
colony-stimulating factor (GM-CSF)]. The induction of VCAM-1 activation by IL-4 and IL-5 
promotes eosinophil adherence to the vascular endothelium (Bochner et al., 1991 ). The 
release of eosinophil-directed chemokines (eotaxin, MCP-1 a, -3, -4, RANTES and MIP-
1 a) by activated vascular endothelial cells induces eosinophil diapedesis through the 
vascular endothelium into the peribronchiole space. Continuing exposure to pro-
inflammatory cytokines [IL-3, IL-5 and granulocyte-macrophage colony-stimulating factor 
(GM-CSF)] and the establishment of chemokine gradients (eotaxin family members) by 
both the airways endothelium and epithelium, maintains eosinophil trafficking through to 
the airways lumen and eventual degranulation of the cell. The extracellular matrix (ECM) 
plays an integral role in the anchoring of pro-inflammatory cytokines and chemokines, and 
the establishment of chemical gradients. In addition, ECM-proteins provide an essential 
site for eosinophil adherence at all stages of the recruitment process. These extracellular 
interactions are central to the "combinatorial mechanism" of leukocyte migration, 
instigating the accumulation of chemoattractant receptors and downstream intracellular 
signalling molecules, and associated cytoskeletal changes within the migrating cell. 
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al., 2000). Once fully diapedised, the eosinophil migrates chemotactically, in response to a 
local chemotactic gradient, a process which involves adhesion molecules of the airways 
lumen and the eosinophil itself, cell-surface integrins and the extracellular matrix (Morland et 
al., 1992). 
1.4.2 The role of the extracellular matrix in eosinophil adhesion and 
migration 
ECM interactions with cell surface receptors play a central role in the recruitment of 
eosinophils to the site of allergic inflammation. The ECM provides a structural framework 
for tissues and cells throughout the body, a matrix composed of glycosaminoglycans and 
covalently linked proteoglycans, and embedded glycoproteins, including collagen and 
elastin (structural), and fibronectin, fibrinogen, vitronectin and laminin (adhesive) (Jacob et 
al., 2001 ). The ECM proteins not only activate intracellular pathways via integrin activation 
on the cell surface, but also control the activity and presentation of chemoattractants 
produced in both the early and late phase of the asthmatic response (Everitt et al., 1996). 
IL-5 is directly bound by heparan sulphate proteoglycans present in the ECM (Lipscombe et 
al., 1998). Although eotaxin binding has yet to be investigated, many related CC 
chemokines have been found to bind to heparan sulphate, providing a pool and possibly a 
gradient of chemoattractant molecules at the site of eosinophil extravasation from the 
vascular endothelium through to the pulmonary epithelium (Figure 1.1 ). 
The role of eosinophil binding to the ECM proteins has been partially investigated ex-vivo. 
Human eosinophils from normal donors adhere poorly to substrates coated with laminin 
(LM), fibronectin (FN), cytotactin (CT), human serum albumin (HAS) or collagen types I or 
IV (Tourkin et al., 1993). By contrast, when eosinophils are activated in-vivo or in-vitro with 
IL-5 they adhere firmly to LM, FN and Col IV (Tourkin et al., 1993). 
Fibronectin (FN) is produced by several types of airways cells, including epithelial cells 
[Shoji et al., 1989 (1 )], fibroblasts [Shoji et al., 1994 (2)] and alveolar macrophages (Delvin 
et al., 1994). Moreover antigen challenge in atopic subjects upregulates local production of 
this protein (Meerschaert et al., 1999). This ECM is encoded by a single gene, but 
alternative splicing of the primary RNA transcript gives rise to polypeptide diversity, 
producing regions of varying affinity and specificity to different ligands (Walsh and Wardlaw, 
1997). Unactivated eosinophils cultured on FN-coated plates adhere via VLA-4 (04~1) 
(Anwar et al., 1993), ~2-integrin Mac-1 and a4~7 (Erle et al., 1994) and survive longer than 
cells cultured on uncoated plates. FN also provides a binding site to various 
proinflammatory cytokines, as illustrated by TNF-cx/ECM interaction, a process which has 
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been shown to induce strong adhesion and provide a stop signal for macrophage 
chemotaxis (Franitza et al., 2000). The role for ECM proteins in the aggregation of 
mediators for eosinophil chemotaxis is yet to be fully investigated, but the combinatorial 
signals produced by bound inflammatory cytokines may provide an additional platform for 
the priming of further eosinophil adhesion, migration and the autocrine production of 
inflammatory mediators. 
The in-vivo movement of cells is also dependent on the ability to degrade and invade the 
ECM, requiring cell-ECM contact and the release of soluble enzymes, including gelatinase 
and the family of matrix metalloproteinases (MMP's) (Madri et al., 1996). MMP's have been 
reported to play crucial roles in the migration of inflammatory cells through the basement 
membrane. Blockade of the ECM/eosinophil interaction has identified the role of several 
MMP's in the transmigration of this cell (Okada et al., 1997; Hayashi et al., 1999; Kumagai 
et al., 1999). Tissue inhibitors of MMP-2 in a murine model of asthma were found to block 
eosinophil infiltration into the airways lumen, increase levels of circulating eosinophils in the 
peripheral blood and reduce antigen-induced AHR (Kumagai et al., 1999). 
MMP-9 is also highly expressed in inflammed airways tissue, with protein expression 
confirmed in the perinuclear spaces of eosinophils, but not in the granules (Ohno et al., 
1997). Upon TNF-a stimulation, human eosinophils upregulate production and secretion of 
MMP-9 by 95%, an increase regulated at both the transriptional and translational level 
(Schwingshackl et al., 1999). Like all MMP's, MMP-9 is secreted as an inactive zymogen 
(proMMP-9) and activated extracellularly by limited proteolytic cleavage (Schwartz et al., 
1998). Release of MMP-9 is increased by IL-5, PAF, or both, but substrate-degrading 
activity is increased only in the presence of both IL-5 and PAF (Okada et al., 1997). The 
activating signals for basement membrane migration of eosinophils are complex, and rely 
on the crosstalk of several signalling pathways to induce secretion and activation of ECM 
degrading MMP's. 
1.4.3 Selectins involved in eosinophil migration 
The three members of the selectin family (L-, E-, and P-selectin) are transmembrane 
glycoproteins, mediating the initial tethering and rolling of leukocytes along the endothelium 
of the vessel wall (Ley et al., 1995). Selectins bind weakly to sialylated carbohydrates or 
with high affinity to specific ligands/counter receptors: the mucosa! addressin cell adhesion 
molecule-1 (MadCAM-1; Berg et al., 1993), CD34+ (Baumheter et al., 1993) and 
glycosylation-dependent cell adhesion molecule-1 (GlyCAM-1; Lasky et al., 1992) are 
ligands for L- selectin; P-selectin glycoprotein ligand-1 (PSGL-1) is a ligand for P-selectin 
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(Moore et al., 1992); and E-selectin binds strongly to E-selectin ligand-1 (ESL-1; Levinovitz 
et al., 1993). 
Under flow conditions on human umbilical vein endothelial cells (HUVEC), mAbs to P-
selectin but not E-selectin strongly inhibited primary tethering, while L-selectin mainly 
mediated inter-eosinophil interactions (Kitayama et al., 1997). Blockade of the P-selectin 
glycoprotein ligand-1 (PSGL-1) was found to inhibit eosinophil recruitment by 80% in BALF 
(Borchers et al., 2001 ). A comparison between human neutrophil and eosinophil 
recruitment under flow conditions found that eosinophils maintained fewer tethers to P- and 
E- selectin and secondary interactions, indicating a lower expression of L-selectin (Patel et 
al., 1997). The initial tethering of flowing leukocytes to the vascular endothelium is 
essential for successful recruitment (figure 1.1) and further characterisation of the selectins 
involved in eosinophil tethering may provide insight to successful therapeutic strategies. 
1.4.4 Eosinophil integrin and adhesion molecule interactions 
lntegrins are a large family of heterodimeric transmembrane receptors that can recognise, 
as ligands, components of the ECM and cell-surface counter-receptors of the 
immunoglobulin and cadherin families (Hynes et al., 1989). They are composed of a and~ 
heterodimeric transmembrane subunits generated from at least 16a and 8~ subunits to 
produce over 20 different receptors, with both chains being required for receptor expression 
and ligand binding (Bochner BS, 1997). Interactions between leukocytes and endothelial 
cells during allergic responses are regulated by vascular- and intercellular- cell adhesion 
molecules (VCAMs and ICAMs, respectively) (Bochner et al., 1991) and the integrins, 
lymphocyte function-associated antigen-1 (LFA-1: the ~rintegrin, CD11a/CD18 adhesion 
complex; Martz E and Gromkowski SH, 1985), Mac-1 (the ~2 integrin, CD11b/CD18 
adhesion complex; Springer T and Anderson DC, 1986) and very-late activation antigen-4 
(VLA-4: the ~1-integrin, C4~1; Hakkert et al, 1991 ). 
Endothelial cells are induced to express VCAM-1, ICAM-1 and E-selectin upon IL-1, TNF-a 
and IFN-y activation (Jagels et al., 1999). Although mAbs to both ICAM-1 and E-selectin 
have been shown to reduce eosinophil adhesion by 20-30% (Bochner et al., 1991 ), anti-
VLA-4 inhibits eosinophil but not neutrophil adherence, suggesting that VCAM-1 expression 
specifically promotes eosinophil recruitment (Seminario et al., 1997). Interestingly, in-vitro 
analysis of transendothelial migration of human eosinophils through human pulmonary 
microvascular endothelial cells (HPMEC) indicates an upregulation in CD69 and ICAM-1 
expression and enhanced survival of migrated eosinophils (Yamamoto et al., 2000). As 
previously mentioned, VLA-4 and Mac-1 are integral to eosinophil binding to the ECM, with 
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a possible role for a4P7 in activated cells. Under flow conditions, a4 integrins were found to 
mediate initial attachment, while E-selectin mediated the subsequent rolling of human 
eosinophils on TNF-a activated HUVEC (Ulfman et al., 1999). Until recently, only ICAM-1 
expression had been identified on respiratory epithelium (Wegner et al., 1990), but recent 
in-vitro studies on human biopsies suggest that cytokine activation (TNF-a and IL-4) can 
induce the expression of VCAM-1 (Atsuta et al., 1997), allowing functional interaction with 
eosinophils via VLA-4. In ICAM-1 deficient mice, pulmonary eosinophilia is almost ablated 
compared to wild-type mice (Broide et al., 1998), further confirming the importance of this 
adhesion molecule in eosinophil transmigration. 
Recent studies have investigated the role of changes in integrin/adhesion molecule 
expression during eosinophil development. Selective upregulation of a functional P7 
integrin was found on differentiating eosinophil progenitors, following the expression of p1 
and P4 on the cell surface (Lundahl et al., 2000). This sequential appearance of specific 
adhesion molecules may play an important role in the selective recruitment of mature 
leukocytes to the inflammatory site. 
1.4.5 Changes in endothelial/epithelial cell-cell contact and eosinophil 
migration 
An integral process in eosinophil migration is the ability of local vascular endothelial and 
airway epithelial cells to de-adhere and modify cell-cell contacts (Leff et al., 1991 ). This 
process is mediated by adhesion molecules such as cadherens and their associated 
cytoplasmic proteins, a-catenin and P-catenin, linking directly to the actin cytoskeleton within 
the junctional complex (Kaibuchi et al., 1999). In asthma, histological examinations have 
demonstrated that severe damage of the bronchial epithelium is closely correlated with the 
extent of eosinophilia (Ohashi et al., 1992). E-cadherin is found basolaterally on airway 
epithelia, with expression decreasing upon antigen challenge (Kobayashi et al., 2000), 
facilitating opening of the adherent junctions and an increase in the severity of late-phase 
responses (Goto et al., 2000). In a guinea pig model of allergic rhinitis, eosinophils and the 
extracellular deposition of eosinophil granule proteins was observed at the sites negative for 
E-cadherin immunoreactivity (Kobayashi et al., 1998). In-vitro treatment of human bronchial 
epithelial cells with IL-4, IL-5 and IL-13 had no effect on cell-cell contact (Relova et al. , 
2001 ), while previous studies had shown the TH1 response involving TNF-a, IFN-y and IL-
1 p damaged normal cells (Kampf et al., 1999). These results collectively suggest that the 
degradation of epithelial cell-cell contact is instigated by TH1-type cytokines and eosinophil 
derived mediators, allowing further leukocyte extravasation and the triggering of epithelial 
destruction. 
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The vascular endothelium, on the other hand, maintains its integrity throughout the 
extravasation process, suggesting that the extracellular signals induced by eosinophil 
migration are not mediated by granule proteins (Del Mashio et al., 1996). Eosinophil 
adhesion to TNF-a activated endothelial cells, precluded the disappearance of adherens 
junction components: vascular endothelial (VE)-cadherin, a-catenin and ~-catenin (Moser et 
al., 1992). Possibly eosinophil adhesion triggers intracellular signals in the endothelial cell 
that regulate VE-cadherin complex organisation. 
1.5 RECEPTOR DYNAMICS IN LEUKOCYTE MIGRATION 
1.5.1 General overview of chemoattractant receptor crosstalk 
As previously mentioned, eosinophil migration in the late-phase results from the complex 
and co-operative signalling events induced by chemoattractants produced, in part, during 
the early-phase of the inflammatory response. The interaction of priming signals (inducing 
an increase in oxidative metabolism, upregulation in chemoattractant receptor expression 
and general increase in the kinetic state of the eosinophil), and chemotactic signals 
(associated with receptor aggregation, intracellular calcium flux and change in cell shape) 
provide the pro-migratory stimuli and directional signal for eosinophil movement (Warringa 
et al., 1992). The ability of leukocytes to prioritise and combine receptor-mediated signals, 
stems from the divergent intracellular signalling cascades that are induced by different 
receptors, enabling the cells to respond effectively and specifically to extracellular stimuli 
(Foxman et al., 1997). 
Crosstalk between receptors and/or between their downstream signalling pathways could 
help prioritise their responses by determining the outcome of sequential or competing 
chemoattractant exposure (Zucker and Ranganathan, 1999). Studies by Campbell et al. 
(1997) have shown that, for a given receptor, the signals required for rapid adhesion to 
vascular integrin ligands are different from those required for chemotaxis. Specifically, this 
functional divergence illustrates that two events dependant on G-protein coupled receptor 
(GPCR) signalling can be coordinated during leukocyte homing (Campbell et al. , 1997). 
Campbell et al. (1997) also found that neutrophils triggered to adhere to endothelium by IL-8 
could subsequently diapedese through the vascular wall in response to an fMLP gradient, 
however, the converse was not true. In the presence of fMLP, neutrophils were unable to 
chemotax towards IL-8. This model would predict that any chemoattractant emanating from 
a target of phagocytosis would override signals generated from the surrounding host 
tissues. Further support for this hypothesis is derived from studies of . heterologous 
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desensitisation of Ca2+ flux, in which signals from fMLPR and C5aR desensitise the receptor 
for host derived attractants (Tomhave et al., 1994). 
The fine-tuning of the cellular response at the site of allergic inflammation is complex, as 
further highlighted by recent studies illustrating the potential antagonism by eotaxin of 
monocyte expressed CCR-2, via the displacement of it's selective ligand, MCP-1 (Ogilvie et 
al., 2001 ). The prioritisation of extracellular signals is crucial in the selection of specific 
leukocyte subsets, and this interplay will determine the dominant regulatory molecule at any 
stage of the inflammatory cascade. 
1.5.2 Receptor localisation - polarisation to the leading edge? 
In-vitro chemotaxis experiments rely heavily on the ability of leukocytes to migrate towards 
an increasing chemotactic gradient, and removal of the concentration gradient results in the 
loss of a chemotactic response. One such study found that i.v administration of high doses 
of IL-8, which counteracts the formation of a gradient, inhibits neutrophil adhesion and 
transmigration through the endothelial barrier and also promotes leukocytosis (Kitayama et 
al., 1997). In addition, a uniform concentration of one chemoattractant can augment the 
migration to the gradient of another (Foxman et al., 1997). Although this could be explained 
by an increase in affinity of adhesion molecules and hence adhesion of leukocytes to 
endothelium, an increase in chemoattractant receptor expression and/or aggregation may 
also be involved (Campbell et al., 1997). The "combinatorial mechanism" whereby multiple 
chemoattractants can participate in the migration of eosinophils to their destination, 
suggests that rather than being redundant, each of the many chemoattractant receptors 
expressed on these cells may contribute to the versatility and efficiency of eosinophil 
targeting. 
Previous studies have indicated that chemokine receptors may polarise to the leading edge 
of migrating leukocytes (Nieto et al., 1997) (figure 1.2). The aggregation of chemokine 
receptors to the leading edge of the cell suggests the importance of this cellular domain in 
signal transduction during migration. Thus, the ability of the eosinophil to polarise in 
response to priming signals may also underlie the importance of chemotactic gradients in 
the migration of this leukocyte (figure 2.1 ). A recent study of chemoattractant dynamics in a 
neutrophil cell-line found no evidence of receptor polarisation, however, there was an 
asymmetrical distribution of cytoskeletal components and downstream signalling mediators 
to the leading edge of migrating cells (Servant et al., 1999). Actin was found to be 
preferentially polymerised at the leading edge (Weiner et al., 1999). The filipodia and 
lamellipodia that constitute a highly folded plasma membrane in the migrating cell may 
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indeed be essential in the process of receptor aggregation and in inducing the recruitment 
and accumulation of intracellular signalling molecules (Servant et al., 2000). 
A similar model could be applied to eosinophils, and in particular the synergistic relationship 
of IL-5 and eotaxin, where prioritisation and integration of chemotactic signals allow the cells 
to migrate effectively to the site of antigen challenge. IL-5 may potentiate eotaxin generated 
signals by inducing changes in the avidity/affinity of integrin/adhesion molecule or 
integrin/ECM interactions, an increase in CCR-3 receptor aggregation, and /or by reducing 
the rate of CCR-3 internalisation. 
1.5.3 Role of membrane microdomains in cell polarisation 
The acquisition of cell polarity appears to rely on the correct localisation of signalling 
molecules involved in cell migration dynamics. One model proposes that highly organised 
lipid raft domains play a crucial role in the aggregation of second messengers and the 
instigation of cell asymmetry (Kurzchalia T and Parton RG, 1999) (figure 1.2). These 
microdomains can be grouped into non-invaginated glycosylphosphatidyl (GPl)-rich rafts 
(Lisanti et al., 1989), clathrin coated pits (Anderson et al., 1978) or caveolae (Gabella G, 
1971 ), each specialised in the aggregation and internalisation of different types of molecules 
(Brown and London, 1998). Peripheral membrane bound caveolae, most directly linked 
with G-protein signalling events (Chun et al., 1994; Roettger et al., 1995; Feron et al., 1997), 
are characterised by small invaginations on the surface of many cells and consist primarily 
of caveolin and GPl-linked proteins (Rothberg et al., 1992). Caveolins form a scaffold onto 
which signalling molecules can aggregate and assemble to form signalling complexes 
(Okamoto et al., 1998). Undoubtedly, these membrane microdomains have the potential to 
instigate and maintain both the spatial and functional asymmetry required for cell 
polarisation. 
Recently, caveolae and their associated caveolins have also been linked to the endocytosis 
of viral mediators via caveosomes directly to the golgi complex (Nichols et al., 2001) and 
endoplasmic reticulum (Pelkmans et al., 2001 ), bypassing other endocytotic compartments 
of the cell (Pfeffer et al., 2001 ). The question that remains to be answered is whether this 
pathway can also be utilised by other GPl-linked proteins for internalisation and re-sorting at 
the golgi complex. 
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Figure 1.2. Diagrammatic model of cell polarisation in response to a 
chemotactic gradient. 
The ability of cells to navigate through complex chemoattractant arrays relies on the 
constant remodelling and extension of the plasma membrane in the direction of the 
predominant chemotactic gradient. Structurally, this remodelling requires the relentless 
assembly of actin subunits into polymerised filaments at the leading edge (cortical actin) , 
the disassembly of which drives propulsion of the cell in the direction of the sensory cue 
(Ridley and Hall A, 1992). Cortical actin at the leading edge is associated with focal 
adhesions, the site of integrin/adhesion molecule and integrin/extracellular matrix protein 
interaction. F-actin also co-localises with membrane microdomains, sites at which 
chemokine receptors and downstream second messengers are believed to asymmetrically 
aggregate (Kurzchalia and Parton, 1999). The microtubular network is highly dynamic in 
the chemoattractant stimulated cell, and directional movement requires the direct targeting 
of microtubules to cortical actin sites (Kaverina et al., 1998). In addition, microtubules 
play a central role in the internalisation and recycling of receptors and signalling 
molecules desensitised by chemokine activation. Briefly, internalisation from membrane 
microdomains occurs via distinct endosomal compartments , a process requiring an intact 
microtubular network (del Pozo et al., 1998). Endosomal contents are targeted for 
lysosomal degradation or recycling within the endosomal compartments themselves 
(Pfeffer et al. , 2001 ), or the golgi apparatus (Nichols et al. , 2001 ), which lies directly 
anterior to the microtubule organising centre (MTOC) in the polarised cell. 
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1.6 INTRA-CELLULAR DYNAMICS IN CELL MIGRATION 
1.6.1 Overview of cytoskeletal dynamics in cell polarity and motility 
The cytoskeleton is a filamentous network of microtubules (tubulin), microfilaments (actin) 
and intermediate filaments, providing both the mechanical strength for cellular processes 
such as migration and cytokinesis, as well as forming a dynamic and continuous connection 
between cellular structures (Janmey PA, 1997). Integrity of a cell's "internal skeleton" is 
essential in the trafficking of cell-surface receptors and intracellular signalling molecules, 
providing the framework within which cell polarity and motility can take place ( del Pozo et 
al., 1998). 
Directional movement underlies the process of cell polarisation, characterised by the 
formation of distinct plasma membrane domains termed pseudopodia, the most dominant of 
which determines the path of migration (Zhelev et al., 1996). This dynamic process relies 
on the polarised targeting of signalling molecules, the regulation of the actin and 
microtubular cytoskeleton, the formation of cell substrate adhesions and the localised 
degradation of the ECM (Nabi et al., 1997) (Figure 1.2). 
1.6.1.1 Actin cytoskeleton 
Briefly, monomeric actin (G-actin) polymerises spontaneously by a nucleation-elongation 
mechanism, however the association of actin-binding proteins, including paxillin, talin, tensin 
vinculin and a-actinin in response to transmembrane signalling upregulates the assembly of 
actin filaments (F-actin) and the organisation of these filaments into an . actin network 
(Schimdt et al., 2000). Once assembled, these filamentous bundles are tethered to the 
plasma membrane, playing an essential role in cell mobility (Senda et al., 1975). In non-
migratory cells, polymerised actin is organised into expansive stress fiber formations, 
however in migratory cells, such as leukocytes, actin localisation appears to be more 
dynamic and centred on focal adhesion complexes (Tourkin et al., 1996). 
Of particular interest in the regulation of migratory signals is the observation that 
asymmetrical establishment and/or maintenance of sites of actin polymerisation correlates 
with directional migration in response to chemotactic gradients. Weiner et al. (1999) found 
that the Arp 2/3 complex, involved in the nucleation of actin, dynamically redistributes to the 
site of maximal chemotactic stimulation, the leading edge (Weiner et al., 1999). Actin 
binding proteins also localise to the leading edge (Matsudaira et al., 1994), illustrated by the 
rapid recruitment of talin to the site of chemoattractant receptor activation in the 
Dictyostelium bacterium (Kreitmeier et al., 1995). In addition, the function of actin 
polymerisation and actin cap formation in chemotaxis is speculated to concentrate receptors 
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and/or signalling molecules spatially in order to reduce the threshold required for full 
activation, or to prolong existing signals (Xiao et al., 1997). 
1.6.1.2 Microtubular cytoskeleton 
The microtubular network plays an important role in a variety of cellular functions including 
organisation of the Golgi apparatus, vesicular transport, and chromosomal separation 
during mitosis (Schliwa M, 1982). Microtubules are derived from globular tubulin proteins, 
a- and ~-tubulin, polymerised into a stiff cylindrical filament. These filaments have polarity, 
with the minus end embedded in the microtubule organising centre (MTOC) and the plus 
ends radiating outward to the cytoplasm, allowing molecular motors such as kinesin and 
dynein to travel directionally along the microtubules (reviewed in Waterman-Storer CM, 
1998). 
In collaboration, microtubules and associated motor proteins are important in vesicular 
transport, in particular the endocytotic internalisation and recycling of receptors and 
signalling molecules (Gruenberg et al., 1989). Many G-protein coupled receptors (GPCR) 
undergo agonist-induced endocytosis by clathrin coated pits, a process which is regulated 
by both the actin and microtubular cytoskeleton and associated motor proteins (Maples et 
al., 1997). The recycling of many receptors and signalling molecules is also mediated by 
clathrin, sorting endosomes and the MTOC, with the microtubular system implicated in the 
re-delivery of these molecules to the leading edge (Hopkins et al., 1997). The microtubular 
cytoskeleton is also essential for the polarisation of the motile cell, indicated by the loss of 
fibroblast polarity in response to microtubule depolymerising agents (Vasiliev et al., 1985), 
rather than the in the formation of pseudopodia (Nabi et al., 1999). In addition, the 
disruption of kinesin motor functions with mAbs also results in the loss of cell polarisation 
and a reduction in pseudopodia! extension (Rodionov et al., 1993). 
Recent studies have embarked on characterising the interplay between microtubule and 
actin cytoskeletal systems. ~he actin binding protein paxillin, focal adhesion kinase (FAK) 
and Pyk2, in addition to their established roles at focal adhesions, have been found to 
localise and bind to the lymphocyte MTOC (Herreras et al., 2000). Members of the Rho-
GTPase family, integral proteins involved in actin signalling, also associate with the 
microtubular cytoskeleton. Rac1 binds directly to tubulin (Best et al., 1996) while 
p190RhoGEF, a specific activator of RhoA, interacts directly with microtubules (van Horck 
et al., 2000). Rac/Cdc42 and p65PAK also regulate the microtubule-destabilising protein 
stathmin, providing a further link between F-actin and microtubular dynamics (Daub et al., 
2001 ). A model proposed by Waterman-Storer (1999) suggests that actin dynamics creates 
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a polarisation of microtubule assembly, resulting in growth at the leading edge and 
shortening at the cell body and uropod. These changes may activate Rho and Rac1 
signalling to the actin cytoskeleton, completing the positive feedback to actin dynamics 
(Waterman-Storer et al., 1999). The co-operation between actin and microtubule systems is 
yet to be fully elucidated, but appears vital to the induction and maintenance of migration in 
response to chemoattractants. 
1.7 INTRACELLULAR SIGNALING IN CELL POLARITY AND MOTILITY 
The crosstalk between signal transduction molecules induced by chemoattractant receptors 
serves to generate distinct and/or amplified cellular responses. The ability of eosinophils to 
generate unique cellular responses lies in the activation of varied receptors controlling 
divergent signalling pathways, while the prioritisation of these responses is established by 
the cross-talk and amplification of down-stream second messengers (figure 1.3). Thus, 
understanding the dynamics of cytoskeletal rearrangement, the .characterisation of cytokine, 
chemokine and integrin receptors, and the signal transduction pathways activated by these 
receptors, is essential in defining the molecular mechanism of eosinophil movement and 
resulting atopic pathogenesis. Although much is known concerning cytoskeletal dynamics 
that drive cell migration, the intracellular signal tranduction pathways that coordinate these 
processes in the context of cell movement are largely undefined (Bowman et al., 1998). 
1.7.1 
1.7.1.1 
Intracellular second messengers in chemokine signalling 
Early Signalling Events 
Following ligand/receptor binding, chemotactic responses generated through G-protein 
coupled receptors appear to be regulated by members of regulator of G-protein signalling 
(RGS) family members (Watson et al., 1996). The ability of RGSs to modulate 
chemotaxis is dependent on their GTPase-activating protein (GAP) activity since RGS 
mutants, previously shown to have impaired Gia binding and GAP activity, are much less 
effective at regulating chemotaxis than wild-type RGS's (Bowman et al., 1998). RGS1, 3 
and 4 appear to modulate the ability of leukocytes to migrate in a chemotactic gradient, 
presumably by decreasing the half-life of the activated G-protein, and regulating the 
duration of G~y activity (Bowman et al., 1998). In addition, the expression of RGS 
proteins has been shown to correlate with a prominent inhibition of cell migration 
(Bowman et al., 1998; Reif et al., 2000). 
Stimulation of chemotaxis by a chemokine requires the functional coupling of the receptor 
to Gia because migration is completely inhibited by treatment of the cells with pertussis 
toxin. Although the importance of the Gia-subunit in chemotactic signals is yet to be fully 
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Figure 1.3. Schematic model of structural and functional signalling 
crosstalk involved in the polarisation and migration of the chemotactically 
stimulated cell. 
The generation of cell polarity and subsequent motility relies on the dynamic crosstalk of 
both structural and functional signalling pathways within the chemotactically stimulated 
cell. The interplay of functional signals induced within focal adhesion complexes, 
membrane microdomains, cell-cell contacts and the extracellular matrix, are closely 
regulated by actin and microtubular cytoskeletal structural signals in the generation of the 
chemotactic response. In addition, the ability of cells to produce unique cellular 
responses, such as adherence, polarity and motility, lies in the activation of varied 
receptors controlling divergent pathways. The prioritisation of these responses 1s 
established by the crosstalk of these intracellular pathways and amplification of 
downstream second messengers. 
Abbreviations used: FAK - focal adhesion kinase; WASP - Wiskott-Aldrich Syndrome 
Protein. 
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elucidated, recent studies have identified the direct binding and activation of Src kinase 
family members, Src and Hck (Ma et al., 2000). It is possible that Gia also activates other 
members of the Src-family expressed in leukocytes, including Fgr, Lek, or Lyn (Stenberg et 
al., 1997). The release of the ~y-subunit from Gia and the GPCR appears to be essential 
for cell migration. Sequestration of the ~y subunit by Gia was found to abolish chemotaxis 
(Neptune et al., 1999) and only ~y subunits released from Gi-coupled receptors, not Gs- or 
Gq- coupled receptors, can mediate chemotaxis (Neptune et al., 1999). Further evidence 
comes from studies with ~-subunit deficient 0. discoideum expressing a GFP-tagged ~-
subunit, which distributes asymmetrically to the leading edge upon chemotactic stimulation 
(Jin et al., 2000). The importance of G~y-mediated signalling in the chemotactic response is 
currently under further investigation and may prove to play a crucial role in the regulation of 
G-protein activation and eosinophil chemotaxis (Figure 1.4). 
G-proteins participate in complex signalling networks, acting at the coupling interface of 
diverging and converging transduction steps. One such network, the mitogen activated 
protein kinase (MAPK) cascade, is known to be activated by both G-protein coupled and 
tyrosine kinase receptors (van Biesen et al., 1995), as illustrated by downstream signalling 
cascades characterised for the IL-8 receptor. The binding of IL-8 to its receptor promotes 
coupling with the Giartype G-protein that subsequently activates a signalling cascade 
leading to the activation of phospholipase C (PLC), protein kinase C (PKC), Rho and Rae 
GTPases, members of the MAPK-family, Src related tyrosine kinases, phosphatidylinositol 
3-kinase (Pl3K) and protein kinase B (PKB) (Baggiolini M, 1997; and Bokoch GM, 1997). In 
particular, the p38MAPK appears to play an important role in cell migration (Nick et al., 
1997). Inhibition of p38 was found to directly block IL-8 mRNA and protein expression 
(Hippenstiel et al, 2000), and chemotaxis of neutrophils (Heuertz et al., 1999) and 
monocytes (Ayala et al., 2000) in in-vitro assays. 
Recently, the role of ~-arrestin in the formation of a G-protein coupled receptor (GPCR)-Src 
protein kinase complex was elucidated. ~-arrestin/GPCR binding was found to terminate 
GPCR/G-protein binding, initiating a second wave of signal transduction via the MAPK 
pathway (Luttrell et al., 1999). Pl3K isoforms also appear to play a role in the relegation of 
G-protein mediated signals to downstream kinase cascades. In particular, the p110y/p101 
isoform becomes activated by direct interaction with the G-protein ~y-subunit, Src-related 
tyrosine kinases or by other phosphotyrosines which are activated by the G-protein a-
subunit after binding to the src homology-2 (SH2) domain of Pl3K (Corey et al. , 1993). 
Leukocytes lacking p11 0y are unable to produce PIP3, resulting in defective neutrophil 
migration (Sasaki et al., 2000). 
30 
Figure 1.4. Model of intracellular signalling events involved in cell migration. 
Chemokine/receptor ligation induces the binding and activation of members of the G-protein 
family. Both the Gia and G~y subunits are believed to play a role in the generation of second 
messengers, including Pl3K, FAK, PLC-~ and the src kinases. Downstream mediators 
activated by FAK and Pl3K include the Rho GTPases (Rho, Rae and Cdc42) , PKB, p70S6K, 
while PLC-~ upregulates Ca2+ flux, IP3 and PKC. Activation of the src kinases induces 
Grb2/Sos association with She and induction of the Ras/MAPK signalling pathway, including 
p38, MAPK, JNK and Raf-1. Cytokine/receptor ligation results in the activation of Lyn, Pl3K, and 
the Shc/Grb2/Sos complex, Rho GTPases, the Ras/MAPK pathway and the JAK/STAT 
pathway. The Pl3K, PLC-~ and Rho pathways are involved in the generation of functional and 
structural signals mediating chemotaxis (chemokine) and chemokinesis (cytokine) , adhesion 
molecule upregulation and chemokine/cytokine gene transcription while the MAPK and 
JAK/STAT pathways focus of the generation of nuclear signals. 
Abbreviations used: Pl3K - phosphatidylinositol 3-kinase; PKB - protein kinase B; PKC - protein 
kinase C; PLC-~ - phospholipase-~; Sos - son of sevenless; FAK - focal adhesion kinase; DAG -
diacylglycerol; NFAT - nuclear factor of activated T-cells ; NFKB - nuclear factor kappa B; MAPK -
mitogen activated protein kinase; JNK - c-Jun NH (2)-terminal kinase; JAK - janus tyrosine kinase; 
STAT - signal transducers and activators of transcription. 
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1. 7.1.2 Rho family GTPases - role in adhesion and migration 
The Rho-family of GTPases are members of the Ras superfamily of monomeric 20-30kda 
GTP-binding proteins, and include Rho A-E, Rho G, Rac1 and-2, Cdc42, and TC10 (Ridley 
et al., 2000). Members of the Rho and Rae families have been shown to regulate actin 
polymerisation, shape change and subsequent cell motility induced by chemokines (Jones 
et al., 2000). The role of Cdc42, Rac1 and Rho in the regulation of integrin-mediated cell-
substratum adhesion and cadherin-mediated cell-cell adhesion (Fukata et al., 1999) is now 
well characterised, indicating the potential for crosstalk between integrin and 
chemoattractant signalling pathways. In addition, these molecules play an important role in 
the co-operative mechanisms utilised by cytokine and chemokine receptors for the 
regulation of leukocyte chemotaxis and adhesion (Figure 1.4). 
In fibroblasts, Pl3K acts as a Ras effector to link this molecule to the Rae/Rho signalling 
cascades. Gia appears to play a direct role in chemoattractant induced GTP-loading of Rho 
in leukocytes, first identified with the fMLP stimulation of neutrophils (Laudanna et al., 1996). 
PKC appears to promote actin polymerisation via Rho, Rae and Cdc42 resulting in the 
formation of membrane ruffles, cell adhesion and actin plaque assemblies (Ridley and Hall, 
1994). Current models of Rho signalling in fibroblasts suggest that the GTPases Cdc42, 
Rae and Rho are coupled in a linear cascade, with Cdc42 stimulating Rae responses that 
initiate cytoskeletal changes controlled by Rho (Nobes and Hall, 1995). 
1.7.1.2.1 Rho 
Rho-kinase (ROCK), an effector of Rho, regulates integrin mediated cell-substratum 
adhesion at focal adhesions, by regulating the phosphorylation state of myosin light chain 
(MLC) (Amano et al., 1996). Studies using Jurkat T-cells found that RANTES and IL-8 
induced the GTP-GDP exchange of RhoA (Bacon et al., 1996), thus directly linking 
chemokine induced signals with the actin cytoskeleton network. Ashida et al. (2001) has 
shown that MCP-1 mediated cell adhesion is regulated by ERK while chemotaxis was 
regulated by p38-MAPK and Rho, demonstrating two distinct MAPK signalling cascades 
leading to integrin activation and chemotaxis (Ashida et al., 2001 ). 
Studies on T cell lines have identified the role of the Rho GTPases on lymphocyte 
polarisation and chemotaxis. Transfection of T cell lines that constitutively display a 
polarized motile morphology with activated mutants of RhoA, Rac1 and Cdc42 impaired cell 
polarization (del Pozo et al., 1999), however, a Cdc42 mutant was able to maintain motility 
in the absence of polarity (Allen et al., 1998). In addition, overexpression of dominant 
negative Cdc42 and activated mutants of all three Rho GTPases significantly inhibited SDF-
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1 a-induced T cell chemotaxis (del Pozo et al., 1999). Recently RhoA, through p160ROCK 
negative regulation of ~2-integrin adhesion, was found to inhibit uropod retraction in 
migrating monocytes (Worthylake et al., 2001 ), potentially linking Rho signalling to both the 
actin and microtubular systems. In addition to their role in adhesion and motility, the Rho 
GTPases also regulate chemokine production. IL-8 mRNA and protein was found to be 
blocked by the inactivation of RhoA/Cdc42/Rac1 by a specific inhibitor, clostridium difficile 
toxin B (Hippenstiel et al., 2000). 
1.7.1.2.2 Rae 
The GTPase Rae plays a pivotal role in T-cell adhesion by promoting cell spreading via the 
generation of actin-rich lamellipodial protrusions and membrane ruffling, rather than by 
altering the level of expression or the affinity of integrin receptors (Ridley et al., 1992; Hall A, 
1992). More specifically, IQGAP-1, an effector of Cdc42 and Rac1, regulates cadherin-
mediated cell-cell adhesion by interacting with ~-catenin and dissociating a-catenin from the 
cadherin-catenin complex (Kuroda et al., 1996). Activated Cdc42 and Rac1 inhibit IQGAP-1 
(Rae GTPase activating protein), stabilising the cadherin-catenin complex, thus acting as a 
negative feedback switch (Kuroda et al., 1999). Another upstream effector, 180kd protein 
downstream of CRK (DOCK180), a member of the COM family, is implicated in the 
production of lamellipodia, confirmed in DOCK2-1- lymphocytes where chemokine-induced 
Rae activation and actin polymerization were almost totally abolished (Fukui et al., 2001 ). 
The generation of migratory signals will, however, rely on the synchronous activation of 
several signalling pathways, and while the Rho GTPases may drive actin polymerisation, 
the activation of MAPK pathways in the regulation of myosin motor functions is also critical 
for cell contraction. Leng et al. (1999) found that during active cell adhesion to the 
extracellular matrix, Rae potentiates the MAPK pathway and influences cell migration by 
selectively synergizing with Raf kinase but not with Ras or MAPK kinase (Leng et al., 1999). 
In fact, the synergy between Rae and Raf kinase increased the chemotactic sensitivity of 
cells to epidermal growth factor by 1000-fold. Therefore, the role of Rae in cell migration not 
only depends on its ability to regulate actin cytoskeletal organization but also on its capacity 
to potentiate chemokine activation of MAPK in a manner that depends on active cell 
adhesion to the extracellular matrix (Leng et al., 1999) 
1.7.1.2.3 Cdc42 
The GTPase Cdc42 has been implicated in the aggregation of chemokine receptors to the 
leading edge of the cell during chemotaxis (Nieto et al., 1997). However, both active and 
inactive forms of Cdc42 do not interfere with Rho-dependent integrin activation by 
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chemokines in lymphocytes (Weber et al., 1998) Cdc42 also controls the integrin-dependent 
activation of extracellular signal-regulated kinase 2 (ERK2) and of PKB, a kinase whose 
activity has been demonstrated to be dependent on Pl3K (Keely et al., 1997). SDF-1 
induced chemotaxis of T-lymphocytes was regulated by Cdc42 and its effector Wiskott-
Aldrich syndrome protein (WASP) (Haddad et al., 2001 ). In-vitro analysis of cc· chemokine-
induced monocyte chemotaxis was inhibited by Cdc42 mutants, however, no effect was 
observed on the Rho-dependant activation of cell adhesion as measured by integrin avidity 
(Weber et al., 1998). In a macrophage cell-line, injection of Rho and Rae mutants inhibited 
cell migration, while cells injected with a Cdc42 mutant were able to migrate but not polarise 
towards a chemoattractant gradient (Allen et al., 1998). Cdc42 may play an integral role in 
the polarisation of leukocytes in response to a chemotactic gradient, and inhibition of this 
protein may indeed ablate directed eosinophil migration to the allergen provocation site and 
subsequent pathogenesis. 
The role of the Rho-GTPases in eosinophil adhesion and chemotaxis is yet to be fully 
characterised. Collectively, the above results suggest that integrin/adhesion molecule 
interactions, cell-cell contact dynamics, cell polarisation and motility, and associated 
cytoskeletal rearrangements in leukocytes may be controlled by interacting and diverging 
signalling pathways, with access to different pools of GTPases within the cell. 
1.7.2 Intracellular second messengers in cytokine signalling 
Although cytokine signalling pathways are yet to be fully characterised Ras/MAPK, Rho and 
Rae GTPases, and Janus tyrosine kinases (JAK)/Signal transducers and activators of 
transcription (STAT) signaling pathways are known to be involved (reviewed in: Adachi and 
Alam, 1998) (figure 1.4). Currently there are four different JAKs (1, 2, 3 and Tyk2) and eight 
STAT's (a, 1~, 2, 3, 3~, 4, 5a, 5~ and 6), all with different DNA binding and transactivation 
properties, allowing for cellular specificity in this signalling pathway (Ransohoff RM, 1998). 
The JAK/STAT pathway represents a mechanism for the rapid transduction of cytokine-
induced signals to the nucleus for the activation of transcription. JAK's become tyrosine 
phosphorylated following activation of cytokine receptors, inducing the tyrosine 
phosphorylation of receptor subunits and signalling intermediates (including cytosolic 
STAT's) (Bagley et al., 1997). Phosphorylation of STAT's results in their homo- or hetero-
dimerisation and is regulated by SH2 domain interactions. Following phosphorylation, these 
transcription factors then translocate to the nucleus, activating transcription by binding to the 
g-activating sequence (GAS) motif of the promoter region of various genes (Stevens et al. , 
1995). Crosstalk between the JAK/STAT and Ras/MAPK pathways has also been identified 
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and involves the activation of the transcriptional regulator c-fos, and in transcription by 
STAT proteins 01\Jyke et al., 1996). The utilisation of the Ras/MAPK, Rho and Rae, and 
PLC-inositol phosphate cascades by both cytokine and chemokine signalling pathways 
provides potential mechanisms whereby these molecules can cooperatively interact to 
regulate eosinophil chemotaxis and motility, and the homing of eosinophils to the site of 
allergen challenge. 
1.7.3 lntegrin Mediated Signalling 
lntegrins can signal through the cell membrane in either direction: "outside-in" signalling, 
transducing signals from the ECM to the intracellular compartment; and "inside-out" 
signalling involving the rapid modification of extracellular binding (reviewed in: Brown and 
Hogg, 1996). Both processes are dependent on changes in the affinity of the receptor for 
ligand, and in avidity, involving the dynamic reorganisation of the integrins into microclusters 
(van Kooyk et al., 2000). The actin cytoskeleton plays an important role in membrane 
remodelling during changes in avidity, and acts as a platform for the aggregation of surface 
receptors and downstream signalling molecules in cell membrane association regions called 
focal adhesion complexes (Chen et al., 1985). lntegrins associate with the actin 
cytoskeleton via actin-binding proteins, including paxillin, a-actinin, talin, vinculin and filamin 
(Sampath et al., 1998). A predominant protein in focal complexes which undergoes rapid 
tyrosine phosphorylation following integrin ligation and clustering is a 120kDa non-receptor 
tyrosine kinase known as focal adhesion kinase (FAK) (Lipfert et al, 1992). Once activated, 
FAK interacts with adaptor proteins, including paxillin (Hildebrand et al, 1995), p130Cas/Crk 
(Sakai et al, 1994), Grb2/Son of Sevenless (SOS) (Zhu et al, 1994), which in turn activate 
many signalling pathways (Figure 1.4 ). 
"Inside-out" signalling pathways are still poorly characterised, however chemokine signalling 
is known to induce rapid changes in integrin activity. In addition, chemoattractants can 
differentially regulate the avidity of ~1 and ~2 integrins, as described in human eosinophils, 
inducing transient activation and rapid deactivation of VLA-4 but prolonged activation of 
Mac-1 01\Jeber et al., 1996). The chemokine activation of integrin function is more 
thoroughly investigated in the context of eosinophil degranulation, and further work will need 
to highlight the role of integrin/chemokine crosstalk in relation to cell polarisation and 
motility. 
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1. 7 .4 Receptors involved in chemokine and cytokine signalling in 
eosinophils 
Chemokines signal through GPC's, distinguished by two conserved cysteines, one in the 
NHrterminal domain and the other in the third extracellular loop that are assumed to form a 
disulfide bond critical for the conformation of the ligand-binding pocket (Trumpp-Kallmeyer 
et al., 1992). Three subgroups are currently recognised: CC, CXC and CX3CR1, which only 
recognise chemokines of the corresponding subfamily (reviewed in: Baggiolini et al., 1997). 
However, most chemokine receptors recognise more than one chemokine, and several 
chemokines bind to more than one receptor, indicating that redundancy and versatility are 
characteristic for this system (Mantovani A, 1999). Recent studies suggest that chemokine 
receptors, as with many members of the GPCR family, undergo homo- and hetero-
dimerisation upon ligand binding (Mellado et al., 2001 ). 
Human eosinophils have been shown to express CCR1-5 (Heath et al., 1997), however, the 
specific use of CCR-3 in eosinophil chemotaxis is indicated in mAb studies. CCR-3 
antibody pretreatment blocks chemotaxis and Ca2+ flux induced by the CCR-3 specific 
ligands eotaxin, RANTES and MCP-2, -3 and -4, and confirmed 95% of the eosinophilic 
response in allergic patients is mediated through this receptor (Heath et al., 1997). In the 
mouse, only CCR-3 and CCR-1 expression has been confirmed (Post et al., 1995). As 
mentioned previously, eotaxin-1, -2 and -3 have been shown to signal exclusively through 
CCR-3, however, RANTES and MCP-3 can signal through both CCR-3 and CCR-1 (Nibbs 
et al., 1997). Not surprisingly, CCR-3 expression on murine eosinophils is high compared to 
that of CCR-1 (Post et al., 1995). In humans, CCR-3 (Combadiere et al., 1995) is 
expressed on eosinophils (Heath et al., 1997), basophils (Uguccioni et al, 1997), mast cells 
(Ochi et al., 1999), a subset of TH2 lymphocytes (Sallusto et al., 1997; Gerber et al., 1997), 
dendritic cells (Rubbert et al., 1998) and microglial cells of the brain (Xia et al., 1997). In 
mice, CCR-3 has only been found to be expressed on eosinophils (Grimaldi et al., 1999). 
In contrast to chemokine receptors, members of the cytokine receptor superfamily are cell-
surface glycoproteins that function as oligomeric complexes consisting of typically two to 
four receptor chains (Bagley et al., 1997). Notably, these receptors display striking 
structural and functional similarities. The receptors for IL-5, IL-3 and GM-CSF consist of a 
unique a-subunit and a ~-subunit that is common to all three (~c) (Tavernier et al., 1991 ). 
The Be-subunit forms a high affinity receptor with all three a-subunits despite its inability to 
bind ligand, and is crucial for signal transduction instigated by the receptor (Jenkins et al., 
1995). Upon ligand binding the a- and ~-subunits of IL-5, IL-3 and GM-CSF oligomerize 
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(Gutheridge et al., 1998), however, the stoichiometry of the ligand-receptor complexes have 
yet to be defined (Gustin et al., 2001 ). 
The IL-5Ra binds IL-5 with low affinity converting to a high affinity interaction upon ~-
common (~c) subunit association, while the ~c subunit does not bind IL-5 in the absence of 
IL-5Ra (Cornelis et al., 1995). Co-expression of the a and ~c subunits results in a few fold 
increase in IL-5 binding affinity (Takahashi et al., 1990), which may also translate to higher 
bioactivity of this cytokine (Tsuruoka et al., 1990). The early expression of the receptor on 
CD34+ progenitors drives differentiation towards the eosinophilic linage, a process regulated 
by IL-5 itself (Tavernier et al., 2000). In humans, IL-5Ra expression is limited to eosinophils 
and basophils, but mice also express the receptor on a subset of B-lymphocytes (reviewed 
in: Takatsu et al., 1995). The restriction of IL-5Ra to a small subset of haematopoietic cells 
indicates its expression is tightly regulated, most likely by cell-specific transcriptional 
mechanisms (Karlen et al., 1996). 
1.7.5 Downstream intracellular signals mediating eosinophil migration 
The signal transduction pathways employed by eosinophils in response to chemoattractants 
are, to date, poorly characterised (figure 1.5). Low numbers of circulating eosinophils in 
normal individuals have made biochemical investigation of this leukocyte difficult. Human 
eosinophilic-like cell-lines, including Eol, AML 14 and AML 14.3010, differ markedly in terms 
of function and morphology from differentiated eosinophils that regulate immune and 
pathophysiological processes. The development of the IL-5 transgenic mouse, producing a 
large supply of non-allergen sensitised eosinophils, provides a strong model for the 
characterisation of intracellular pathways involved in cytokine and chemokine crosstalk. 
1.7.5.1 IL-5R signalling in the eosinophil 
The cytokines IL-5 is involved in the priming mechanism for eosinophil effector functions 
(Koenderman et al., 1996). In particular, IL-5 has been shown to promote JAK/STAT 
interactions: JAK2/STAT1a (van der Bruggen et al., 1995; Alam et al., 1995); and 
JAK2/STAT5 (Ogata et al., 1998) (figure 1.5). IL-5 is also known to be a potent activator of 
the MAPK family members ERK2 (Bates et al., 1996), JNK (Hebestreit et al., 1998) and p38 
(Kampen et al., 2000), playing a role in the survival and the priming of eosinophil responses. 
The protein tyrosine kinases Lyn (Pazdrak et al., 1995), Syk (Yousefi et al., 1996) and Fyn 
(Appleby et al., 1995) are also activated by the IL-5 receptor on eosinophils, leading to the 
downstream activation of the MAPK pathway. Lyn, JAK2 and a downstream signalling 
mediator of both kinases, Raf-1, play critical roles in the anti-apoptotic effect of IL-5 
38 
Figure 1.5. Current knowledge of intracellular signalling events induced by 
CCR-3 and IL-5 receptor activation. 
Eotaxin/CCR-3 ligation is known to induce the activation of a Gi-protein, Pl3K, the src-
kinases Fgr and Hck, MAPK family members p38 and Erk, PLC-~ and downstream 
mediators including PKC, IP3 and the induction of Ca2+ flux. Cytokine/receptor ligation 
results in the activation of Lyn, Pl3K, the Shc/Grb2/Sos complex, SHPTP2, ROCK and 
Rho, the Ras/MAPK pathway including p38 and Erk, PKC and RACK-1, and the 
JAK/STAT pathway. The Pl3K, PLC-~ and Rho pathways are integrally involved in the 
generation of functional and structural signals mediating cell chemotaxis. Members of the 
MAPK pathway (p38 and Erk) and the JAK/STAT pathway both lead to transcription factor 
activation and DNA synthesis integral to adhesion molecule upregulation and 
chemokine/cytokine gene transcription. Although poorly characterised to-date, Pl3K and 
the MAPKs provide potential sites of crosstalk between chemokine (eotaxin) and cytokine 
(IL-5) signalling cascades. 
Abbreviations used: Pl3K - phosphatidylinositol 3-kinase; PKB - protein kinase B; PKC -
protein kinase C; PLC-~ - phospholipase-~; Sos - son of sevenless; DAG -
diacylglycerol; NFAT - nuclear factor of activated T-cells; NF1eB - nuclear factor kappa B; 
MAPK - mitogen activated protein kinase; SHPTP2 - src homology 2 protein tyrosine 
phosphatase; RACK-1 - receptor for activated C-kinase; JAK - janus tyrosine kinase; 
STAT - signal transducers and activators of transcription. 
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(Pazdrak et al., 1998). These studies also identified that a tyrosine phosphatase, SRC 
homology 2 protein tyrosine phosphatase (SHPTP2), physically interacts with the ~c-chain 
and Grb2 upon IL-5 stimulation, once again feeding into the MAPK pathway cascade 
(Pazdrak et al., 1997). Rho GTPases may also play a central role in the priming of 
eosinophils by cytokines, inducing cytoskeletal changes and cell motility. 
Chemoattractants stimulate very rapid guanine nucleotide exchange on RhoA, a critical 
component of the signalling cascade responsible for fast integrin-dependent leukocyte 
adhesion (Laudanna et al., 1996), and this mechanism may play a role in eotaxin-mediated 
cytoskeletal changes, alterations in· cell adhesion and cell polarisation. A study by Alblas et 
al. (2001) described that the inhibition of Rho and ROCK lead to impaired detachment of the 
eosinophil-uropod from the substratum, while injection of the tat-fusion construct containing 
active RhoA resulted in cell detachment upon chemoattractant stimulation (Alblas et al., 
2001 ). The RhoA-ROCK pathway appears to be essential for the detachment of polarising 
eosinophils. 
The Src family kinases Hck and c-Fgr are associated with CCR-3 in human eosinophils 
following agonist induced internalisation, triggering tyrosine phosphorylation and the 
mediation of cell polarisation and chemotaxis (EI-Shazly et al., 1999). CCR-3 mediated 
pathways have also been shown to activate the MAP kinases ERK2 and p38 (Bates et al., 
2000) while ERK1 and ERK2 activation by eotaxin was found to be IL-5 dependent 
(Kampen et al., 2000), identifying a potential site of crosstalk between chemokine and 
cytokine signalling pathways. 
Second messengers involved in IL-5 and eotaxin crosstalk will need to be further 
characterised with the aim of elucidating the interaction of chemokinetic (motile) and 
chemotactic (polarising) intracellular signals within the migrating eosinophil. The IL-5 
transgenic mice provide us with an ideal model for the characterisation of eosinophil 
signalling pathways, observations that may be correlated to human eosinophil functions. 
These studies will no doubt highlight the importance of functional and structural signalling in 
the generation of receptor aggregates and asymmetrical intracellular signals in the 
eosinophil migratory response. 
1.7.6 In-vivo and in-vitro inhibition of eosinophil migration 
The abolition of eosinophil trafficking to the site of allergy may play a major role in reducing 
allergic inflammation. Strategic approaches for the inhibition of eosinophil recruitment 
include: the targeting of unique intracellular pathways and transcription factors; disruption of 
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ECM/integrin and adhesion molecule/integrin interactions; blockade of the relatively specific 
CCR-3 receptor; and the inhibition of cytokine (IL-4, IL-5 and IL-13) production and specific 
cytokine receptor antagonism. 
1.7.6.1 Intracellular signalling inhibitors 
The inhibition of intracellular signalling pathways that mediate eosinophil chemotaxis have 
been partially investigated. Several studies have investigated the role of arachidonic acid 
and lysophospholipid pathway antagonists on eosinophil migration. Lipoxin A4 and aspirin-
triggered 15-epi-LXA4 (ATL), products of the arachidonic pathway, have been found to 
block allergic eosinophilia, through the inhibition of IL-5 and eotaxin generation (Bandeira-
Melo et al., 2000). PLA2 is the rate-limiting enzyme involved in the conversion of 
membrane phospholipids to arachidonic acid and lysophospholipids (Bingham and Austen, 
1999). Inhibition of cPLA2 was found to inhibit both AHR and eosinophil infiltration in a 
guinea pig model of asthma, but the potential role of endogenous PLA2 products such as 
the lipoxins was not confirmed in this study (Myou et al., 2000). Leukotriene pathway 
blockage, with the selective inhibition of 5-lipoxygenase (zileuton) and the L TB4-receptor 
itself (L T84 dimethyl amide) caused a concentration dependant inhibition of eosinophil 
migration (Munoz et al., 1997). 
Targeting the inhibition of nitric oxide, tyrosine kinases and the p70s6K pathway on 
eosinophil migration has also been investigated. Chronic blockade of nitric oxide synthesis 
with n-omega-nitro-L-arginine methyl ester (L-NAME) resulted in the inhibition of eosinophil 
migration both in-vivo and in-vitro in a rat allergic model (Ferreira et al., 1996). Inhibition of 
tyrosine kinase signalling with herbimycin A and erbstatin was found to ablate eotaxin-
induced chemotaxis of human eosinophils, however pervanadate inhibition only partially 
blocked chemotaxis (EI-Shazly et al., 1998). Inhibition of the p70S6K pathway with 
rapamycin confirmed the involvement of this pathway in both airways hyperreactivity and 
eosinophil migration (Francischi et al., 1993). However, the use of intracellular signalling 
inhibitors to block eosinophil migration in-vivo is limited, unless unique pathways and/or 
interactions are identified and exploited. 
1.7.6.2 Adhesion molecule/integrin and ECMlintegrin association inhibitors 
Several studies have investigated the inhibition of eosinophil migration using antagonists to 
adhesion molecule/integrin interactions. The importance of the VCAM-1, ICAM-1 , VLA-4 
and LFA-1 on leukocyte migration has been identified in mouse models of allergic airways 
disease (Montefort et al., 1993). Inhibitory antibodies of the VCAM-1 NLA-1 pathway, but 
not of ICAM-1 or of LFA-1, suppressed eosinophilia, in contrast to T-cell infiltration which 
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was reduced upon LFA-1/ICAM-1 and VLA-4NCAM-1 inhibition (Nakajima et al., 1994). 
Administration of anti-CD49d monoclonal antibodies (PS/2) reduced eosinophilia (75%), and 
abolished mucus cell metaplasia and AHR, while the addition of soluble P-selectin 
glycoprotein ligand-1 (PSGL-1) resulted in the complete abolition of eosinophilia (Borchers 
et al., 2001 ). In another study, human eosinophil adhesion was strongly inhibited by mAbs 
against CD18 (~2) and CD11a-c, and to a lesser extent against CD29 (~1), CE49d (a4) and 
VCAM-1 (NcNulty et al., 1999). Interestingly, eosinophil adhesion in this study was 
unaffected by PT, PAF, nor antibodies directed against IL-8, IL-8R, CCR-3, IL-3, IL-5 and 
GM-CSF (McNulty et al., 1999). 
Targeting special motifs with small peptides to inhibit downstream signal transduction of 
adhesion molecule/integrin interactions has also been investigated. Of particular interest 
was the discovery of the specific motif (QIDSPL) within domain one of VCAM and its critical 
role in VLA-4 binding (Vonderheide et al., 1994; Osborn et al., 1994). However, as with the 
inhibition of intracellular signalling pathways, the goal in effective blockade of eosinophil 
migration must lie in the identification and abolition of unique adhesion 
molecule/integrin/ECM interactions. 
1.7.6.3 CCR-3 antagonists- receptor blockade 
Due to the relative specificity of CCR-3 expression, this receptor poses an ideal target for 
the blockade of eosinophil infiltration. Several studies have identified non-peptide 
antagonists: UCB35625 inhibited cell shape change, CCR-3 internalisation and chemotaxis 
in response to eotaxin MIP-1 a and MCP-4 (Sabroe et al., 2000); SB-328437 binds with high 
affinity to CCR-3, inhibiting Ca2+ flux and eosinophil chemotaxis in response to eotaxin, 
eotaxin-2 and RANTES (White et al., 2000); Compound X was found to inhibit eotaxin 
induced Ca2+ flux and chemotaxis (Saeki et al., 2001 ). mAbs specific for CCR-3 have also 
been shown to deplete eosinophil recruitment in the lung in response to parasitic infection 
(Grimaldi et al., 1999). There is no doubt that to be therapeutically useful, chemokine 
antagonists need to be potent and selective. 
1.7.6.4 IL-5 and IL-SR antagonists 
IL-5 is a major determinant in the survival, differentiation and effector function of 
eosinophils, and the restricted expression of the IL-5R on eosinophils and basophils 
provides a prime target for the inhibition of eosinophil function. mAb treatment against IL-5 
has been shown to suppress allergen-induced airway eosinophilia in guinea pigs, monkeys 
and mice (Chand et al., 1992; Mauser et al., 1995). In the monkey model of allergic 
asthma, eosinophil numbers were depleted and AHR remained low for up to 3 months 
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following a single injection of IL-5 mAb (Mauser et al. , 1995). In human trials, humanised 
anti-lL-5 decreased eosinophil numbers in the sputum of mild asthmatics for up to 16 weeks 
following a single dose, however AHR remained unaffected (Leckie et al. , 2000). Further 
caution on the use of humanised mAb in clinical testing is highlighted by Zabeau et al. 
(2001 ), suggesting that strong neutralising antibodies may in fact upregulate the cross-
linking of IL-SR complexes, potentiating IL-5 signalling pathways (Zabeau et al. , 2001 ). 
With these observations in mind, the role of humanised anti-lL-5 in the long-term reduction 
of eosinophil recruitment will need to be further investigated. 
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SPECIFIC AIMS OF THIS THESIS 
1. To develop specific and reliable biochemical and immunohistochemical protocols for 
the analysis of intracellular signalling events in eosinophils. 
2. To characterise downstream signalling mediators involved in CCR-3-mediated 
eosinophil chemotaxis, in particular, the utilisation of G-protein subunits. 
3. To dissect the role of the Gz-protein in eosinophil recruitment and allergen-induced 
pathophysiology in murine models of allergic airways disease. 
4. To examine the localisation of CCR-3, IL-SR and downstream functional signalling 
mediators in response to a time-course of chemotactic and chemokinetic stimuli. 
5. To qualitatively dissect the role of the actin and microtubular cytoskeleton in response 
to chemotactic and chemokinetic stimuli, and determine the relationship between these 
structural signals and functional signalling responses. 
6. To examine the potential role of blocking CCR-3 signalling by employing a CCR-3 mAb 
(19-4) in the restriction of eosinophil trafficking in murine models of allergic airways 
disease. 
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CHAPTER 2: 
Role of G-proteins in 
Eosinophil Signalling 
and 
Allergic Responses 
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2.1 INTRODUCTION 
The importance of G-protein coupled receptors in cell migration is well documented 
(Molski et al., 1984; Becker et al., 1985; Goldman et al., 1985). In particular, the central 
role of pertussis toxin sensitive heterotrimeric G-proteins and their downstream effectors 
in leukocyte chemotaxis (Molski et al., 1984; Lad et al., 1985; Becker et al., 1985) has 
been well characterised. To date, research had focused on the importance of the py 
subunit of the heterotrimeric Gi-proteins in chemotaxis (Neptune et al., 1997; Arai et al., 
1997). Blockade of py release from Gia, but not Gs or Gq family members, has been 
found to abolish chemotaxis (Neptune et al., 1999). However, the role of the Gia subunit 
has not been fully characterised, and through the activation of downstream signalling 
mediators, this subunit may play a critical role in directed cell migration (Stenberg et al., 
1997). Gia-induced signals may play an important role in the activation of Src-family 
members (Ma et al., 2000; Stenberg et al., 1997), the MAPK cascade (Winitz et al., 1993) 
and actin polymerisation (Togashi et al., 1998). 
Another important aspect of G-protein coupled receptor signalling is the specificity by 
which these receptors recruit and activate individual G-protein family members (Reed RR, 
1990; Duzic and Lanier, 1992; Sato et al., 1995). Selective G-protein coupling by CC 
chemokine receptors has been investigated to a limited extent, linking specific cellular 
responses such as exocytosis and chemotaxis with various G-protein family members 
(Kuang et al., 1996; Nasman et al., 2001 ). Of the Gia family members, Gia2 has been 
closely linked with chemotaxis (Damaj et al., 1996; Liu et al., 2001 ), while Gia3 activation 
is associated with cellular exocytotic events (Pinxteren JA, 1998). 
To date, the Gi-proteins associated with ligand-induced CCR-3 chemotaxis are unknown, 
and characterisation is essential in terms of understanding eosinophil migration. Although 
various cell-lines have been employed as models of eosinophil biology, none are truly 
representative of cellular function or morphology. To definitely determine functionally 
relevant processes within eosinophils studies in this thesis have employed primary murine 
eosinophils. The mouse eosinophil was characterised in preference to the human as it 
was intended to translate observations on cellular function to in-vivo systems of cell 
migration in murine allergic disease models. 
Gz is a member of the Gi subfamily of G-proteins, but with the distinction of being the sole 
member which is not a substrate for pertussis toxin (Fong et al. , 1988; Casey et al., 1990), 
and to date, its role outside of the central nervous system (CNS) is poorly characterised. 
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The role of this G-protein in leukocyte migration and activation is unknown. The role of Gz 
in neural pathways in the CNS also suggest that this protein may regulate peripheral 
neural responses and thus potentially airways reactivity to spasmogens. Initial studies in 
the Foster laboratory suggested that leukocyte trafficking to the lung in asthma models 
was abnormal in mice deficient in Gz (Gz-1-) (unpublished data). Thus in the current study, 
Gz-1- mice were fully characterised in a model of allergic airways disease. The potential of 
Gz to regulate airways reactivity was also investigated at baseline and in mice with 
allergic disease of the lung. As the expression of the allergic phenotype and airways 
reactivity varies between strains, both BalbC and C57BL/6 Gz-1- mice were characterised. 
Strain comparisons were also made to ascertain if the phenotypes obtained with Gz-1-
mice were consistent across the different genetic backgrounds. 
In this chapter, I have endeavoured to elucidate the expression of the Gia-proteins in 
murine eosinophils, and which of these, if any, interact directly with the CCR-3 chemokine 
receptor in the induction of chemotactic responses. In association with cellular studies on 
G-proteins, I have characterised allergic inflammatory responses in Gz-1- mice with a view 
to defining the role of this protein in leukocyte motility and in the pathophysiology of 
allergic disease. In addition, a direct comparison was made between responses from the 
BalbC and C56BL/6 Gz-1- mice in our allergic airways model, to investigate potential 
genetic variation in the predisposition of the diseased state. 
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2.2 
2.2.1 
2.2.1.1 
MATERIALS AND METHODS 
G-protein expression and signalling 
Mice 
Male C57BL/6 wildtype (WT) mice were used in RNA expression studies and male IL-5 
transgenics were used in protein expression/association studies ( originally obtained from 
Dr. Lindsay Dent, Uni. of Adelaide). Both groups of mice were bred and maintained by 
the animal breeding establishment (ABE), John Curtin School of Medical Research 
(JCSMR), Australian National University (ANU). Mice were treated in accordance with 
ANU animal experimentation guidelines 
2.2.1.2 Generation of non allergen-sensitised eosinophils in the peritoneal 
cavity of wild-type mice 
Eosinophils were stimulated to accumulate In the peritoneal cavity of wild-type mice 
following an intense protocol of Polymyxin B (Sigma, St.Louis, MO, USA) injections 
(Pincus SH, 1978). 200µ1 of Polymyxin B (1 00µg) in 0.9% saline was injected 
intraperitoneally (i.p) twice weekly for a period of 8 weeks. Eosinophils were collected 
from the peritoneal cavity and purified by FAGS (section 2.2.1.3). 
2.2.1.3 Fluorescence activated cell sort (FACS) analysis of murine eosinophils 
Leukocyte populations to be sorted were freshly extracted from IL-5 transgenic mice by 
peritoneal lavage. Briefly, mice were sacrificed and the peritoneal cavity exposed by an 
incision through the abdominal skin. Using an 18-gauge needle, 3 x 5ml of sterile Hanks 
basal salt solution (Hanks) were used to wash the cavity. The wash or "lavage" was 
retained and centrifuged at 1,500 g for 5 min, the supernatant removed, and cells 
resuspended in red cell lysis buffer (RCLB) for 5 min. The cells were re-centrifuged at 
1,500g for 5min, supernatant removed and cells resuspended in sterile Hanks (max. 
concentration of 1 x 107 cell/ml). Cells were filtered through sterile gauze (to remove cell 
clumps and debris prior to sorting) into sterile 4ml FACS tubes (Falcon #2054 12x75mm) 
and placed on ice prior to cell sorting. 
The BO FACStar Plus (BO, Franklin Lakes, NJ, USA) was used to sort mature eosinophils 
from the peritoneal cell mix, based on forward and side scatter parameters, and polarised 
light (modified by Osborne G., Flow Cytometry Unit, JCSMR, from Shapiro et al Practical 
Flow Cytometry, 3rd Ed., 2000) (figure 2.1 ). Eosinophils were sorted into 30% FCS/Hanks 
and kept on ice prior to use. Cell counts from FACS and eosinophil viability were 
confirmed using the trypan blue 
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Figure 2.1. Comparison of wildtype and IL-5 transgenic peritoneal cavity cell 
sort 
Leukocytes were extracted by washing the peritoneal cavity (section 2.2.1.2) of wild-type 
polymyxin B treated mice (figure 2.1 a) and IL-5 transgenic mice (figure 2.1 b). The 
eosinophil gate is identical, and is determined by forward scatter, side scatter and 
polarised light parameters. The mature eosinophil population is consistent between 
groups, however, the number of circulating progenitors is higher in the IL-5 transgenic 
sample, an observation confirmed with May Grunwald/Giemsa staining of cytospin 
preparations. 
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exclusion assay: 1 0µI of a 1: 1 solution of suspended cells and 0.4% trypan blue (Sigma-
Aldrich, USA) mounted and counted on a haemocytometer. 
2.2.1.4 Determination of G-protein mRNA expression in WT eosinophils 
2.2.1.4.1 Isolation of total RNA 
Wild-type ova-sensitised mice (male C57BL6, 6-8 weeks of age) were sacrificed and 
bronchoalveolar lavage (BAL) (section 2.2.2.3) and bone marrow lavage (BML) was 
performed. BML consisted of epiphysis excision, insertion of a 26-gauge needle into the 
head of the femur and puncture of the opposing head. 2mls of PBS were used to wash 
the bone marrow cavity. Following red blood cell lysis (RBCL), eosinophils were purified 
using FACS (see section 2.2.1.2) utilising sorting gates specific for the isolation of 
eosinophils in BAL and BML. Eosinophil purity was assessed by cytospin analysis 
(Giemsa-May staining) at >99%. Purified cells were resuspended in 1 00ul PBS and 
placed into 1 0 volumes of RNAzol B (BIOTEX Laboratories, Houston, Texas, USA) on ice. 
The samples were homogenised and the RNA extracted using RNAzol B according to the 
manufacturer's instructions. RNA samples were stored in RNase-free water at -70°C. 
2.2.1.4.2 Reverse transcription-polymerase chain reaction of Gia subunit (RT-PCR) 
RNA (1µg) was transcribed to first strand cDNA using Superscript II RNase Reverse 
Transcriptase (lnvitrogen, Carlsbad, CA, USA) according to manufacturer's instructions. 
Reaction mixture (25µ1) contained: 1µg of RNA, 8µg/ml random hexamer, 4µ1 5 x 1st 
strand buffer, 8mM dithiothrietol, 80µg/ml BSA, 40U RNAsin and 10mM each of dATP, 
dCTP, dGTP and dT_TP (Promega, Madison, WI, USA); in DEPC treated H20. To the 
sample 200U of Superscript II RT was added while the equivalent volume of DEPC-H20 
was added to the control. 
cDNA (5µ1 of a ¼ dilution of RT sample) was added to a 20µ1 reaction mix containing 5µM 
each of the forward primer and reverse primer, 0.2U AmpliTaq DNA polymerase (Perkin 
Elmer, Roche Molecular Systems, Branchburg, NJ, USA), 2µ1 PCR buffer [1 00mM Tris 
pH9.0, 500mM KCI, 0.1 % gelatin, 15mM MgCl2 and 1 % Triton X-100 (Perkin Elmer, 
Roche Molecular Systems, Branchburg, NJ, USA)] and 5mM each of dATP, dCTP, dGTP 
and dTTP (Promega, Madison, WI, USA). To control for contamination, a water control 
was also included replacing sample with DEPC-H20. 
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The Gai specific primers used were: 
Tm-5°C 
Gai1 F CTGGGGCTGCAGAAGAAGGCTTT 67 
R TGGTCTTCACTCTGGTTCTGAGG 65 
Gai2 F CTGCAGAGGAACAAGGGATGCTT 63 
R CACATCAAACATCTTGAAGTGTAAG 63 
Gai3 F TGGGAGTGCTGAAGAAGGAGTC 63 
R CTTCACTCTTGTCCGAAGAACATCT· 63 
The primers were developed by Francis Willard and Michael Crouch (Molecular 
Signalling) and Klaus Matthaei (Gene Targeting Facility) at the John Curtin School of 
Medical Research (ANU). 
The PCR was run using a FTS-1 Thermal Sequencer (Corbett Research, Sydney, 
Australia) under the following conditions: denaturation of samples at 95° C for 3 minutes; 
35 cycles of denaturation at 95°C for 5 seconds, annealing at 63°C for 5 seconds and 
extension at 72°C for 1 minute; extension at 72°C for 3 minutes; cycle concluded at 25°C 
for 5minutes. PCR products were electrophoresed using a 2% agarose gel. 
2.2.1.5 Determination of translated G-protein and G-protein/CCR-3 association 
2.2.1.5.1 Preparation of whole cell lysates for SDS-PAGE. 
Freshly sorted murine eosinophils were kept in 30%FCS/Hanks on ice prior to analysis. 
Cells were centrifuged at 1,500g for 5min, resuspended in PBS, and counted using a 
haemocytometer. Aliquots of 1 x106 cells/sample were placed in 1.5ml conical 
eppendorfs. Samples were incubated on ice, with eotaxin (1 00ng/ml) for times as 
indicated per experiment or left unstimulated. Cell suspensions were centrifuged and the 
cell pellets were resuspended in 200ul SOS-PAGE sample buffer [10% glycerol (Sigma, 
St. Louis, USA); 12% upper tris buffer (50mM tris/HCI and 2.5mM tris-base (Sigma, St. 
Louis, USA) in 100ml H20); and 1 0mM sodium dodecyl sulphate (SOS) (Sigma, St.Louis, 
USA)]. Samples were kept at -20°C prior to analysis. 
2.2.1.5.2 Protein immunoprecipitation protocol 
Freshly sorted murine eosinophils were kept in 30%FCS/Hanks on ice prior to analysis. 
Cells were centrifuged at 1,500g for 5min, resuspended in PBS, and counted using a 
haemocytometer. Aliquots of 1 x106 cells/sample were placed in 1.5ml conical 
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eppendorfs. Samples were incubated on ice, with eotaxin (1 00ng/ml) for times as 
indicated per experiment or left unstimulated. Cell suspensions were centrifuged and the 
cell pellet lysed with 500ul lysis buffer [1 0mM tris/HCI pH 7.9, 0.3M sucrose, 1.5mM 
MgC'2, 0.3% TritonX-100, 1 mM phenylmethylsulfonylflouride (PMSF), 100µ1 of Protease 
Inhibitor Cocktail per 1 ml lysis buffer, and 1 0µI of Phosphatase Inhibitor 11 per 1 ml lysis 
buffer (all reagents: Sigma, St.Louis, USA)] was added, with care taken to resuspend the 
whole pellet. The cell/lysis buffer mix was allowed to sit on ice for 1 hour and then 
fractionated by centrifugation. Samples were centrifuged at 800g for 4 minutes to remove 
the nuclear fraction and then the supernatant centrifuged at 14,000 g for 1 0 minutes to 
obtain the cytoskeletal pellet (triton insoluble fraction). The remaining supernatant 
represented the cytosol and soluble cell-membrane components (triton soluble fraction). 
Following the addition of 500µ1 lysis buffer, the triton insoluble pellet was "solubilised" by 
sonication (Virsonic 50, Gardiner, NY, USA) on high for 30 seconds and re-centrifuged at 
14,000g to remove any remaining insoluble debris. 
Antibody to be used for immunoprecipitation was added at 1 µg/ml to the triton soluble and 
insoluble fractions [anti-mouse Gia1, anti-mouse Gia2 and anti-rabbit Gia3 (Biomol, 
Plymouth Meeting, PA, USA), and anti-rabbit Gia2 raised against the COOH terminal 
(KENLKDCGLF) (provided by Dr. Michael Crouch, Molecular Signalling, JCSMR)]. 
Samples were mixed overnight at 4°C (Platform rocker, Edwards Instruments, Australia). 
Protein-A CLB4 sepharose beads (Pharmacia Biotech, Uppsala, Sweden) were washed 3 
times in 1 ml of tris-buffered saline (TBS) (1 00mM NaCl and 50mM Tris-base (Sigma, St. 
Louis, USA) pH 7.4). Protein-A suspension (50µ1) was added to each sample, 
representing 4mg dry weight of sepharose beads. Samples were incubated for 1 hour, 
with agitation (Platform rocker, Edwards Instruments, Australia), followed by 3 washes 
with TBS, and then re-pelleted by centrifugation at 14,000g for 2 minutes at 4°C. SOS-
PAGE sample buffer (20-50µ1) was added to samples, which were then thoroughly 
vortexed and stored at -20°C. 
2.2.1.5.3 SDS-Polyacrylamide Gel Electrophoresis (PAGE) 
Samples were boiled for 4min prior to loading on to 4-20% pre-cast Tris-glycine gels 
(Novex, CA, USA), and run using the Novex mini electrophoresis apparatus (Novex, CA, 
USA). See-Blue prestained molecular weight standards (Novex, CA, USA) were run 
alongside samples. Gels were loaded once immersed in running buffer (50mM tris-base, 
0.4M glycine, 7mM SOS), and run at 125V for 1-2 hours. When appropriate, gels were 
stained in commassie stain [50% methanol, 10% glacial acetic acid and 2mg/ml 
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commassie blue (all: Sigma, St. Louis, USA)] for 30min and subsequently destained [25% 
methanol, 10% glacial acetic acid (Sigma, St. Louis, USA)] until protein bands were 
clarified. 
2.2.1.5.4 Western blotting protocol 
Gels were western blotted using a flat bed semi-dry electrophoretic transfer apparatus 
(Bio-Rad, CA, USA). Blotting paper and immobilon-P PVDF transfer membrane (Millipore, 
North Ryde, Australia) were cut to gel size. PVDF membrane was quickly immersed in 
methanol and then equilibrated in anode buffer no.2 (2.5% 500mM Tris-base, 20% 
methanol and 77.5% H2O, pH to 10.4) prior to use. Briefly, two sheets of blotting paper 
were wet in anode buffer no.1 (60% of 500mM tris-base, 20% methanol and 20% H2O, pH 
to 10.4) and placed in the centre of the graphite plate. Sheets soaked in anode buffer 
no.2 were placed on top of the initial sheets, followed by the pre-soaked transfer 
membrane, "run" SOS-PAGE gel, and finally, 2 sheets soaked in cathode buffer (2.5% of 
500mM tris-base, 20% methanol, 77.5% H2O and 26mM glycine, pH to 9.4). Blots were 
run at constant current for 1 hour based on the formula: gel size x 0.8 = mamps, which 
was increased to 2hours when running 2 gels simultaneously. 
Once transferred, membranes were rinsed in wash buffer [60µM polyethyleneglycol 
(PEG), 1.5% bovine serum albumin (BSA), 0.2M sodium chloride (NaCl), 50mM tris-HCI 
ph 7.4] and immersed for 1 hour in blocking buffer [wash buffer and 3% bovine serum 
albumin (BSA)]. The membrane was again rinsed in wash buffer and immersed in wash 
buffer containing 1 µg/ml primary antibody overnight at 4°C or alternatively, for 2hours at 
room temperature. Primary antibodies used were anti-mouse Gia1 and anti-rabbit Gia3 
(Biomol, Plymouth Meeting, PA, USA), anti-rabbit Gia2 (provided by Dr. Michael Crouch, 
Molecular Signalling, JCSMR), and rat anti-murine CCR-3 (6S2-19-4) (DNAX, Palo Alto, 
CA, USA). Following incubation, the membrane was washed 2 x 15 minutes with wash 
buffer and 1 x 15 minutes with 1 % Tween (Sigma, St. Louis, MO, USA) in PBS. 
Secondary antibody was applied to the membrane at 1 :2000 in 1 % Tween/PBS and 
allowed to incubate for 1 hour at room temperature. Following incubation, the membrane 
was washed 3-6 times (15 minute changes) with 1 % Tween/PBS. Protein bands were 
detected using the enhanced chemiluminescence (EGL) detection system (Amersham, 
Buckinghamshire, UK) (allowing re-probing) or the western blue substrate detection 
system (Promega, Madison, USA). 
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2.2.2 Characterisation of Gz_,_ mice 
2.2.2.1 Mice 
Male Gz-1- mice (originally derived by Dr. Ian Hendry and Dr. Klaus Matthaei , JCSMR) 
were bred and maintained in the laboratory of Dr. I Hendry, JCSMR, ANU. Mice were 
treated in accordance with AN U animal experimentation guidelines. 
2.2.2.2 Sensitisation and antigen challenge 
Mice were injected i.p with a mixture of 50µg/ml ovalbumin (Ova; Sigma, St. Louis, MO, 
USA) and 1 mg alhydrogel in 0.9% saline on day 0. Control animals were sensitised with 
adjuvant and saline only. The aeroallergen provocation (OVA) regime began on day 12 
(day 26 of the long model) and comprised 3 x 30-minute exposures to nebulised OVA with 
a 30-minute break between exposures. These challenges were repeated on days 14 and 
16 (days 28 - 30 in the long model). On days 11 , 13, 15 and 17 (27, 29 and 30 in the long 
model), peripheral blood smears from the tail vein were taken for Geimsa-May staining 
and differential cell counts. Mice were sacrificed 24 hours after their last challenge. 
Short- model for ova-sensitisation 
Day 
0 
Ova 
11 
P.B 
12 
Aero 
3x30 
13 
PB 
2.2.2.3 Bronchoalveolar lavage 
14 
Aero 
3x30 
15 
PB 
16 
Aero 
3x30 
Ova - 50ug/ml ovalbumin 
PB - peripheral blood 
Aero - aerosol 
17 
Sacrifice 
Mice 
BAL was performed as follows: mice were killed by cervical dislocation and the skin on the 
throat cut to expose the trachea; the muscle layer around the trachea was removed and 
the trachea cannulated with a blunt-ended 18-gauge needle. A 1 ml volume of Hank's 
buffered salt solution (HBSS) x 2 was introduced into the lung via a 1 ml syringe and 1.6-
1.7ml of bronchalveolar lavage fluid (BALF) recovered . Samples were kept on ice prior 
to sample preparation. BALF was centrifuged at 1 000g for 5 minutes at room temperature, 
the supernatant discarded and the cell pellet resuspended in red blood cell lysis buffer 
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(RBCLB) for 5 minutes. Samples were then recentrifuged at 1 000g for 5 minutes. Once 
the supernatant was discarded, the cell pellet was resuspended in 1 ml of HBSS, and cell 
numbers were determined using a haemocytometer. Cells were centrifuged (2 x 105) 
(Cytospin, Shandon Southern Instruments) onto glass slides at 300g for 3 minutes and the 
resulting cytospin stained with May Grunwald/Giemsa stain. 200-300 cells were counted 
using 40x magnification and differentiated on the basis of morphological characteristics 
( de Cock et al., 1980). 
2.2.2.4 Histological analysis of pulmonary tissue 
The large (anatomical left) lobe of the lung was removed and placed in 10% neutral-
buffered formalin for at least 2 days. The Histological Unit, JCSMR, cut transverse and 
longitudinal sections. Samples were stained with Carbol's chromotrope and eosinophils 
and other cells were differentiated on the basis of standard morphological characteristics. 
Other sections were stained to highlight mucus (Alcian blue-periodic acid Schiffs), cut 
from adjacent sections of the same block, enabling direct comparison. 
2.2.2.5 Measurement of airways hyperreactivity (AHR) 
A non-invasive whole body plethysmograph (BUXCO Electronics, Troy, NY) interfaced 
with a computer through a differential pressure transducer was used to measure AHR. 
Mice were exposed to an aerosol of sterile double distilled water to obtain a baseline Penh 
(enhanced pause) response. Throughout the experiment a 2-minute exposure period and 
3-minute recording period were utilised. Changes in airways reactivity were measured as 
Penh using the function described in Hamelmann et al (1997): 
Penh= [(T J0.3Tr) - 1] X [2Petf3Pif] 
Where Penh enhanced pause 
Te expiratory time (seconds) 
Tr relaxation time (seconds) 
Pet peak expiratory flow 
Prr peak i nspi ratory flow 
Following the baseline dose (H20), mice were exposed to increasing concentrations of~-
methacholine in ddH20 (3.125 - 50mg/ml). For each individual mouse, Penh recordings 
were obtained and averaged before collating with other mice from the same experimental 
group. 
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2.2.2.6 Identification of surfactant producing cells using transmission electron 
microscopy 
The large (anatomical left) lobe of the lung was removed, placed in 2% gluteraldhyde, 
rapidly dissected into 1 mm cubes and incubated at 4°C overnight. Samples were 
washed in 0.1 M sodium cocadylate (Sigma, St. Louis, USA) buffer, postfixed in 1 % 
osmium tetroxide for 90 minutes, stained in 2% uranyl acetate, dehydrated in graded 
alcohol solutions and embedded in Spur's resin (ProSciTech, Australia). Sections (1 µm) 
were stained with toluidine blue to identify intact regions of pulmonary tissue. Ultra-thin 
sections (80 - 85 nm) were cut on a Reichert-Jung Ultracut E ultramicrotome. The 
samples were stained with lead citrate before analysis using a Hitachi transmission 
electron microscope (H-7000; Hitachi, Japan). 
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2.3 RESULTS 
2.3.1 Gi-protein expression and association with CCR-3 in eosinophils 
2.3.1.1 Gia2 and Gia3, but not Gia1, mRNA is expressed in BAL and BM wild-
type eosinophils. 
Gia mRNA expression was quantified in both BM and BAL pools of wild-type eosinophils. 
Gia1 was not expressed in either BAL or BM purified eosinophils, although both of these 
eosinophil pools were found to express Gia2, identified as a 268bp fragment, and Gia3, a 
21 Obp fragment (figure 2.2). Brain extracts were used as a positive control in these 
experiments. 
2.3.1.2 Gia2 and Gia3 are translated to protein: Gia2 co-immunoprecipitates 
with CCR-3 in response to eotaxin-1 stimulation in murine eosinophils. 
Western blots of Gia1, Gia2 and Gia3 immunoprecipitates confirmed the translation of 
Gia2 (41 kd) and Gia3 (42kd) to protein in both the triton soluble and triton insoluble 
fractions (figure 2.3). Corresponding to the Gia1 mRNA profile, protein for this subunit 
was not produced. Whole cell lysates were Western blotted with the Gia2 antibody, 
illustrating a single band at 41 Kd and the specificity of this antibody. 
Gia2 and Gia3 immunoprecipitates were western blotted with CCR-3 mAb. Gia2 was 
found to co-immunoprecipitate with CCR-3 in both the triton soluble (figure 2.4 and figure 
2.5) and triton in-soluble fractions (figure 2.5). Although this association was evident in 
cells with no external agonist (time 0), this interaction was substantially increased upon 
1-minute eotaxin stimulation (1 OOng/ml) (figure 2.4). No evidence was found for Gia3 
association with CCR-3 in control or eotaxin stimulated eosinophils. Western blotting of 
whole cell lysis with CCR-3 mAb confirmed the specificity of this antibody, illustrating a 
distinct band corresponding to this receptor at 55Kd (figure 2.4). 
The association of Gia2 with CCR-3 was confirmed with the reprobing of Western blots 
(figure 2.5). lmmunoprecipitates using Gia2 mAb were Western blotted with CCR-3, 
illustrating the association of CCR-3 with Gia2 upon eotaxin stimulation (1 OOng/ml), and 
reprobed with Gia2 to confirm the specificity of the immunoprecipitate, as indicated by a 
strong specific band at 41 kd. Whole cell lysates were Western blotted with CCR-3 mAb 
and reprobed with Gia2, illustrating specific bands at 55kd and 41 kd respectively. 
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Figure 2.2. Analysis of Gai mRNA expression in murine eosinophils. 
mRNA expression was investigated in BAL and BM purified eosinophils of WT ova-
sensitised mice, using specific primers for Gia1, Gia2 and Gia3 (section 2.2.1.4) . No 
Gia1 was detected in BALF or BM (figure 2.2). Both Gia2 (268bp) and Gia3 (210bp) were 
expressed in both BALF and BM eosinophil pools . Brain (Br) extracts were used as 
controls for all experiments. The 1 00kilobase (kb) ladder was used as the standard in all 
expression experiments. 
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Figure 2.3. Both Gia2 and Gia.3 are translated in murine eosinophils. 
Purified IL-5 transgenic eosinophils were fractionated and immunoprecipitated with anti-
mouse Gia1, anti-rabbit Gia2 and anti-rabbit Gia3 (section 2.2.1.5.1 ). Western blots were 
performed on immunoprecipitates with the appropriate antibody to detect translation of 
Gia mRNA (section 2.2.1.5.4). No protein expression of Gia1 was detected, while both 
Gia2 (41 kd) and Gia3 (40kd) were expressed in both the triton soluble and insoluble 
fractions. Specificity of the Gia2 antibody was confirmed by detection of a specific band 
at 41 kd in the whole cell lysate (wcl). 
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Figure 2.4. CCR-3 co-immunoprecipitates with Gia2, but not Gia3, in eotaxin 
stimulated murine eosinophils. 
Triton soluble extracts from control and eotaxin (1 00ng/ml) stimulated eosinophils were 
immunoprecipitated with anti-rabbit Gia2 and Gia3 (section 2.2.1.5.1 ). Western blots 
were performed on the immunoprecipitates and whole cell lysate (wcl) with anti-murine 
CCR-3 (section 2.2.1.5.4). Gia2, but not Gia3, was found to co-immunoprecipitate with 
CCR-3, an association that was greatly enhanced following 1-minute eotaxin stimulation. 
Specificity of the CCR-3 Ab was confirmed by detection of a specific band corresponding 
to this protein at 55kd in the wcl. 
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Figure 2.5. Confirmation of the association of CCR-3 with Gia2 in response 
to eotaxin stimulation. 
Triton soluble and insoluble extracts isolated from eotaxin (1 00ng/ml) stimulated 
eosinophils were immunoprecipitated with anti-mouse Gia2 (section 2.2.1.5.1 ). Western 
blots were performed on immunoprecipitates and unstimulated whole cell lysate with anti-
murine CCR-3 (section 2.2.1.5.4). Gia2 was confirmed to co-immunoprecipitate with 
CCR-3 (55kd), and the blot reprobed to confirmed specificity of the Gia2 (41 kd) 
immunoprecipitating antibody. Heavy chain (50kd) was also detected in the 
immunoprecipitates due to the use of mouse primary and secondary abs in the initial 
immunodetection. Specificity of the CCR-3 and Gia2 antibodies was confirmed by 
detection of a specific band corresponding to these proteins at 55kd and 41 kd, 
respectively, in the corresponding wcl. 
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2.3.2 Characterisation of Gz-/- mice 
2.3.2.1 Characterisation of basal and OVA/OVA (Ova-sensitised/Ova-
provocated) responses in C57BL/6 Gz-deficient (Gz·'·) and wild-type (WT) mice in the 
long model of ova sensitisation. 
The phenotype of the Gz+ mouse was investigated for the potential role of the Gz-protein 
in leukocyte migration and activation, and subsequent airway pathology. Initial 
experiments were carried out using C57BL/6 Gz+ mice taken through the long model of 
ova-sensitisation. The most striking result was obtained prior to i.p sensitisation, with the 
mice being measured for "basal" (no Ova-sensitisation/no Ova-provocation) airway 
responsiveness (AR) to methacholine on day 31. The Gz+ mice exhibited a significantly 
higher AR compared to WT controls (figure 2.6a). This elevation was evident from 
25mg/ml ~-methacholine, reaching up to a two-fold difference at 50mg/ml. Due to the low 
numbers of Gz+ C57BL/6 mice available, post ova-provocation AR measurements could 
not be made, as these mice were diverted to the examination of BALF composition and 
histological analysis. 
Following ova-sensitisation and provocation, leukocyte profiles in both the peripheral 
blood and BALF were investigated. A direct comparison of SAL/SAL treated mice from 
WT and Gz+ groups demonstrated a peripheral blood eosinophilia (PBE) of less than 3% 
on day 31 (figure 2.6b). WT SAL/OVA (saline-sensitised/ova-provocated) treated mice 
maintained a PBE of 3% while SAL/OVA Gz+ mice demonstrated a slight but significant 
elevation in PBE of 5% at day 27 when compared to SAL/SAL (saline-sensitised and 
provocated) controls. OVA/OVA mice from both groups showed a significantly elevated 
PBE from SAL/SAL controls of 19-22% on day 31. However, there was no significant 
difference between the Gz+ and WT OVA/OVA (Ova-sensitised and provocated) PBE 
throughout ova-aerosol challenge. 
OVA/OVA treated mice generated a much higher level of leukocyte infiltrate in the BALF 
than the WT SAL/SAL treated groups (figure 2.6c), which predominantly composed of 
eosinophils and lymphocytes (figure 2.6d). In addition, Gz·1- OVA/OVA mice displayed a 
significantly elevated level of infiltrate over WT OVA/OVA mice, with total cells in the 
BALF increasing from 3.5 x 106 to 5.5 x106 (figure 2.6c). OVA/OVA cellular infiltrate was 
significantly greater in the BALF of OVA/OVA treated Gz+ mice by comparison to that of 
WT. However, total eosinophil numbers were left unchanged between Gz+ and WT 
OVA/OVA treated groups (figure 2.6c and d). 
64 
-Cl) 
a 
1200 
c: 1000 
Cl) 
"' n, 
.c 
E 
0 
~ 
.... 
Cl) 
"' n, ~ 
0 
C: 
~ 0 
-
..c: 
800 
600 
400 
c: 200 Cl) 
a.. 
-+- wr 
--- Gz-/-
* 
0 -+-------------~-------------, 
12 25 
~-methacholine (mg/ml) 
Figure 2.6a Basal AHR responses in WT and Gz·'· C57BL/6 mice. 
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Airways responsiveness to methacholine was examined in basal (no Ova-sensitisation/no 
Ova-provocation) Gz+ C56BL/6 mice and compared to WT controls. Airways 
responsiveness was significantly elevated in Gz-1- C57BL/6 mice compared to WT controls 
from 25mg/ml , reaching up to a 2-fold elevation at 50mg/ml. 
Values represent mean+ SEM for groups of 4 mice. Significant differences are given in 
respect to the WT mice: * p<0.05. 
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Figure 2.6b - d. Peripheral blood and BALF in SAL/SAL (S/S), SAL/OVA (S/0) 
and OVA/OVA (0/0) treated WT and Gz·'· C57BL/6 mice using the long model 
of Ova-sensitisation. 
Gz_,_ and WT C57BL/6 mice were exposed (i.p) to saline or Ova (1 0mg/ml) and challenged 
with an aerosol of saline or Ova (1 0mg/ml) (section 2.2.2.2 and 2.2.2.3). (b) Gz_,_ and WT 
OVA/OVA treated mice showed a significantly elevated peripheral blood eosinophilia at 
19-22%, compared to 3% for both groups of SAL/SAL mice. (c) Total BALF cells and 
eosinophil numbers were significantly increased in OVA/OVA treated WT and Gz_,_ 
groups compared to both SAL/SAL and SAL/OVA controls . In the Gz_,_ OVA/OVA group, 
total cells were significantly elevated above WT OVA/OVA mice, however, eosinophil 
numbers remained unchanged. (d) Although Gz_,_ OVA/OVA mice exhibited a marked 
elevation in infiltrate, eosinophils accounted for 43% of the cells , compared to 65% for the 
WT OVA/OVA treated mice. 
Values represent mean+ SEM for groups of 4 mice. Significant differences are given in 
respect to the WT controls of each group: * p<0.05 , ** p,0.001 
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2.3.2.2 Characterisation of OVA/OVA (Ova-sensitised/Ova-provocated) 
responses in the BalbC and C57BL/6 Gz·1· backgrounds compared to WT controls in 
the short model of ova sensitisation. 
The short model of ova sensitisation was adopted for subsequent experiments due to the 
severity of airways disease produced in the long model in both Gz+ and WT OVNOVA 
mice. Further investigations were aimed at investigating the genetic variation in leukocyte 
profiles and lung morphology in OV NOVA challenged mice of the BalbC and C57BL/6 
Gz+ mouse. As no significant differences were observed between Gz-1- and WT SAL/SAL 
mice in the long model, only SAL/SAL WT mice of both backgrounds were taken through 
the protocol. Due to the similarity obtained in these observations, only C56BL/6 WT 
results are shown and denoted to represent WT SAL/SAL mice. 
Following on from initial observations made in the long model, AR was measured in both 
backgrounds, in basal (no Ova-sensitisation/no Ova-provocation) and OV NOVA (Ova-
sensitised/Ova-provocated) mice on day 17 of the short model. Basal AR was significantly 
increased in the C57BL/6 Gz+ background with significant differences seen between WT 
and Gz+ responses from 12mg/ml ~-methacholine (figure 2.7a), reaching a 3-fold 
difference in Penh at 50mg/ml. Ova sensitisation and provocation (figure 2.7b) induced a 
strong AR response at the maximal dose in all mice compared to their basal controls. In 
comparison to their WT controls, both Gz+ groups displayed significant differences in AR 
from 12mg/ml ~-methacholine to a 2-fold increase in Penh at 50mg/ml. However, the 
variation in AR between the two backgrounds was not significant during the course of 
methacholine challenge. 
Comparisons were made between PBE in WT and Gz+ OVNOVA sensitised mice in both 
the BalbC and C57BL/6 backgrounds in response to the short model (figure 2.7c). The 
BalbC Gz_,_ mice displayed a consistently lower PBE than their WT counterparts, 
demonstrating 24% PBE on day 17 compared to 31 % for their WT controls. This trend 
was reversed in the C57BL/6 background with Gz+ mice demonstrating 31 % PBE on day 
17 compared to 24% for the WT control mice, however, this elevation was only apparent 
following the final aerosol. 
OV NOVA C57BL/6 Gz+ mice did not exhibit a significantly altered total cell infiltrate nor 
eosinophil numbers in comparison to their WT counterparts (figure 2.7d). Total cell and 
eosinophil numbers in OV NOVA BalbC Gz-1- mice were elevated from WT controls, but 
due to the low experimental numbers (6) this value was not significant (figure 2.7d) . In 
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Figure 2.7a and b. AHR responses in basal (non Ova-sensitised/non Ova-
provocated) and OVA/OVA (Ova-sensitised and Ova-provocated) WT and 
Gz·'· BalbC and C57BL/6 mice using the short model of Ova-sensitisation. 
Airways responsiveness was examined on day 17 of the short model (section 2.2 .2.2), 
using the Buxco system and reactivity to ~-methacholine (section 2.2.2.5). (a) Basal AHR 
responses (no Ova-sensitisation/no Ova-provocation) were significantly elevated in both 
Gz+ backgrounds, with C57BL/6 Gz-1- mice reaching a 3-fold difference in Penh at 
50mg/ml ~-methacholine. (b) Ova-sensitisation/Ova-provocation (OVA/OVA) induced a 
significant elevation in AHR in BalbC and C56BL/6 Gz+ mice from corresponding WT 
control groups. BalbC Gz-1- mice displayed a marked elevation in Penh from 12mg/ml ~-
methacholine, peaking at a 2-fold increase at 50mg/ml, reversing the dominance of the 
C57BL/6 mice under basal conditions. 
Values represent mean + SEM for groups of 6 mice. Significant differences are given in 
respect to the corresponding WT group: * p<0.05, ** p,0.001 
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Figure 2.7c - e. Peripheral blood and BALF in OVA/OVA (0/0) treated Gz·1· and 
WT BalbC and C57BL/6 mice in the short model of Ova-sensitisation. 
Gz+ and WT mice of the BalbC and C57BL/6 backgrounds were exposed (i.p) to saline or 
Ova (1 0mg/ml), and provocated with an aerosol of saline or Ova (1 0mg/ml) (section 2.2.2.2 
and 2.2.2.3). Due to the similarity in WT SAL/SAL (S/S) profiles of both backgrounds, 
C57BL/6 results are shown and denoted as WT SIS. (c) The BalbC Gz_,_ mice displayed 
consistently lower peripheral blood eosinophilia (PBE) compared to WT controls. This trend 
was reversed in C57BL/6 Gz_,_ mice that exhibited an 8% increase in PBE from WT 
littermates. (d) Total BALF cells and eosinophil numbers did not significantly vary between 
Gz+ and WT groups of the same background, nor between either Gz_,_ group. (e) C57BL/6 
Gz+ mice displayed a significantly higher % of eosinophils in the BALF compared to 
background specific WT mice and BalbC Gz_,_ mice. 
Values represent mean + SEM for groups of 6 mice. Significant differences are given in 
respect to corresponding BalbC 0/0 treated group: * p<0.05. 
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this model, eosinophils comprised 65% of the OVA/OVA C57BL/6 Gz-1- infiltrate, compared to 
55% in the WT controls, while eosinophil numbers were not significantly altered in the BalbC 
Gz+ compared to WT controls (figure 2.7e). A direct comparison of BalbC and C57BL/6 
Gz+ OVA/OVA treated mice showed no significant differences in total infiltrate or eosinophil 
numbers (figure 2. 7d), however, eosinophils did make up a more significant proportion of the 
total infiltrate in the C57BL/6 background (figure 2. 7e ). 
2.3.2.3 Morphological characterisation of SAL/SAL and OVA/OVA treated lungs 
in the BalbC and C578L/6 Gz_,_ backgrounds compared to SAL/SAL and OVA/OVA WT 
controls. 
Due to the similarities observed in both the BalbC and C57BL/6 backgrounds following 
SAL/SAL and OVA/OVA treatment, C57BL/6 profiles were used to represent both groups of 
mice. Histological examination of lung tissue (figure 2.8) in WT mice showed morphological 
changes to the lung of OVA/OVA treated mice, including mucus secretion (detailed later), 
epithelial cell shedding and airway plugging (figure 2.8b). Although some eosinophils were 
evident in the parenchyma of OVA/OVA treated mice, the majority of eosinophils were 
localised around the airways and pulmonary blood vessels (figure 2.8b). There was a 
significant tissue eosinophilia in OVA/OVA (average 50 eosinophils /40 x field) compared 
with SAL/SAL (average 2.1 eosinophils/40 x field) (figure 2.8g). 
Comparison of SAL/SAL treated C57BL/6 (figure 2.8c) and BalbC (figure 2.Bei) Gz+ mice 
with WT controls (figure 2.8a) indicated no visual morphological differences and no 
significant tissue eosinophilia (an average 2.1 eosinophils/40 x field) (figure 2.8g) between 
the groups. All SAL/SAL samples illustrated non-inflamed parenchyma, no basal eosinophil 
infiltration and intact airways epithelium. No significant change in tissue eosinophilia was 
found between the OVA/OVA treated groups (figure 2.8g), confirming the lack of visual 
morphological differences between WT (figure 2.8b), C57BL/6 (figure 2.8d) and BalbC 
(figure 2.Bf) Gz+ mice. 
2.3.2.4 Mucus profile of SAL/SAL and OVA/OVA treated lungs in the BalbC and 
C57BL/6 Gz·1- backgrounds compared to WT controls. 
The expression of mucus secreting cells was compared between SAL/SAL and OVA/OVA 
treated WT and Gz+ mice. No mucus secreting cells were evident in either WT [BalbC 
(figure 2.Bii) and C57BL/6 (figure 2.Bki)] or Gz+ [BalbC (figure 2.Bji) and C57BL/6 (figure 
2.Bli)] SAL/SAL groups. Large numbers of mucus-secreting cells were evident in the larger 
airways of OVA/OVA treated mice, with no significant differences found in cell numbers 
between WT [BalbC (figure 2.Biii) and C57BL/6 (figure 2.Bkii)] or Gz+ [BalbC (figure 
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Figure 2.8a and b. Histological comparison of SAL/SAL and OVA/OVA treated 
lungs from WT C57BL/6 and BalbC mice in the short model of Ova-
sensitisation. 
WT C57BL/6 and BalbC mice were exposed (i.p) to saline or Ova and challenged with 
aerosol of saline or Ova (section 2.2.2.2). On day 17, lungs were removed and fixed in 10% 
NBF before sectioning and staining with chromotrope (section 2.2.2.4). Profiles of the WT 
C57BL/6 mice are shown as representative due to the similarly in lung morphology of both 
backgrounds under the experimental conditions employed. (a) SAL/SAL lungs were 
characterised by non-inflamed parenchyma, intact airways epithelium and no tissue 
eosinophilia. (b) Conversely, large numbers of inflammatory cells (mainly eosinophils) were 
localised in the peribronchial and perivascular regions of OVA/OVA treated lungs. OVA/OVA 
WT lungs also exhibited epithelial cell shedding (open arrow) and airways occlusion (black 
arrow). 
Specimens illustrated: (a) SAL/SAL WT and inset; (b) OVA/OVA WT and inset. Images are 
representative of 3 separate experiments. 
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Figure 2.8c - f. Histological comparison of SAL/SAL and OVA/OVA treated 
lungs from Gz·'· BalbC and C578L/6 mice in the short model of ova-
sensitisation. 
BalbC and C57BL/6 Gz-1- mice were exposed (i.p) to saline or Ova and challenged with 
aerosol of saline or Ova (section 2.2.2.2). On day 17, lungs were removed and fixed in 10% 
NBF before sectioning and staining with chromotrope. (c and e) No differences were 
visualised between the SAL/SAL treated lungs of C57BL/6 and BalbC Gz-1- mice, nor with the 
WT control (figure 2.8a). (d and f) OVA/OVA treated C57BL/6 and BalbC lungs were 
characterised by the same morphology displayed in the WT control (figure 2.8b ), namely, 
large numbers of inflammatory cells (mainly eosinophils) localised in the peribronchial and 
perivascular regions. 
Specimens illustrated: (c) SAL/SAL C57BL/6 Gz-1- and inset; (d) OVA/OVA C57BL/6 Gz-1- and 
inset; (ei) SAL/SAL BalbC Gz-1- and inset; (fi) OVA/OVA BalbC Gz+ and inset. 
WT SAL/SAL (figure 2.8a) and OVA/OVA (figure 2.8b) results were used for direct 
comparison. 
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Figure 2.8g and h. Quantification of eosinophils and mucus secreting cells in 
SAL/SAL and OVA/OVA treated lungs from Gz·'· and WT BalbC and C57BL/6 
mice in the short model of ova-sensitisation. 
BalbC and C57BL/6 Gz+ mice were exposed (i.p) to saline or Ova and challenged with 
aerosol of saline or Ova (section 2.2.2.2). On day 17, lungs were removed and fixed in 10% 
NBF before sectioning and staining to detect eosinophils and mucus-secreting cells. 
(g) Eosinophils were significantly increased in the airways of all OVA/OVA treated mice when 
compared to SAL/SAL treated members of each group (50 eosinophils/40 x field compared 
to 2.1 eosinophils/40 x field). However, quantification of tissue eosinophilia in OVA/OVA 
mice confirmed no significant upregulation in eosinophil numbers in the peribronchial and 
perivascular regions of the Gz+ groups compared to WT controls. (h) No mucus secreting 
cells were present in the airways of all SAL/SAL mice, increasing to high expression in the 
larger airways of OVA/OVA treated mice (48 mucus-secreting cells/40 x field) . No significant 
difference was found in mucus cell expression between Gz+ groups and their WT controls 
following OVA/OVA sensitisation. 
Values represent mean + SEM for groups of 4 mice. Significant differences are given in 
respect to the corresponding WT group: * p<0.05, ** p,0.001 . 
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2.8jii) and C57BL/6 (figure 2.81ii)], confirmed quantitatively in figure 2.8h (average 48 mucus-
secreting cells/40 x field). 
2.3.2.5 Surfactant profile of basal (non-sensitised/non-provocated) C57BL/6 Gz·'· 
lungs compared to WT controls. 
In light of the observed elevation in airways hyperresponsiveness displayed by both Gz+ 
backgrounds a brief examination was made of surfactant production in the C57BL/6 
background. Surfactant production of the lung was examined by EM analysis of basal WT and 
Gz+ mice. In the WT mice, intact surfactant cell expression was low and rarely visible (figure 
2.9a), however in the Gz+ lungs surfactant cell expression was high, with surfactant still present 
in many of the intact epithelial cells (figure 2.9b ). 
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Figure 2.8i - I. Comparison of the numbers of mucus secreting cells in SAL/SAL 
and OVA/OVA treated lungs from Gz_,_ and WT BalbC and C57BL/6 mice in the 
short model of ova-sensitisation. 
BalbC and C57BL/6 Gz+ mice were exposed (i.p) to saline or Ova and challenged with aerosol 
of saline or Ova (section 2.2.2.2). On day 17, lungs were removed and fixed in 10% NSF 
before sectioning and staining with alcian blue-periodic acid Schiffs (ABS) to delineate mucus 
production. (ii-Ii) No mucus secreting cells were visualised in either BalbC or C57BL/6, WT or 
Gz+ SAL/SAL treated groups, (iii-Iii) while following OVA/OVA treatment expression was high in 
all groups. Black arrows (red/crimson stain) indicate mucus-secreting cells in the OVA/OVA 
treated specimens. 
Specimens illustrated: (ii) SAL/SAL WT BalbC and (iii) OVA/OVA WT BalbC; U) SAL/SAL Gz+ 
BalbC and Uii) OVA/OVA Gz-1- BalbC; (ki) SAL/SAL WT C57BL/6 and (kii) OVA/OVA WT 
C57BL/6; (Ii) SAL/SAL Gz-1- C57BL/6 and (Iii) OVA/OVA Gz-1- C57BL/6. 
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Figure 2.9a and b. Surfactant cell expression in basal (non-sensitised/non-
provocated) lungs from Gz_,_ and WT C57BL/6 mice. 
C57BL/6 Gz+ and WT mice were sacrificed , lungs removed and dissected directly into 1 mm 
blocks in 2% gluteraldehye. EM sections were prepared according to the protocol outlined in 
section 2.2.2.6. Micrographs were visualised for morphological differences between Gz+ and 
WT non-sensitised airways. (a) Alveolar cells of the WT C57BL/6 displayed no intact surfactant 
cells (b) The most striking feature of the Gz-1- airway was the high expression of both intact (blue 
arrow) and empty (small red arrow) surfactant cells within the alveoli. 
Specimens illustrated: (a) C57BL/6 WT lung; (b) C57 BL/6 Gz+ lung. Images are representative 
of 3 mice within each group. 
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2.4 DISCUSSION 
Up until the last 5 years, signalling mechanisms underlying cellular processes in eosinophils 
were poorly characterised. However, with the development of more specific eosinophilic-like cell 
lines, the IL-5 transgenic mouse, and the evolution of more advanced in-vitro eosinophil assays, 
elucidation of eosinophil biology has come to the fore (van der Bruggen and Koenderman, 
1996; Koenderman et al., 2001 ). In allergy research, this work has focused on characterising 
processes underlying eosinophil migration and homing to sites of allergen provocation. The 
directed migration (chemotaxis) of eosinophils to these sites is a complex and dynamic process, 
involving the activation of chemokine receptors by chemoattractant agonists, the activation of 
intracellular signalling pathways, crosstalk with integrin/cell adhesion processes, and interaction 
with actin and tubulin cytoskeletal signalling pathways. 
Although the specificity in which chemokine agonists interact with chemokine receptors is well 
documented, the specificity of the interaction of the chemokine receptor with its G-protein target 
remains to be evaluated. In this Chapter, I have characterised the relationship between Gi-
proteins and the most eosinophil specific and highly expressed of the chemokine receptors, 
CCR-3. Previous in-vitro studies had shown that this receptor initiates its chemotactic signals 
through a pertussis toxin sensitive Gi-protein/s (Agrawal et al., 1992), however, the identity of 
the specific Gi-protein involved had not been elucidated. 
Using murine eosinophils, rather than eosinophilic-like cell lines that are poorly representative of 
this cell, mRNA expression was confirmed for both the Gia2 and Gia3 subtypes (figure 2.2), as 
was their translation to protein (figure 2.3). Neither protein nor mRNA expression was detected 
for the Gia1 subtype (figure 2.2 and 2.3). The next step was to identify whether either of these 
Gi-proteins was involved in CCR-3 mediated chemotaxis. Employing eotaxin as a specific 
CCR-3 agonist, a direct interaction was observed between Gia2 and CCR-3 (figure 2.4 and 
2.5). Interestingly this association was present to a much lesser degree in non-eotaxin-
stimulated cells, suggesting the presence of residual endogenous eotaxin prior to cell lysis and 
immunoprecipitation or basal interactions between CCR-3 and Gia2 (figure 2.4). No interaction 
was identified between CCR-3 and Gia3, identifying Gi-protein specificity in the generation of 
chemotactic signals in eosinophils. Previous studies in other cell types have focused on the 
importance of the Gi-protein ~y subunit in the mediation of cell migration (Neptune et al. , 1997; 
Arai et al., 1997). However, the specific utilisation of Gia2 in response to chemoattractant 
stimulation of CCR-3 suggests, importantly, that the a-subunit plays an active role in second 
messenger activation and the generation of chemotactic signals . Selective G-protein coupling 
by CC chemokine receptors has been investigated to a limited extent, linking specific 
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physiological responses including chemotaxis and exocytosis with various G-protein family 
members (Kuang et al., 1996; Nasman et al., 2001 ;). Of the Gia family members, Gia2 has 
been closely linked with chemotaxis (Damaj et al., 1996; Liu et al., 2001 ), while Gia3 activation 
is associated with cellular exocytotic events (Pinxteren JA, 1998). 
The characterisation of signalling specificity underlies the potential to develop therapeutic 
strategies. For example, if in response to an agonist a cell can undergo a variety of cellular 
responses, then pharmacological intervention may allow the divergence from one signalling 
pathway to another, or ideally, blockade of the response altogether. In a fully differentiated cell, 
such as the mature eosinophil, the variety of physiological outcomes becomes increasingly 
limited, focusing on cell recruitment/migration and apoptosis/necrosis, making preferential 
signals easier to target and inhibit. 
In contrast to other Gia family members, mRNA expression of the pertussis-toxin insensitive Gz 
has been identified at very low levels in a limited number of tissues: neuronal tissue [brain 
(Spicher et al., 1988), retina (Hinton et al., 1990), symphathetic neurons (Jeong and Ikeda, 
1998), platelets (Carlson et al., 1989), and natural killer cells (Maghazachi et al, 1996). Interest 
in the Gz+ mouse and the characterisation of it's phenotype in relation to airways morphology 
stemmed from initial experiments suggesting abnormalities in eosinophil recruitment to the lung 
upon Ova-sensitisation/Ova-provocation (OVA/OVA) in these mice (observations by Koskinen A 
and Dr K Matthaei, unpublished data). Coupled with the potential role of Gz in peripheral neural 
events and airways hyperreactivity, the Gz-1- mouse was investigated in our allergic airways 
model. 
Although the supply of Gz+ was restricted, due to the high mortality rate of post-natal pups, 
several groups of both BalbC and C57BL/6 Gz+ mice were analysed for basal and Ova-induced 
allergic responses. Initial studies focused on Gz-1- characterisation in the C57BL/6 background 
utilising the long-model of ova-sensitisation. The most striking result was the elevation in basal 
(non-sensitised/non-provocated) airways responsiveness compared to WT in these mice (figure 
2.6a). However, it became quickly apparent that the severity of disease induced by OVA/OVA 
treatment in both WT and Gz+ mice would make comparisons of leukocyte parameters and 
histology difficult, hence the short-model was adopted in subsequent experiments. Using the 
short-model, basal airways responsiveness was significantly elevated in both BalbC and 
C57BL/6 backgrounds compared to WT controls, while in C57BL/6 mice this increase reached 
up to a 4-fold difference (figure 2. ?a). Following OVA/OVA treatment, airways responsiveness 
remained elevated 2-fold from WT in both Gz-1- groups, with no significant difference between 
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backgrounds. However, the importance of genetic variation in the analysis of experimental 
parameters (Drazen et al., 1999) was highlighted by the reduction in PBE found in the BalbC 
Gz-1-, while this trend was reversed in C57BL/6 mice that displayed elevated PBE compared to 
WT controls. Even in the short-model, no other significant differences were observed in the 
leukocyte parameters measured, including tissue ultrastructure (figures 2.8a-f) and mucus 
production (figures 2.8g-j) in response to Ova-sensitisation and provocation. 
The cellular and molecular mechanisms underlying the development of AHR are yet to be fully 
characterised. Thus the changes observed in airways responsiveness in the Gz+ mouse were 
of considerable interest. Initial studies into the key cellular mediators focused on the role of 
eosinophils (Elwood et al., 1992), the cytokines IL-4 and IL-5 (Hammelmann et al., 1997), and 
more recently the importance of IL-13 in AHR development (Zhu et al., 1999). The sustained 
elevation in AHR observed in the ova-sensitised Gz+ groups may have been partially due to an 
increase in eosinophil trafficking. Although BALF eosinophilia was not significantly increased in 
either background, previous studies have suggested that AHR correlates most closely with 
tissue eosinophilia rather than eosinophilia in the BALF (Yamada et al., 1994). In addition, 
many studies have concluded that eosinophils play little, if no role in the induction of allergen 
associated AHR (Corry et al., 1996; Tournoy et al., 2000). However, the significant basal 
difference in AHR in the absence of eosinophil recruitment suggests ablation of Gz has a direct 
effect on neurogenic activity in the lung. 
The close collaboration of neurogenic pathways with the generation of AHR and 
bronchoconstriction is well characterised (Barnes et al., 1992). Airways smooth muscle control 
is mediated primarily through parasympathetic cholinergic nerve stimulation (Vornanen and 
Tirri, 1981) and is counteracted through the activation of sympathetic adrenergic (Vornanen M, 
1982) and non-adrenergic, non-cholinergic (NANC) nerves (Mackay et al., 1991 ). NANC nerves 
are activated by the neurotransmitters acetylcholine and adrenaline, tachykinins (substance P, 
neurokinins (NK) A and B) and VIP (Barnes et al., 1991; Reynolds et al., 1997; Choi et al., 
1998; Barnes, 2000). 
To date, studies on the G protein selectivity of muscannic cholinergic receptors and ~-
adrenergic receptors have identified the functional promiscuity of these receptors for G-protein 
family members (Gavett and Wills-Karp, 1993; Wong and Ross, 1994). Although some 
receptors have been identified to signal via a subset of G-proteins (Kostenis et al., 1999), the 
high probability of redundancy suggests that the lack of Gz expression would not result in the 
direct inhibition of smooth muscle contraction or relaxation. However, Gz ablation may result in 
the modulation of neurogenic signalling pathways, possibly through changes in neurotransmitter 
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release (Khawaja and Rogers, 1996). Increasing evidence suggests that signals instigated by 
GPCR/Gz coupling do indeed diverge from signalling pathways activated by other members of 
the Gi-protein family (Ho and Wong, 2001 ). In addition, Gz has been shown to play a direct role 
in the establishment of neural pathway development in the mouse (Kelleher et al., 1998), 
suggesting the lack of Gz may result in poor lung innervation and alterations in smooth muscle 
control. 
The alveoli and distal airways are lined by pulmonary surfactant, consisting mainly of 
phospholipids and surfactant proteins (Holmskov and Jensenius, 1993). SP-A and D are 
glycoproteins whereas SP-B and C are extremely hydrophobic proteolipids released from large 
precursors by proteolysis (Rooney et al., 1994 ). SPs function to reduce surface tension at the 
air-liquid interface and to provide tissue protection (Hoppe and Reid, 1994). Electron-
microscopic analysis revealed a strong upregulation in surfactant cell expression and SP 
production in Gz+ mice under basal (non-sensitised/non-provocated) conditions. Increased SP 
release into the airways may be due largely to altered post-translational processes, augmented 
release, and/or reduced uptake by epithelial cells during allergic inflammation (Wright and 
Dobbs, 1991 ). Observations of SP-A and SP-D levels in the BALF of bronchial asthmatic 
patients are conflicting in previous studies (Cheng et al., 2000; Haczku et al., 2001; Wang et al., 
2001 ). In relation to our Gz+ AHR results, SP upregulation has been associated with a 
decrease in airway responsiveness (Kurashima et al., 1997). However SP viscosity will 
determine the efficiency of airflow and an upregulation in serum protein concentration may still 
promote airways bronchoconstriction (Enhorning and Holm, 1993). Future studies should be 
aimed at performing a morphometric analysis and the quantification of surfactant proteins and 
lipids to substantiate these observations. 
In conclusion, G-proteins play a central role in modulating the machinery that cell's utilize in the 
transduction of extracellular signals into intracellular responses. Characterisation of signal 
transduction pathways will allow us to better understand these cellular responses and also 
provide us with strategies in the development of specific therapeutic targets. In this chapter 
Gia2 was found to specifically associate with CCR-3, thus playing an important role in 
eosinophil migration. Furthermore, the Gz-protein was identified as an important regulator of 
airways reactivity to methacholine, potentially through the modulation of innervation to the lung 
and changes in SP production and composition. 
88 
CHAPTER 3: 
Functional Asymmetry 
• 1n 
Eosinophil Chemotaxis 
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3.1 INTRODUCTION 
CCR-3 is the most widely expressed chemokine receptor on murine eosinophils and is 
thought to play a crucial role in eosinophil trafficking. To date the downstream second-
messengers involved in the generation of chemotactic signals through this receptor are 
poorly characterised. The reasons for this have been threefold: 1) the lack of a consistent 
and plentiful source of non-activated eosinophils; 2) the highly proteolytic nature of the 
eosinophil, making reproducibility in intracellular biochemical investigations difficult; and 3) 
the strongly cationic charge of the granular contents of eosinophils making traditional 
immunohistochemical protocols ineffective. In this Chapter, the IL-5 transgenic mouse 
model was used as a source of eosinophils. This enabled the development of an 
eosinophil-specific immunohistochemical protocol (3.2.3.2) to allow the visualisation of 
cell-surface and intracellular dynamics of this granulocyte. In particular, cellular dynamics 
regulated by eotaxin and IL-5 was investigated. In conjunction with the 
immunohistochemical studies, subsequent biochemical protocols were developed that 
minimised proteolytic activity during cell sorting and analysis (2.2.1.4.1 ). 
Of particular interest was the characterisation of CCR-3 and IL-SR localisation in response 
to both priming and chemoattractant stimulation. The ability of cells to polarise structurally 
in response to a chemotactic gradient is broadly accepted (Weiner et al., 1999), however, 
functional polarisation or the asymmetrical aggregation of signalling mediators is still 
highly controversial (Servant et al., 2000), and important for understanding how highly 
motile cells such as the eosinophil migrate. As with other G-protein coupled receptors, 
CCR-3 undergoes the dynamic process of internalisation/recycling in response to agonist 
stimulation. Previous biochemical studies by Zimmerman et al had found that in response 
to agonist stimulation up to half of the CCR-3 pool internalised for up to 18 hours in an 
eosinophilic-like cell line (Zimmerman et al., 1999). The aim of the current study was to 
visualise CCR-3 internalisation and trafficking, providing an insight into the ability of ligand 
exposed cells to re-sensitise and respond to subsequent changes in chemoattractant 
gradients. 
The possible role of IL-5 priming in the modification of CCR-3 trafficking was also 
investigated. IL-5 is known to upregulate a number of effector functions in the eosinophil 
(Lopez et al., 1988), including enhancing integrin-mediated adhesion by increasing the 
expression of membrane associated receptors (Neeley et al., 1993; Walsh et al., 1990) 
and upregulating the chemotactic response (Coeffier et al., 1994). IL-5 priming of 
eosinophil migration may be regulated at the receptor level. Hence, changes in CCR-3 
aggregation at the plasma membrane and modifications to the internalisation time-course 
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were examined. In addition, localisation of the IL-SR was examined in response to both 
ligand-specific and chemoattractant stimulation. The ability of the receptor to functionally 
polarise and establish leading edge proximity would suggest a role for the IL-SR and its 
downstream second messengers in chemotactic events. These investigations were also 
conducted with a view to gaining further insights into how IL-S and eotaxin cooperate to 
promote eosinophilia. 
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3.2 MATERIALS AND METHODS 
FACS sorting of peritoneal eosinophils Section 2.1.1.2 
3.2.1 Generation of non allergen-sensitised eosinophils in the peritoneal 
cavity of wild-type mice 
Eosinophils were stimulated to accumulate in the peritoneal cavity of wild-type mice 
following an intense protocol of Polymyxin B (Sigma, St.Louis, MO, USA) injections 
(Pincus SH, 1978). 200µ1 of Polymyxin B (1 00µg) in 0.9% saline was injected 
intraperitoneally (i.p) twice weekly for a period of 8 weeks. Eosinophils were collected 
from the peritoneal cavity and purified by FACS (section 2.2.1.3). 
3.2.2 FACS analysis of cell-surface antigens - CCR-3 and IL-5Ra 
expression on wildtype (see 3.2.1) and IL-5 transgenic eosinophils 
Freshly sorted murine eosinophils were kept in 30%FCS/Hanks on ice prior to analysis. 
Cells were centrifuged at 1,500g for 5min and pellets resuspended in 200µ1 of 2% human 
lgG (Sigma-Aldrich, USA) in PBS for 1 hour (blocking non-specific Fe-receptor staining). 
The primary antibodies, rat anti-CCR-3 (mAb 19-4; DNAX, Palo Alto, CA, USA) and rabbit 
anti-lL-5Ra (Santa Cruz Biotechnology, CA, USA) were added to blocking buffer at 
1 µg/ml, (previously optimised) and incubated for 1 hour on ice. Cells were washed three 
times in PBS and pelleted. BODIPY FL® (Molecular Probes, Eugene, OR, USA) 
conjugated secondary antibodies (emission at 505-513) were added at 1 0µg/ml in PBS 
and cells incubated for 1 hour on ice. Following incubation, cells were once again washed 
three times in PBS and resuspended in 100µ1 fresh PBS. Cell-surface expression of 
CCR-3 and IL-5Ra was analysed on the FACSscan (Becton Dickinson, Franklin Lakes, 
NJ, USA) utilising a single laser at 488nm. 
3.2.3 CCR-3 signalling events - receptor phosphorylation and 
internalisation 
3.2.3.1 Protein immunoprecipitation protocol 
See section 2.2.1.4.1 for general protocol. For receptor phosphorylation studies, 500µ1 
cell fractions were immunoprecipitated with 1 µg/ml of anti-mouse phosphotyrosine ( clone 
4G1 0; Upstate Biotechnology, NY, USA), while for receptor internalisation studies, cell 
fractions were immunoprecipitated with 1 µg/ml rat anti-CCR-3 (mab 6S2-19-4; DNAX, 
Palo Alto, CA, USA). 
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3.2.2.2 5D5-Polyacrylamide Gel Electrophoresis (PAGE) 
See section 2.2.1.4.2. 
3.2.3.3 Western blotting protocol 
See section 2.2.1.4.3 for general protocol. For both receptor phosphorylation and 
internalisation studies, blocked membrane was incubated with 1 µg/ml rat anti-CCR-3 
(mab 6S2-19-4; DNAX, Palo Alto, CA, USA) overnight at 4°C. Secondary anti-rat HRP 
conjugated antibody (DAKO, Carpinteria, CA, USA) was applied at 1 :2000. 
3.2.4 Fluorescence immunohistochemistry and confocal protocol 
3.2.4.1 lmmunohistochemical and confocal analysis using cell cytospins 
Leukocytes were extracted by peritoneal lavage (see section 2.2.1.2) from IL-5 transgenic 
mice and kept in 30% FCS/Hanks on ice prior to analysis. Cells were stimulated with 
eotaxin (1 00ng/ml) (Peprotech, Rocky Hill, NJ, USA) for 10 minutes in a 1.5ml eppendorf 
tube. 2 x 105 cells were centrifuged (Cytospin, Shandon Southern Instruments, Sewickly, 
PA, USA) onto glass microscope slides at 300g for 3 minutes. Cells were fixed in 4% 
paraformaldehyde (Sigma, St. Louis, USA) for 4 minutes. Non-specific binding sites were 
blocked extensively with 2% human lgG (Sigma, St. Louis, USA) for 2 hours at room 
temperature or overnight at 4°C. The primary antibody, anti-CCR-3 (mab 6S2-19-4; 
DNAX, Palo Alto, CS, USA) was added to blocking buffer, at a previously optimised 
concentration, and the slide incubated for 1 hour on the "plate rocker" at 4°C. Cytospins 
were washed 5 times with PBS. Fluorochrome conjugated anti-rat secondary antibody 
was added in PBS, to the primary-bound and control cytospins, at a previously optimised 
concentration, and slides were covered in foil and incubated on the "plate rocker'' for 1 
hour at 4°C. Slides were washed 5 times with PBS and samples covered with a cover 
slip and sealed. Fluorescent staining was visualised on the confocal microscope (Leica 
LCS, Germany) utilising the Krypton/Argon laser emitting light at 488, 568, and 64 7 nm 
wavelengths. 
3.2.4.2 lmmunohistochemical and confocal analysis using transwell 
preparations 
(Figure 3.1 Flow diagram of transwe/1 immunohistochemical protocol) 
Freshly sorted murine eosinophils were kept in 30%FCS/Hanks on ice prior to analysis. 
Polycarbonate transwell filters (Corning Costar, MA, USA) were coated with 50µg/ml 
fibronectin (Sigma, St. Louis, USA) and allowed to "dry" 2 hours at 37°C. Prior to 
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Eosinophils sorted from peritoneal lavage of IL-5 transgenic 
C56BL/6 mice using BD-FACSStar Plus cell sorter 
+ Cells placed in upper chamber of polycarbonate transwell 
3µM pore (50ug/ml fibronectin coated) - no agonist 
__ ___,;,, ___ ....,;,;;;;a~ __ _____.-t 
1 mm 
Agonist added to lower well 
Creation of chemoattractant gradient 
+ 
Cells adhere or migrate towards gradient in lower chamber 
Time course 
+ Cells fixed (4% paraformaldehyde) and permeabilized (0.5% 
SDS) 
+ 
Extensive blocking of non-specific binding sites 
2% human lgG 
t 
Fluorescent immunohistochemical staining 
t Analysis by confocal microscope 
Figure 3.1. lmmunohistochemical protocol for murine eosinophils 
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analysis, transwells were washed twice with RPMI and placed in an empty transwell plate. 
Cells were placed in the upper chamber of the transwell , at 1 x 106 cells/ml in RPMI and 
allowed to adhere for 30 minutes. Agonist was added to the lower well (plate well) 
[eotaxin (Peprotech, NJ, USA) at 1 00ng/ml and IL-5 (Dr. I. Young , BMB, JCSMR) at 
1 Ong/ml, platelet activating factor (PAF) (Cayman Chemicals, Michigan, USA) at 1 o-7M]. 
Cells were left to migrate towards the gradient in the lower chamber over a pre-
determined time course, at the end of which cells were fixed in 4% paraformaldehyde 
(Sigma, St. Louis, USA) for 4 minutes and permeabilised with 0.5% SOS (Sigma, St. 
Louis, USA) for 30 minutes (Table 3.1 ). Non-specific binding sites were blocked 
extensively with 2% human lgG (Sigma, St. Louis, USA) for 2 hours at room temperature 
or overnight at 4°C. 
Table 3.1. Investigation into fixation/permeabilisation protocol for eosinophils 
Protocol (fixation followed by permeabilisation) 
(1) 0.7% glutaraldehyde 15 min + 0.2% Triton X-100 15 min 
(4) 3.7% formalin 10 min + 5% saponin 30 min 
Staining 
(5) 0.4% p-benzoquinone 1 0min + 0.74% n-octyl-b-d-glucopyranoside 6min -
(3) 4% paraformaldehyde 15 min + 0.2% Triton X-100 15 min + 
(6) 4% paraformaldehyde 15 min + 5% saponin 30 min 
(7) 4% paraformaldehyde 15 min + 0.5% SOS + 
Filters were excised from the transwell and placed in PBS within a new 24-well plate 
(Nalgene Nunc, NY, USA). Fluorochrome conjugated antibody or primary antibody was 
added to blocking buffer, at a previously optimised concentration, and the foil covered 
plate incubated for 1 hour on the "plate rocker" at 4°C. Filters were washed 5 times with 
PBS. Fluorochrome conjugated secondary antibody (if primary antibody was 
unconjugated to fluorochrome) was added in PBS, at a previously optimised 
concentration, and plates were once again covered in foil and incubated on the "plate 
rocker'' for 1 hour at 4°C. To examine nuclei, were incubated with 1 0ug/ml propidium 
iodide (Sigma, St. Louis, USA) and washed 5 times with PBS. Filters were mounted with 
glycerol on glass slides, covered with a cover slip and sealed. Fluorescent staining was 
visualised on the Leica LCS confocal system (Germany), utilising the Krypton/Argon laser 
emitting light at 488, 568, and 647 nm wavelengths . 
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IL-5Ra was detected using an anti-rabbit IL-5Ra antibody at 1 µg/ml (Santa Cruz 
Biotechnology, CA, USA) followed by the BODIPY anti-rabbit secondary (Molecular 
Probes, Eugene, OR, USA) at 1 0µg/ml. In preliminary experiments (figures 3.4, 3.5, 3.8), 
CCR-3 was detected using the two-step staining protocol: anti-rat CCR-3 (mab 6S2-19-4; 
DNAX, Palo Alto, CA, USA) was used at 1µg/ml, followed by BODIPY anti-rat (Molecular 
Probes, Eugene, OR, USA) at 1 0µg/ml. In later experiments (figure 3.6) the CCR-3 mab 
was directly conjugated to the Alexa 488 fluorochrome (Molecular Probes, Eugene, OR, 
USA) (see section 3.2.3.1 ), and a one step staining procedure was utilised. 
3.2.3.2 Preparation of anti-CCR-3/Alexa 488 conjugate 
1 ml of murine CCR-3Ab at 2mg/ml was obtained from DNAX (Palo Alto, CA, USA), 
enabling the direct conjugation of the antibody to fluorochrome using the Alexa Flour 488 
Protein Labelling Kit (Molecular Probes, Eugene, OR, USA). Labelling reaction: 50µ1 of 
1 M sodium bicarbonate (pH 8.3) was added to 0.5ml of antibody solution, which was then 
added to a vial of reactive dye. The reaction mixture was stirred gently for 1 hour at RT, 
and the reaction stopped with the addition of hydroxylamine. Stirring was continued for 30 
minutes at RT. Purification of labelled antibody: the chromatography column was loaded 
with resin and drained. The reaction mixture was added gently to the column and allowed 
to enter the resin. The addition of elution buffer resolved two coloured bands, the first of 
which contained labelled antibody and was collected (second band consists of unlabelled 
dye). 
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3.3 RESULTS 
3.3.1 In-vitro analysis of eosinophil biology: development of a model 
system to investigate eosinophil biology at a cellular level. 
Up until the last few years, eosinophil biology remained poorly characterised due to the 
lack of a reliable and plentiful source of non-activated eosinophils and eosinophilic-like 
cells. The human eosinophilic-like cell lines AML 14 and AML 14.3D1 0 (Paul et al., 1995) 
and Eol-1 (Yoshie et al., 1989) were investigated, but the lack of strong homogeneity in 
these populations detracted from their use in signalling experiments (data not shown). 
Only small eosinophil numbers can be isolated from wild-type mice making biochemical 
investigations virtually impossible. In initial experiments, eosinophils were generated by 
polymyxin B injection into the peritoneal cavity of wild-type C56BL6 mice (Pincus SH, 
1978). This intense and long (8 weeks) protocol generated on average 1x106 
eosinophils/mouse, requiring stringent FACS sorting prior to analysis. Generation of the 
IL-5 transgenic mouse provided a plentiful source of eosinophils, with a strong peritoneal 
eosinophilia (8 - 21x106 eosinophils/mouse) characteristic of the non-sensitised 
phenotype (Dent et al., 1990). Characterisation of primary murine eosinophils allowed 
dissection of cellular processes in fully differentiated cells. This provided an opportunity to 
relate in-vivo experimentation in eosinophil trafficking to studies at a cellular level, in 
addition to providing enough cells to perform immunohistochemical and biochemical 
analyses. 
3.3.2 Comparison of CCR-3 expression on WT and IL-5 transgenic 
peritoneal eosinophils 
In order to establish the viable use of the IL-5 transgenic eosinophil in in-vitro studies the 
expression of CCR-3 and IL-5Ra was compared with WT cells. In these FACscan 
analyses, the BODIPY-conjugated secondary was used due to its non-ionic nature. FACS 
sorted WT and IL-5 transgenic eosinophils (section 2.2.1.2) were shown to express both 
CCR-3 (figure 3.2a) and the IL-5a receptor (figure 3.2b). Both CCR-3 and IL-5Ra 
expression were higher in the IL-5 transgenic eosinophils when compared to WT. The IL-
5 transgenic eosinophil was adopted as a good model for the characterisation of 
intracellular signalling pathways for in-vitro analysis. 
3.3.3 CCR-3 is tyrosine phosphorylated in response to eotaxin 
(1 00ng/ml) stimulation. 
The ability of eotaxin to induced phosphorylation of CCR-3 was investigated. FACS 
sorted peritoneal IL-5 transgenic eosinophils were stimulated with eotaxin (1 00ng/ml) for 0 
- 5 minutes, then fractionated into triton soluble and in-soluble samples, following the 
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Figure 3.2a and b. 
transgenic eosinophils 
CCR-3 and IL-5Ra expression 1n wild-type and IL-5 
Freshly sorted unstimulated wild-type (section 3.2.1) and IL-5 transgenic eosinophils were 
labelled with CCR-3/BODIPY (figure 3.2a) or IL-5Ra/BODIPY (figure 3.2b) (section 3.2.2), 
and analysed for surface expression of these receptors. Increased expression of CCR-3 
and IL-5Ra was found on the IL-5 transgenic eosinophils (indicated by curve 3) compared 
to wild-type mice (curve 2) . BODIPY controls were included to confirm specificity of 
primary antibody staining (curve 1). 
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removal of the nuclear pellet (section 2.2.1.4.1 ). Fractions were immunoprecipitated with 
anti-phosphotyrosine antibody (section 2.2.1.4.1 and 3.2.2.1) and western blotted with 
CCR-3 mab (2.2.1.4.3 and 3.2.2.3). CCR-3 was found to be tyrosine phosphorylated by 
eotaxin at 1 minute in both fractions (figure 3.3). By 5 minutes there was a slight 
decrease in phosphorylated CCR-3 in the soluble fraction (figure 3.3; left) coupled with 
an increase in band intensity in the insoluble fraction (figure 3.3; right). Interestingly, 
phosphorylated receptor was detected at time O in the soluble fraction, most probably due 
to activation of the receptor by endogenous eotaxin. However, this was substantially 
increased by eotaxin stimulation (figure 3.3; left). 
3.3.4 Localisation of CCR-3 in murine eosinophils 
The immunohistochemical characterisation of intracellular signalling mediators in 
eosinophils has been limited, to a large extent, by strong autofluorescence and non-
specific binding of antibodies to the highly cationic granule proteins. With this in mind, an 
extensive investigation was carried out into the most suitable and consistent fixation and 
lysis method (Table 3.1 ). The final protocol used in these studies employed an extensive 
blocking protocol to eliminate non-specific binding and autofluorescence, in conjunction 
with the use of non-ionic fluorochromes and pre-conjugated primaries in 
immunohistochemical detection (section 3.2.3.2). 
3.3.4.1 Initial characterisation of immunohistochemical staining with CCR-
3/BODIPY in eotaxin stimulated eosinophils 
Several techniques were explored to establish a visual profile of CCR-3 localisation during 
agonist stimulation. Initial experiments focused on characterising the specificity of the 
anti-CCR-3 primary and BODIPY-conjugated secondary. As with FACSscan analyses, the 
BODIPY fluorochrome was ideal due to its non-ionic nature and resistence to 
photobleaching. Specificity of the CCR-3 antibody was illustrated by the fact that only 
eosinophils were found to stain positively for this receptor within the peritoneal leukocyte 
pool (figure 3.4ai and aii). To confirm this result, images were viewed under 
transmission settings, allowing the positive identification of the distinction eosinophil 
nucleus corresponding to cells positive for CCR-3 (data not shown) . In parallel with these 
experiments, control slides of the BODI PY-conjugated secondary showed specificity of the 
unconjugated fluorochrome (figure 3.4 bi and bii). As expected for cell-surface staining, 
close examination found a distinct cell membrane localisation of CCR-3 (figure 3.4ci and 
cii), while disruption of the cell membrane in some eosinophils was illustrated by the lack 
of peripheral localisation and radial staining in the cytosol of the cell (figure 3.4di and dii). 
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(1 00ng/ml) stimulation 
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Sorted IL-5 transgenic eosinophils were incubated with eotaxin (1 OOng/ml) for 0, 1 or 5 
minutes, then fractionated and immunoprecipitated with anti-phosphotyrosine antibody 
(section 2.2.1.4.1 and 3.2.2.1 ). Western blots were performed on immunoprecipitates with 
anti-CCR-3 (section 2.2.1.4.3 and 3.2.2.3). CCR-3 was found to be tryosine 
phosphorylated by eotaxin stimulation at 1 minute in both the triton soluble and insoluble 
fractions. The slight decrease in band intensity at 5 minutes in the triton soluble fraction 
was coupled with an increase in CCR-3 phosphorylation in the triton insoluble fraction . 
This blot is representative of three separate experiments. 
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However, the limitation of cytospin preparations was highlighted by the lack of migratory 
structures (pseudopodia, cell polarisation) due to the high level of mechanical stress 
enforced on the cytospun cells. 
3.3.4.2. lmmunohistochemical localisation of CCR-3 using the transwell 
migration protocol 
3.3.4.2.1 CCR-3 localisation following a time-course of eotaxin stimulation 
A transwell migration protocol was developed enabling a more representative in-vitro 
model for investigating eosinophil adhesion and motility (section 3.2.3.2). Cell 
polarisation and lamellipodia formation was readily maintained and the leading edge could 
easily be discriminated due to the degradation of fibronectin in the path of the migrating 
cell and orientation towards the site of the shallow gradient (pores of the filter). 
CCR-3 localisation was studied in response to a time-course of eotaxin stimulation. In 
unstimulated eosinophils (time 0), CCR-3 was localised at, and adjacent to, the cell 
membrane (figure 3.5a). Short-term (10 minutes) eotaxin stimulation could induce a 
distinct polarisation of the cell and asymmetrical distribution of this receptor to the leading 
edge (figure 3.5b, arrow). Continued incubation (30 minutes) resulted in the CCR-3 pool 
in many cells undergoing internalisation/recycling and localised predominantly to the 
cytosolic region, with only a small fraction of the receptor still localised to the cell 
membrane (figure 3.5c). By 60 minutes, a high proportion of the eosinophils had 
migrated through the filter (figure 3.5di - iii). 
A comparison was then made on the effect of eosinophil priming with IL-5 on the 
localisation of CCR-3 in the eotaxin-stimulated cell. As observed with eotaxin alone, 
eosinophils were beginning to polarise by 10 minutes and CCR-3 had begun to localise 
asymmetrically adjacent to the leading pseudopod (figure 3.5ei - iii) . By 30 minutes, 
migrating cells were highly polarised and although in some cells CCR-3 was undergoing 
internalisation, many cells still maintained asymmetrical distribution of the receptor (figure 
3.5fi - iii). As with eotaxin-stimulated eosinophils, the most intense period of pseudopod 
formation and cell polarisation/elongation occurred during short-term (up to 30 minutes) 
chemotactic stimulation. A high proportion of eosinophils had migrated through the filter 
by 60 minutes, and although CCR-3 was partially internalised, most of the receptor was 
localised adjacent to the cell membrane (figure 3.5gi - iii). In summary, the main 
differences observed between eotaxin stimulated and IL-5 primed/eotaxin stimulated 
eosinophils was the longer retention of CCR-3 asymmetry in the migrating cell and the 
maintenance of receptor localisation in close proximity to the cell membrane. 
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Figure 3.4a - d. Characterisation of immunohistochemical staining with 
CCR-3/BODIPY using leukocyte cytospin preparations 
Leukocytes were extracted by peritoneal lavage from IL-5 transgenic mice (see section 
2.2.1.2) and stimulated with eotaxin (1 00ng/ml) for 10 minutes . Cytospin samples were 
prepared and labelled with anti-CCR-3 (mab 6S2-19-4) and BODIPY-conjugated 
secondary ( see section 3.2.3.1) and were visualised using the Krypton/Argon laser of the 
confocal microscope (Leica LCS, Dassel , Germany). CCR-3 localisation was 
characterised by: (a) anti-CCR-3/BODIPY staining of the leukocyte pool to confirm 
specificity of anti-CCR-3 primary; (b) BODIPY-conjugated secondary control; (c) anti 
CCR-3/BODIPY cell-surface staining of intact eosinophils .; (d) anti CCR-3/BODIPY stain 
of cell membrane disrupted eosinophils. These cytospin stains were representative of 
three separate experiments. Each panel is supplemented with a gray-scale inverted 
image. 
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Figure 3.5a - d. lmmunohistochemical localisation of CCR-3 using the 
transwell migration protocol: time-course of eotaxin stimulation. 
FACS sorted peritoneal IL-5 transgenic eosinophils (section 2.2.1.2) were left to adhere for 
30 minutes onto fibronectin coated transwell filters and stimulated with eotaxin (1 00ng/ml) 
for (a) 0, (b) 10, (c) 30 and (d) 60 minutes (section 3.2.3.2 for the transwell 
immunohistochemical protocol). Cells were fixed, permeabilised and stained with anti-
CCR-3 and BODIPY-labelled secondary antibody. Ventral CCR-3 (green) staining was 
visualised using the Krypton/Argon laser of the confocal microscope (Leica LCS, 
Germany). Figure (d) is shown as a grayscale/inverted image to highlight CCR-3 
localisation against the intense nuclear stain. Arrowhead denotes dominant 
pseudopodia/leading edge. These images are representative of three separate 
experiments carried out in duplicate. Bar indicates 5µm. 
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Figure 3.5e - g. lmmunohistochemical localisation of CCR-3 using the 
transwell migration protocol: time-course of eotaxin stimulation following IL-
5 priming. 
FACS sorted peritoneal IL-5 transgenic eosinophils (section 2.2.1.2) were left to adhere 
for 30 minutes onto fibronectin coated transwell filters, primed with IL-5 (1 Ong/ml) for 30 
minutes and stimulated with eotaxin (100ng/ml) for (e) 10, (f) 30 and (g) 60 minutes 
(section 3.2.3.2 for the transwell immunohistochemical protocol). Cells were fixed, 
permeabilised and stained with anti-CCR-3 and BODIPY-labelled secondary antibody and 
propidium iodide (nuclear stain). Ventral staining was visualised using the Krypton/Argon 
laser of the confocal microscope (Leica LCS, Germany). Images show: (i) anti-CCR-
3/BODIPY (green); (ii) anti-CCR-3/BODIPY (green) and nuclear stain (red); (iii) inverted 
gray-scale image of (ii). Arrowhead denotes dominant pseudopodium/leading edge. 
Controls of the BODIPY-labelled secondary were performed confirming specificity of 
binding to the primary antibody (data not shown). These images are representative of two 
separate experiments carried out in triplicate. Bar indicates Sµm. 
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3.3.4.2.2 CCR-3 localisation in poorly adherent eosinophils 
The role of eosinophil adherence in establishing cell polarisation/motility and its effect on 
CCR-3 localisation were investigated. Eosinophil interactions with uncoated transwell 
filters provided a good model for poorly adherent eosinophils. In control cells, CCR-3 was 
localised evenly around the cell membrane (figure 3.6a). Ten minutes stimulation with 
eotaxin (1 00ng/ml) did not induce cell polarisation or CCR-3 asymmetry, but CCR-3 
internalisation was initiated (figure 3.6b). At 30 minutes, receptor aggregation (at several 
points on the cell membrane) and internalisation were apparent (figure 3.6c), with both 
trends becoming strongly enhanced by 60 minutes (figure 3.6d). 
In the absence of strong eosinophil adhesion, eotaxin was unable to induce cell 
polarisation and motility. Although CCR-3 did not undergo asymmetrical re-distribution, 
there was a marked aggregation of the receptor at several points on the cell membrane 
(figure 3.6c and d). The intracellular trafficking of CCR-3 did not co-localise with nuclear 
staining but to a site central to the cell and nucleus (figure 3.6 b,c and d). The radial 
profile of CCR-3 internalisation (figure 3.6c and d) was reminiscent of receptor staining in 
cell membrane-disrupted eosinophils following cytospin preparation (figure 3.4di and dii). 
3.3.4.2.3 Confirmation of CCR-3 localisation using CCR-3/Alexa488 conjugate 
In order to further confirm the specificity of CCR-3 staining and to enable double-labelling 
procedures, a conjugate of anti-CCR-3 and the Alexa 488 dye was developed. Earlier 
receptor localisation studies, in response to IL-5 priming and eotaxin stimulation, were 
repeated using the CCR-3/Alexa 488 conjugate. Previous results were confirmed using 
this antibody while the initial characterisation of staining with unconjugated anti-CCR-3 
and BODIPY-labelled secondary allowed the establishment of secondary controls not 
possible with the direct conjugate. 
Mid-section staining of eosinophils stimulated for 10 (figure 3.7ai - iii) and 15 (figure 
3.?bi-iii) minutes induced a strong polarisation of the cell membrane and asymmetrical 
distribution of CCR-3 (figure 3.7bi - iii). CCR-3 had begun to internalise by 20 minutes, 
appearing to "track" along a distinct line (figure 3. 7ci -iii). By 30 minutes, CCR-3 was 
localised within the polarised pseudopod, adjacent to the cell membrane and internalising 
strongly following a "radial" pattern, coupled with some mid-line receptor staining ventral 
to the nucleus (figure 3.7di - iii). A large proportion of the IL-5 primed cells had 
migrated through the filter by 60 minutes eotaxin treatment and were found adhered to the 
underside of the filter, illustrated in this ventral section (figure 3.7di - iii). CCR-3 was 
localised adjacent to the cell membrane and central to the nucleus, once again utilising 
distinct "tracks" during the internalisation process (figure 3. 7di - iii; top cell). 
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Figure 3.6a - d. lmmunohistochemical localisation of CCR-3 using the 
transwell migration protocol: poor adherence and eotaxin stimulation 
Freshly sorted peritoneal eosinophils from the IL-5 transgenic mouse (see section 
2.2.1.2), were left to adhere for 30 minutes onto un-coated transwell filters and stimulated 
with eotaxin (100ng/ml) for (a) 0, (b) 10, (c) 30 and (d) 60 minutes (see section 3.2.3.2 for 
the transwell immunohistochemical protocol). Cells were fixed, permeabilised and stained 
with anti-CCR-3 and a secondary BODIPY antibody. Mid-sectional CCR-3/BODIPY 
staining was visualised using the Krypton/Argon laser of the confocal microscope (Leica 
LCS, Germany). Images show CCR-3 (green) staining with grayscale/inverted insert to 
highlight positive staining. Controls of the BODIPY-labelled secondary were performed 
confirming specificity of binding to the primary antibody (data not shown). These images 
are representative of two separate experiments carried out in triplicate. Bar indicates 
5µm. 
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3.3.4.2 Biochemical detection of CCR-3 internalisation in response to eotaxin 
stimulation +/- IL-5 priming 
To further support the observations made by immunohistochemical localisation of CCR-3, 
a biochemical analysis was performed of IL-5 primed and eotaxin stimulated eosinophils. 
In control cells (time 0), no CCR-3 was detected in the triton soluble fraction (figure 
3.8a; right) while in the triton insoluble fraction expression was high (figure 3.8a; left). 
At 1 - 5 minutes eotaxin stimulation, CCR-3 was localised primarily in the soluble fraction, 
followed by a sharp decrease in presence at 10 - 30 minutes (figure 3.8a; right). In the 
insoluble fraction, receptor expression decreased O - 5 minutes, returning to high 
expression at 10 minutes (figure 3.8a; left). The decrease of receptor expression in this 
fraction at 5 minutes corresponded with an increase of CCR-3 localised to the soluble 
fraction (figure 3.8a). At 10 -30 minutes, the receptor is once again primarily localised to 
the insoluble fraction (figure 3.8a; left). Taken in parallel with the immunohistochemical 
results, CCR-3 undergoes a distinct time-course of receptor cell-membrane recruitment 
and internalisation. 
In cells primed with IL-5 (1 Ong/ml) prior to eotaxin stimulation, CCR-3 localisation was 
substantially altered. In the soluble fraction, CCR-3 was detected at O - 30 minutes, with 
expression remaining low but consistent when compared to the transient localisation of 
the receptor in this fraction in eotaxin stimulated cells (figure 3.8b and c; right). In the 
insoluble fraction, receptor expression is low at O - 1 minute, increasing strongly from 5 -
30 minutes (figure 3.8b and c; left). In contrast to eosinophils stimulated with eotaxin 
alone, CCR-3 association with the insoluble fraction of the cell remained high and was 
retained. In general, localisation of the receptor in response to eotaxin is less erratic in IL-
5 primed cells. 
3.3.4 Localisation of IL-5Ra in murine eosinophils 
IL-5Ra localisation was investigated in response to IL-5 priming and eotaxin stimulation. 
The transwell adhesion/migration protocol was utilised to allow for comparison with CCR-3 
localisation studies. In unstimulated cells, IL-5Ra was localised at the cell membrane 
(figure 3.9ai and ii), and short-term (10 minutes) IL-5 stimulation appeared to have no 
effect on the distribution of the receptor (figure 3.9bi and ii). Although IL-5 is known to 
induce the upregulation of integrin mediated adhesion, the distinct "flattening" of cells 
evident in primed wild-type cells was not apparent. This suggests that prolonged exposure 
to high concentrations of IL-5 may alter eosinophil responsiveness to this cytokine 
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Figure 3.7a - c. Confirmation of the immunohistochemical localisation of 
CCR-3 using the transwell migration protocol: CCR-3/Alexa 488 conjugation 
Freshly sorted peritoneal eosinophils from the IL-5 transgenic mouse (see section 
2.2.1.2), were left to adhere for 30 minutes onto fibronectin coated transwell filters and 
treated with: (a) eotaxin (100ng/) for 10 minutes; (b) eotaxin for 10 minutes; (c) 15 minutes 
eotaxin; (d) eotaxin for 20 minutes; and (e) IL-5 primed (1 Ong/ml) for 30 minutes and 
eotaxin stimulated for 60 minutes (see section 3.2.3.2 for the transwell 
immunohistochemical protocol). Cells were fixed, permeabilised and stained with anti-
CCR-3 conjugated directly to the Alexa 488 fluorochrome. Antibody labelling with CCR-
3/Alexa488 was visualised using the Krypton/Argon laser of the confocal microscope 
(Leica LCS, Dassel, Germany). 
Images show: (i) CCR-3 (green); (ii) CCR-3 and nucleus (green and red); (iii) 
grayscale/inverted image of (ii) for enhanced clarity. Images (c-e) depict the ventral 
surface, while (a) 1s representative of the mid-section. Arrowhead denotes dominant 
pseudopodia/leading edge. These images are representative of three separate 
experiments carried out in triplicate. Bar indicates 5µm. 
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Figure 3.8. Time-course of CCR-3 internalisation in response to eotaxin 
stimulation +/- IL-5 priming: biochemical analysis 
Sorted peritoneal IL-5 transgenic eosinophils were incubated at 37°C for 30 minutes with 
IL-5 (1 Ong/ml) or no agonist. Cells were then stimulated with eotaxin for 0, 1, 5, 10 and 30 
minutes and fractionated into nuclear, triton insoluble and triton soluble fractions . 
Fractions were immunoprecipitated with anti-CCR-3 antibody (section 2.2.1 .4 .1 and 
3.2.2.1 ). Western blots were performed on immunoprecipitates with anti-CCR-3 (section 
2.2.1.4 .3 and 3.2.2.3). Panels represent: (a) cells stimulated with eotaxin alone; (b) cells 
primed with IL-5 and stimulated with eotaxin ; (c) exposure of blot (b) altered to enhance 
CCR-3 specific band. This result is representative of one experiment, carried out in 
duplicate. 
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However, IL-5 was found to induce much stronger adhesion to fibronectin substrate than 
control cells alone. By 30 minutes, the receptor was strongly internalised into the 
cytosolic region, ventral to the nucleus (figure 3.9ci and ii). In the absence of distinct cell 
polarisation and motility, IL-5Ra activation still resulted in the subsequent internalisation of 
the receptor. Eotaxin stimulation of IL-5 primed cells induced the rapid polarisation of 
many eosinophils, with IL-5Ra localised to the leading edge/pseudopod and the rear 
(uropod) of many migrating cells (figure 3.9di and ii). With the subsequent addition of 
chemotactic agonist, IL-5Ra asymmetry was achieved, indicating a role for this receptor in 
cell migration events. 
Utilising Z-series analysis on the confocal microscope, IL-5Ra trafficking was further 
investigated in IL-5/eotaxin stimulated eosinophils. Images from the dorsal (figure 
3.1 Oi), mid-section (figure 3.1 Oii) and ventral (figure 3.1 Oiii) surfaces confirm strong IL-
5Ra localisation at the leading edge/dominant pseudopod and some uropod localisation. 
Of particular interest is the mid-line localisation of the receptor, becoming more evident at 
the ventral side of the cell (figure 3.1 Oiii). In contrast to CCR-3 localisation, the 
polarisation of IL-5Ra to the uropod may be indicative of the role of signalling through this 
receptor in adhesion/de-adhesion mediated events. 
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Figure 3.9a - e. lmmunohistochemical localisation of IL-5Ra using the 
transwell migration protocol: IL-5 priming and eotaxin stimulation 
Sorted peritoneal eosinophils from the IL-5 transgenic mouse (see section 2.2.1.2), were 
left to adhere for 30 minutes onto fibronectin coated transwell filters and stimulated with 
IL-5 (1 Ong/ml) for (a) 0, (b) 10 and (c) 30 minutes, or (d) IL-5 and eotaxin (1 00ng/ml) for 
10 minutes in succession. Cells were fixed, permeabilised and stained with anti-lL-5Ra 
and BODIPY-conjugated secondary, and propidium iodide. (e) BODIPY controls were 
performed to confirm specificity of binding by the secondary antibody. Mid-sectional IL-
5Rcx/BODIPY and nuclear staining was visualised using the Krypton/Argon laser of the 
confocal microscope (Leica LCS, Germany). 
Images for (a) and (c) show of: (i) IL-5Ra (green); (ii) IL-5Ra (green) and nuclear stain 
(red), while for (b): (i) IL-5R (green); and (ii) inverted gray-scale image of (i). Filled 
arrowhead denotes dominant pseudopodia/leading edge while unfilled arrowhead points 
to uropod. These images are representative of three separate experiments carried out in 
duplicate. Bar indicates 5µm. 
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Figure 3.10. lmmunohistochemical localisation of IL-5Ra using the transwell 
migration protocol: Z-series of IL-5/eotaxin stimulated cell. 
Eosinophils were sorted from the peritoneal cavity of IL-5 transgenic mice (see section 
2.2.1.2) and left to adhere for 30 minutes onto fibronectin coated transwell filters and 
stimulated with IL-5 (1 Ong/ml) and eotaxin (1 00ng/ml) for 15 minutes in succession. Cells 
were fixed, permeabilised and stained with anti-lL-5Ra and a BODIPY-labelled secondary 
antibody. Z-series analysis was performed on migrating eosinophils and visualised using the 
Krypton/Argon laser of the confocal microscope (Leica LCS, Germany). Images depict: (i) 
the dorsal surface; (ii) mid-section; and (iii) ventral surface. Filled arrowhead denotes 
dominant pseudopodia/leading edge while unfilled arrowhead points to uropod. Controls of 
the BODIPY-labelled secondary were performed confirming specificity of binding to the 
primary antibody (data not shown). These images were taken as part of three separate 
experiments. Bar indicates 5µm. 
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3.4 DISCUSSION 
To further understand how eosinophils migrate at a cellular level, investigations into the 
spatial and temporal localisation of signalling molecules in response to priming and 
chemoattractant stimuli was undertaken. The visual characterisation of these interactions, 
however, by traditional immunohistochemical techniques had proved to be inadequate for 
specific immunodetection in these cells. Thus, an extensive investigation was undertaken 
that resulted in the development of a dynamic and reproducible immunohistochemical 
protocol that enabled the immuno-labelling of cells following stimulation with agonist and 
subsequent adherence/migration. 
The ability of cells to navigate through complex chemoattractant arrays relies on the 
constant remodelling and extension of the plasma membrane in the direction of the 
predominant chemotactic gradient. Structurally, this remodelling requires the assembly of 
actin subunits into polymerised filaments at the leading lamellipodia, the dis-assembly of 
which drives propulsion of the cell in the direction of the sensory cue (Ridley AJ and Hall 
A, 1992). The microtubular network is also believed to play an important role in 
establishing cell polarity (Tanaka E and Sabry J, 1995; Liao et al., 1999; Nabi IR, 1999) 
and motility, and both these structural processes are investigated in Chapter 4. 
Functional polarisation or the asymmetrical localisation of receptors and second-
messengers at the leading edge is another potential way the cell responds towards 
chemoattractants. Membrane microdomains have been shown to provide the scaffold 
under which signalling-complexes are formed at the plasma membrane (Simons and 
Toomre, 1997; Manes et al., 1999). 
The underlying premise of functional polarisation lies in whether there is a need for 
establishing proximity of receptors and downstream signalling mediators that participate in 
the induction and maintenance of cell migration. Cross-talk and transactivation between 
receptors and/or their downstream signalling mediators could play a role in upregulating 
cellular events and prioritising responses to sequential or competing chemoattractant 
exposure (Zucker and Ranganathan, 1999; Mira et al., 2001 ). Short-term exposure of 
eosinophils towards a shallow gradient of eotaxin did indeed result in the strong 
polarisation of CCR-3 at the leading edge, towards the direction of the gradient (figure 3.5 
and 3.7). Interestingly, the IL-5R was also induced to polarise in response to eotaxin 
(figure 3.9d), a response absent in cells exposed to a gradient of IL-5 alone (figure 3.9 b 
and d). Cytokine stimulation of these cells resulted in the maintenance of a uniform 
distribution of IL-5Ra at the cell-surface. Eotaxin induced cell polarisation was strongly 
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reliant on the prior establishment of adhesion to the fibronectin substrate, as no leading 
edge formation was evident in poorly adhered cells (figure 3.6) . This is not surprising , as 
integrin mediated ECM substrate adhesion provides the site of force transmission 
necessary for the induction and maintenance of cell migration (Vuori and Ruoslahti , 1999). 
Due to the volatile nature of primary eosinophils, live-cell analysis of CCR-3 localisation 
using GFP-CCR-3 transfection was not a viable option. The use of the substrate coated 
transwell migration wells in these studies enabled the establishment of strong adhesion, 
the formation of shallow chemoattractant gradients and permitted timed stimulation and 
subsequent fixing of cells. In a study utilising similar conditions, the polarisation of both 
CCR2 and CCR5 in chemoattractant-stimulated lymphocytes was observed (Nieto et al. , 
1997). Several other studies dispute the role of functional asymmetry in response to 
chemoattractant stimulus. Discrepancies reflect the different techniques used in these 
analyses, in particular, the use of a uniform concentration rather than a shallow gradient of 
chemoattractant, and the fixing of cells at variable times after the application of stimulus 
(Walter RJ and Marasco WA, 1987; Weinbaum et al., 1984). The use of GFP-receptor 
constructs has done little to elucidate the controversy. In a live-cell analysis in D. 
discoideum, the cytosolic regulator of adenylyl cyclase (CRAC), an activator of the G-
protein signalling pathway, was found to aggregate at the leading edge of polarised cells 
(Parent et al., 1998). However, the primary cAMP receptor expressed by this cell 
remained evenly distributed on the cell-surface (Xiao et al., 1997). GFP-C5a receptor 
localisation in response to a chemotactic gradient found no evidence of receptor 
polarisation (Servant et al. , 1999). The use of a myeloid cell-line in this study in the 
absence of efficient neutrophil transfection, and the D. discoideum slime mould as models 
of leukocyte function, may reflect differences in receptor trafficking profiles between 
primary cells and cells transfected with proteins of interest. Subsequent studies by 
Servants' group found distinct asymmetry of GFP-tagged pleckstrin homology domain of 
protein kinase B (PHAKT), a mechanism which was strongly dependant on the proximity 
and activation of Pl3K and the Rho GTPases (Servant et al. , 2000) . The importance of 
these collective observations, is that even in the absence of receptor polarisation, 
signalling asymmetry is consistent between cellular models. In addition, Servant did 
concede that the asymmetrical distribution of the plasma membrane in the polarised cell 
may result in microdomain and receptor aggregation at the leading edge (Servant et al,. 
1999). 
The aggregation of receptors and downstream mediators at the site of cell-membrane 
microdomains provides the proximity necessary for protein interaction and subsequent 
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generation of cellular responses. Ligand induced activation of CCR-3 resulted in the rapid 
phosphorylation of the receptor itself (figure 3.3), most likely by GPCR kinases (Sibley et 
al., 1984). This process is believed to occur in conjunction with the ~-arrestins, promoting 
the rapid internalisation of the receptor (Fergusson et al., 1996). In the eotaxin stimulated 
eosinophil, CCR-3 polarisation was rapidly followed by the gradual internalisation of the 
receptor (figure 3.5, 3. 7 and 3.8). The process of internalisation promotes the functional 
resensitisation of signal transduction by delivering phosphorylated ('desensitised') 
receptors to an endosomal-associated phosphatase (Pippig et al., 1993; Pitcher et al., 
1995), promoting rapid recycling of the newly resensitised receptor to the plasma 
membrane. lmmunohistochemical localisation suggested this internalisation followed a 
distinct pattern: firstly, a gradual re-location of de-sensitised receptor within the leading 
lamellipodia, and secondly, the trafficking of receptor to the "clear zone" of the cell. This 
clear zone that lies in the centre of the donut shaped nucleus, is devoid of granular 
contents, and houses both the golgi complex and microtubular organising centre · (MTOC) 
of the cell (Koonce et al., 1984). However, CCR-3 internalisation was not dependent on 
strong eosinophil adhesion, and trafficking of the receptor was maintained in these cells 
(figure 3.6). The distinct "tracking" of CCR-3, observed during eotaxin-induced 
internalisation, suggested a role for cytoskeletal filaments in the trafficking of this receptor, 
and was investigated more thoroughly in Chapter 4. 
The biochemical analysis of receptor internalisation, although rudimentary, showed a 
distinct trafficking of receptor from the soluble to insoluble fractions in eotaxin-stimulated 
cells (figure 3.8). The insoluble fraction contained not only cytoskeletal components, but 
also glycosphingolipid-cholesterol-enriched complexes (DIG's) known to be associated 
with membrane microdomains (Fiedler et al., 1993). In addition, IL-5 priming reduced the 
rate of internalisation by inducing a more constant level of CCR-3 expression at the cell-
surface. However, expression of the receptor in the soluble membrane was consistently 
low, with most of the CCR-3 pool remaining bound to the insoluble fraction. IL-5 priming 
may promote CCR-3 association with DIG's, leading to the upregulation of receptor-
signalling complexes within cell-surface microdomains. This process of receptor 
aggregation may play a role in the underlying synergy of IL-5/eotaxin mediated responses 
(Mould et al., 1997; Collins et al., 1995) and should be investigated further. 
Localisation of the IL-5Ra itself was briefly examined, providing a marked contrast to 
chemokine receptor dynamics. The IL-5 receptor remained evenly distributed around the 
plasma membrane in response to IL-5 activation (figure ·3.9b), as this cytokine is known to 
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upregulate integrin mediated adhesion (Walsh et al., 1990; Neeley et al., 1993). 
Chemoattractant stimulation and subsequent polarisation of the cell induced strong 
asymmetry of the receptor to both the leading edge and uropod (figure 3.9d and 3.10). 
The aggregation of IL-5Ra at the uropod may also be regulated by membrane 
microdomains, once again providing the proximity for direct interaction with integrin 
signalling mediators. Activation of the receptor induced trafficking, with internalisation of 
the receptor being cytoplasmic (figure 3.9c and 3.10) and consistent with endosomal 
localisation (Salisbury et al., 1983; Herman et al., 1983). The IL-5 transgenic eosinophil, 
however, did not provide the ideal model for the characterisation of IL-5 signalling. 
Problems were apparent upon IL-5 priming, which did not promote "cell flattening" to the 
same extent as the priming of wild-type eosinophils. The prolonged exposure to high 
concentrations of endogenous IL-5 may result in the altered responsiveness of 
eosinophils to this cytokine. 
This Chapter has focused on the spatial and temporal characterisation of CCR-3 in 
response to eotaxin ligation and the effect of IL-5-induced priming on these phenomena in 
primary eosinophils. IL-5Ra dynamics were also investigated in response to both IL-5 
and eotaxin stimulation. Both CCR-3 and IL-5Ra were found to aggregate at the leading 
edge of eotaxin-stimulated cells suggesting the need for establishing asymmetrical 
receptor proximity in the generation of migratory responses. CCR-3 aggregation at the 
leading edge was rapidly followed by internalisation of the receptor, a process found to be 
modulated by IL-5-induced priming. The following Chapter will investigate the role of 
structural responses to chemotactic stimuli, highlighting the interplay of chemical and 
mechanical signals in the generation of eosinophil migration . 
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CHAPTER 4: 
Chemokine Signalling 
to 
Cytoskeletal Remodelling 
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4.1 INTRODUCTION 
In the previous chapter, CCR-3 localisation was investigated in response to both priming 
(IL-5) and chemotactic ( eotaxin) stimuli. In this chapter I further characterise the 
intracellular mechanisms involved in CCR-3 polarisation and internalisation in response to 
these agonists, in particular, the structural responses of the cell to chemotactic stimuli and 
the dynamic interplay of chemical and mechanical signals in the induction and 
maintenance of cell migration. 
The actin cytoskeleton and associated signalling proteins have been shown to play an 
integral role in cell adhesion (Chong et al,. 1987), receptor aggregation (Daniels MP 1990; 
Dai et al., 2000), cell polarisation (Oliver JM, 1978; Valerius et al., 1982; Nabi IR, 1999) 
and the internalisation of receptors and signalling molecules (Gottlieb et al., 1993; Parton 
et al., 1994; Dekkert et al., 1996). Although cell migration is largely driven by the actin 
cytoskeleton, interactions between the microtubular and actin cytoskeleton are required to 
steer cell motility (Danowski BJ, 1989; Waterman-Storer et al., 1999; Nabi IR, 1999). 
Conversely, microtubules are believed to be the main regulators of vesicle and organelle 
transport within the cell, while recent studies have highlighted the co-operation of both 
systems in intracellular trafficking (Rodionov et al., 1998; Rogers and Gelfand, 1998). 
For these reasons, the role of the cytoskeleton in agonist mediated CCR-3 polarisation 
and aggregation at the leading edge, have been characterised in the present Chapter. 
Initially, a direct comparison was made between the actin and microtubule profiles of 
relatively static cells, the Swiss 3T3-fibroblast cell-line, and primary murine eosinophils. In 
fibroblasts, agonist stimulation induced distinct stress fiber formation, known to originate 
from the establishment of a focal adhesion between an F-actin bundle in the 
lamellipodium and the substratum (Wang YL, 1984). Subsequently, a fibre grows radially 
from the adhesion point, elongating in conjunction with the rear-ward flowing cortex 
(Heath and Holifield, 1991 ). However, in a highly motile cell, such as the eosinophil, there 
appears limited time to enable the formation of the highly organised stress fiber network, 
and actin remains localised in a tight dot-like formation (Tourkin A, 1996). The need for 
rapid re-organisation also extends to the microtubular network. When compared to a low-
motile cell, microtubules in leukocytes are highly dynamic (Ding et al., 1995). In 
comparison to the relaxed microtubular network characteristic of static cells, the agonist-
stimulated eosinophil displays a distinct astral formation of microtubules radiating from the 
MTOC, rapidly extending towards the leading edge in response to chemoattractant 
stimulation. 
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lmmunohistochemical localisation studies (Chapter 3) had suggested that CCR-3 
internalisation did indeed appear to be controlled by cytoskeletal dynamics, indicated by 
the distinct "tracking" of internalised receptor towards the clear zone of activated cells. In 
this Chapter, processes elicited by CCR-3 ligation were further characterised. CCR-3 co-
localisation with the microtubule and actin cytoskeleton was investigated in response to 
both priming and agonist stimulation, and results suggested a direct role of the 
microtubular network in CCR-3 trafficking events. In association with these observations, 
microdomain expression in the eosinophil was briefly studied, providing the potential link 
between functional and structural responses in the chemotactically stimulated cell. In 
addition, the possible crosstalk of integrin based adhesion systems and chemokine 
signalling through the interaction of FAK and CCR-3 was investigated. Co-localisation of 
FAK with both the actin and microtubular networks was observed and highlighted the 
complexity of signals involved in the dynamic balance between cell adhesion and motility 
of the eosinophil. 
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4.2 MATERIALS AND METHODS 
FACS sorting of peritoneal eosinophils Section 
Preparation of CCR-3/Alexa 488 conjugate Section 
2.1.1 .2 
3.2.1.1 
4.2.1 Fluorescence immunohistochemistry and confocal protocol 
4.2.1.1 lmmunohistochemical and confocal analysis of Swiss 3T3 cells 
Swiss 3T3 cells were seeded onto glass coverslips in RPMI with 10% FCS at 1.5 x 104 
cells/ml and allowed to attach overnight at 37°C. The medium was replaced with 
unsupplemented RPMI, and the following day cells were left inactivated or incubated with 
1 o-7M PAF (Cayman Chemicals, Michigan, USA) for 7 hours. Cells were stained to 
visualise the polymerised actin cytoskeleton (F-actin) using Texas Red®-X phalloidin at 
0.2µM, the microtubular cytoskeletal network using mouse anti-p-tubulin at 1 0µg/ml, 
followed by BODI PY® FL goat anti-mouse at 1 0µg/ml (both from: Molecular Probes, 
Eugene, OR, USA) or for the small GTP-ase Rac1 using anti-Rac1 /TRITC at 1 0ug/ml (BO 
Transduction Laboratories, Lexington, KY, USA). 
4.2.1.2 lmmunohistochemical and confocal analysis of leukocytes using 
transwell preparations 
(see section 3.2.3.2 for standard transwe/1 immunohistochemica/ protocol) 
Agonists used in lower chamber: PAF (Cayman Chemicals, Michigan, USA) at 1 o-7M; 
PMA (Sigma, St. Louis, USA) at 10-7M; IL-5 (Dr. I. Young, BMB, JCSMR) at 10ng/ml; and 
eotaxin (Peprotech, NJ, USA) at 1 00ng/ml. Fluorochrome conjugated or primary 
antibodies used: Texas Red®-X phalloidin and Alexa Fluor 568 phalloidin, both at 0.2µm, 
(both from: Molecular Probes, Eugene, OR, USA); anti-p-tubulin at 1 0µg/ml (Sigma, 
St.Louis, USA); anti-CCR-3/Alexa 488 conjugate at 5µg/ml (section 3.2.3.3) (CCR-3: 
mab6S2-19-4, DNAX, Palo Alto, CA, USA; Alexa Fluor 488 binding kit: Molecular Probes, 
Eugene, OR, USA); and mouse anti-FAK at 5µg/ml and anti-Rac1/TRITC at 1 0µg/ml (BO 
Transduction Laboratories, Lexington, KY, USA). Fluorochrome conjugated secondary 
antibodies used: BODIPY® FL goat anti-mouse and BODIPY® FL goat anti-rabbit were 
both used at 1 0µg/ml (both from: Molecular Probes, Eugene, OR, USA); and Texas Red 
anti-mouse at 5µg/ml (Jackson lmmunoresearch, Westgrove, PA, USA). 
In earlier experiments, fluorescent staining was visualised on the Leica LCS (Dassel, 
Germany) confocal microscope, while in later experiments, the Radiance 2000 system 
(Bio-Rad, CA, USA) was utilised. Both confocal systems use the Krypton/Argon laser 
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emitting light at 488, 568, and 64 7 nm wavelengths. Co-localisation studies were 
performed exclusively on the Radiance2000 due to the automatic production of merged 
images from separate emission sources and more reliable co-localisation signals. 
4.2.2 FACS analysis of cell-surface antigens - monitoring CCR-3 
internalisation in response to agonists and cytoskeletal inhibitors 
Freshly sorted murine eosinophils were kept in 30%FCS/Hanks on ice prior to analysis. 
Cells were centrifuged at 1,500g for 5 minutes and pellets resuspended in 200µ1 of 2% 
human lgG (Sigma-Aldrich, USA) in PBS for 1 hour (blocking non-specific Fe-receptor 
staining) hour on ice. Cells were re-centrifuged at 1,500g for 5 minutes: control cells were 
resuspended in 500µ1 PBS and incubated at 37°C; treated cells were incubated with 
nocodazole (10µm) or cytochalasin D (1µm) for 30 minutes at 37°C (both from: Sigma, St. 
Louis, USA). Cells were washed three times in PBS and pelleted. Anti-CCR-3/Alexa 488 
was added to samples to be stained (CCR-3: mab 6S2-19-4, DNAX, Palo Alto, CA, USA; 
Alexa Flour 488 binding kit: Molecular Probes, Eugene, OR, USA), and cells incubated for 
1 hour on ice. Following incubation, cells were once again washed three times in PBS 
and pelleted. Cell-surface expression of CCR-3 was analysed on the FACSscan (Becton 
Dickinson, Franklin Lakes, NJ, USA) utilising a single laser at 488nm. 
4.2.3 CCR-3 signalling events - FAK and ~-tubulin association with 
CCR-3 in control and eotaxin stimulated eosinophils 
4.2.3.1 Protein immunoprecipitation protocol 
See section 2.2.1.4.1 for general protocol. For the FAK association studies, 500ul cell 
fractions were immunoprecipitated with 1 µg/ml of mouse anti-FAK (BO Transduction 
Laboratories, Lexington, KY, USA). In the ~-tubulin association studies, cell fractions 
were immunoprecipitated with anti-CCR-3 (mab 6S2-19-4; DNAX, Palo Alto, CS, USA) 
1 0µg/ml mouse anti-~-tubulin (Sigma, St. Louis, USA). 
4.2.3.2 SDS-Polyacrylamide Gel Electrophoresis (PAGE) 
See section 2.2.1.4.2. 
4.2.3.3 Western blotting protocol 
See section 2.2.1 .4.3 for general protocol. For the FAK association studies, blocked 
membrane was incubated with 1µg/ml rat anti-CCR-3 (mab 6S2-19-4; DNAX, Palo Alto, 
CA, USA) overnight at 4°C. A secondary anti-rat HRP conjugate (DAKO, Carpinteria, CA, 
USA) was applied at 1 :2000. Upon stripping, (section 2.2.1.4.3) the membrane was 
128 
incubated with mouse anti-FAK (BO Transduction Laboratories, Lexington, KY, USA), 
followed by an anti-mouse HRP conjugate (DAKO, Carpinteria, CA, USA). In the ~-tubulin 
association studies, blocked membrane was incubated with 1 µg/ml rat anti-CCR-3 (mab 
6S2-19-4; DNAX, Palo Alto, CA, USA), followed by an anti-rat HRP conjugate (DAKO, 
Carpinteria, CA, USA) at 1 :2000. 
4.2.4 Collection and processing of eosinophils for transmission electron 
microscopy 
Freshly extracted eosinophils (2.2.1.2) were left to adhere for 30 minutes on 1 % BSA 
(Sigma, St. Louis, USA) coated polycarbonate coverslips, before being fixed in 2% 
gluteraldehyde in 0.1 M sodium cocadylate (Sigma, St. Louis, USA), pH 7.4 at 4°C 
overnight. Cells were postfixed in 1 % osmium tetroxide for 90 minutes, stained en bloc in 
2% uranyl acetate, dehydrated in graded alcohol solutions and embedded in Spur's resin 
(ProSciTech, Australia). Ultra-thin sections (80 - 85 nm) were cut on a Reichert-Jung 
Ultracut E ultramicrotome. The samples were stained with lead citrate before analysis 
using a Hitachi transmission electron microscope (H-7000; Hitachi, Japan). 
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4.3 
4.3.1 
4.3.1.1 
RESULTS 
Cytoskeletal remodelling in migrating eosinophils 
F-actin localisation in cultured Swiss 3T3 fibroblasts compared to 
primary murine eosinophils 
Initial experiments investigating F-actin localisation were conducted in cultured Swiss 3T3 
fibroblasts. In unstimulated cells (figure 4.1 a.i-iii), a dorsal to ventral cross-section of the 
cell identified the actin arc as the most prominent F-actin based structure. Upon 
chemoattractant (PAF 1 o-7M) stimulation, F-actin became highly organised into a stress 
fiber network throughout the cytoplasm of the cell (figure 4.1 bi and ii), while an extensive 
array of membrane ruffles were evident at the dorsal surface of activated cells (figure 
4.1biii). 
In stark contrast, F-actin localisation in eosinophils was characterised by distinct dot-like 
structures, as observed previously in other highly motile leukocytes [(macrophages: Lehto 
et al., 1982; Linder S et al, 2000), (neutrophil: Weiner et al., 1999). One other study has 
observed F-actin localisation in human eosinophils. However, using laminin as the 
adhesive substrate, migration of chemotactically stimulated cells was largely inhibited by 
the formation of dense F-actin based peripheral belts in (Tourkin et al., 1996). In 
unstimulated eosinophils on a fibronectin matrix, F-actin was primarily localised at, and 
adjacent to, the peripheral cell-membrane, with some staining co-localised with internal 
cellular structures close to the ventral edge of the cells (figure 4.3a). Priming with IL-5 
enhanced the formation of contacts throughout the entire ventral surface (figure 4.3b) . 
. 
F-actin nucleation and polymerisation was increased in eosinophils stimulated with IL-
5/eotaxin or eotaxin alone, and cells began to polarise towards the source of 
chemoattractant and actin based contacts formed distinct "tracks" within the cell (figure 
4.3c and d). Utilising the fibronectin matrix, no F-actin "belt" formation was evident and 
chemotactic stimulation was able to induce a profound cell polarisation and the 
accumulation of F-actin towards the leading pseudopod (figure 4.3c and d) . 
4.3.1.2 ~-tubulin localisation in cultured Swiss 3T3 fibroblasts compared to 
primary murine leukocytes 
Utilising the fixation and permeabilisation optimised for, among other intracellular proteins, 
~-tubulin staining (Table 3.1 ), localisation of this microtubular protein was initially 
observed in cultured Swiss 3T3 cells and previously characterised primary leukocytes. In 
quiescent fibroblasts, ~-tubulin was localised throughout the extensive microtubular 
network of the cell (figure 4.4a), extending radially from the centrally located MTOC 
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Figure 4.1 a and b. lmmunohistochemical F-actin localisation in well-
characterised cells: control and PAF stimulated Swiss 3T3 fibroblasts . 
Swiss 3T3 cells were seeded onto glass coverslips and allowed to attach overnight. The 
following day, cells were (a) left inactivated or (b) stimulated with PAF for 7 hours . Cells 
were fixed , permeabilised and stained with the F-actin specific Texas-Red labelled anti-
phalloidin (section 4.2.1 .1 ). Staining was visualised using the Krypton/Argon laser of the 
confocal microscope (Leica LCS, Dassel , Germany). Images show the localisation of F-
actin , as indicated by thick white arrows , in fibroblasts: (a) inactivated (i -iii) dorsal to 
ventral view showing actin arc formation and (b) stimulated with PAF for 7 hours (i and ii) 
ventral sections highlight stress fiber formation; (iii) membrane ruffles on the dorsal 
surface. These images are representative of two separate experiments carried out in 
triplicate. The scale bar represents 1 Oµm. 
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Figure 4.3a-d. lmmunohistochemical localisation of F-actin 1n control, IL-5 
and eotaxin stimulated eosinophils 
Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (see section 2.2.1.2) , were 
left to adhere for 30 minutes onto fibronectin coated transwell filters and (a) left un-
stimulated ; (b) primed with IL-5 (1 Ong/ml) for 30 minutes; (c) stimulated with eotaxin 
(1 OOng/ml) for 10 minutes; (d) primed with IL-5 (30minutes) and eotaxin (1 Ominutes) 
(section 3.2 .3.2 and 4.2.1.2). Cells were fixed , permeabilised and stained with Texas 
Red-labelled anti-phalloidin for the detection of F-actin (section 4.2.1.2). Ventral sections 
were visualised using the Krypton/Argon laser of the confocal microscope (Leica LCS, 
Germany). Images showing the localisation of F-actin are supplemented with 
grayscale/inverted inserts to highlight positive staining. Arrowheads denote leading edge 
formation, while thin white arrows indicate direction of migration . These images are 
representative of four separate experiments carried out in triplicate. Scale bar represents 
5µm . 
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(ventral to image shown) . Long-term PAF stimulation induced cell division, and the 
localisation of P-tubulin to the mitotic spindle of the dividing cell (figure 4.4b) . In 
comparison, microtubules are dynamic structures in highly motile leukocytes , with 
relatively rapid turnover kinetics (Robinson JM and Vandre DD, 1995). In the primary 
macrophage, PAF induced rapid chemotactic migration associated with the local isation of 
the MTOC towards the direction of the gradient (figure 4.4c) , reorientation of which is 
believed to occur in conjunction with the golgi apparatus (Nerilere et al., 1985). 
In unstimulated eosinophils, P-tubulin appears punctate and non-polymerised, localised 
radially from the MTOC and around the peripheral cell membrane (figure 4.5a). The 
addition of agonist induces rapid P-tubulin polymerisation and the formation of a distinct 
radial microtubular_ network (figures 4.5b), most prominent following PMA stimulation. 
Phorbol esters are known to induce cell spreading onto matrix proteins in other 
leukocytes, resulting in the extension of microtubules in radial array from the MTOC 
(Robinson JM and Vandre DD, 1995). Under more specific eosinophil-priming conditions, 
IL-5 also induces limited P-tubulin polymerisation in a non-relaxed radial array, although 
not to the extent of PMA stimulation (figure 4.5c). The consistent lack of eosinophil 
adhesion in the presence of IL-5 may result from the IL-5 transgenic origin of the cells and 
will be highlighted in the discussion. 
Following chemoattractant stimulation, microtubules become rapidly reoriented along the 
anterior-posterior axis of the migrating cell (figure 4.5d) and , as observed in 
macrophages, with the MTOC located between the leading edge and the nucleus 
(Nemere et al., 1985). Upon longer exposure (>60minutes) to chemoattractant a random 
microtubule orientation was observed in non-migrated cells , suggesting cells were no 
longer exhibiting directed migration or responding to chemoattractant (figure 4.Se) . In 
contrast to macrophages, the MTOC in migrating eosinophils remained localised at the 
centre of the elongated nucleus, slightly anterior towards the leading pseudopodia . 
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Figure 4.4a-c. lmmunohistochemical localisation of ~-tubulin 1n well 
characterised cells: control and PAF stimulated 
Swiss 3T3 cells were seeded onto glass coverslips and allowed to attach overnight 
(section 4.2.1.1 ). The following day, cells were left (a) inactivated or (b) stimulated with 
PAF for 7 hours. Leukocytes were extracted from the peritoneal cavity of the IL-5 
transgenic (section 2.2.1.2) and stimulated with PAF (1 o-7M) for 10 minutes. Cells were 
fixed, permeabilised and stained with the ~-tubulin and BODIPY-labelled secondary for 
the detection of the microtubular network (section 3.2.3.2 and 4.2.1.2) . Staining was 
visualised using the Krypton/Argon laser of the Leica LCS confocal microscope (Dassel, 
Germany) . Images show the localisation of ~-tubulin: (a) mid-section of control fibroblasts; 
(b) mid-section of PAF stimulated fibroblasts; ( c) ventral section of PAF stimulated 
macrophage. Controls of the BODIPY-labelled secondary were performed confirming 
specificity of binding to the primary antibody (data not shown). Arrowheads denote leading 
edge formation, while thin white arrows indicate direction of migration. These images are 
representative of three separate experiments carried out in triplicate. Scale bar indicates 
1 0µm for (a) and (b), and 5µm for (c). 
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Figure 4.Sa-e. lmmunohistochemical localisation of ~-tubulin in control, 
PMA, IL-5 and eotaxin stimulated eosinophils 
Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (see section 2.2.1.2) were 
left to adhere for 30 minutes onto fibronectin coated transwell filters and (a) left un-
stimulated; (b) stimulated with PMA (10-7M) for 10 minutes; (c) with IL-5 (10ng/ml) for 30 
minutes; (d) with eotaxin (1 00ng/ml) for 10 minutes; and (e) with eotaxin for 60min 
(section 3.2.3.2 and 4.2.1.2). Cells were fixed, permeabilised and stained with anti-~-
tubulin and BODIPY-labelled secondary for the detection of the microtubular network 
( section 4 .2.1.2). Z-series sections from the dorsal to ventral surface (i - iv) were 
visualised using the Krypton/Argon laser of the confocal microscope (Radiance 2000, 
Biorad , Hempstead, UK). Controls of the BODIPY-labelled secondary were performed 
confirming specificity of binding to the primary antibody (data not shown). These images 
are representative of three separate experiments carried out in duplicate. Scale bar 
represents 5µm. 
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4.3.1.3 Co-localisation of F-actin and p-tubulin in control and agonist stimulated 
eosinophils 
The role of the actin cytoskeleton in cell migration is well documented, however, the co-
ordinate function of the microtubular system in cell motility is still an area of intense 
debate. In this section of work, I endeavoured to explore whether these two cytoskeletal 
components do indeed interact through a series of co-localisation studies. In control 
eosinophils, non-polymerised actin and P-tubulin co-localised at the periphery of the cell, 
the MTOC devoid of actin localisation (figure 4.6a). Upon phorbol ester stimulation, ~-
tubulin rapidly polymerised and actin condensed towards the MTOC, becoming partially 
co-localised with ~-tubulin at this site (figure 4.6b ). Stimulation of these PMA activated 
cells with chemoattractant induced strong polymerisation and anterior-posterior orientation 
of ~-tubulin. However, the lack of F-actin polarisation suggested no leading edge had 
been initiated under these strong adhesive conditions (figure 4.6c). F-actin expression 
was also elevated and localised within the cytoplasm of the cell, although only limited co-
localisation was apparent. 
In cells stimulated with chemoattractant alone, the leading pseudopodia was distinguished 
by the co-localisation of F-actin contacts on extended microtubules and P-tubulin rich 
aggregates, with a small proportion of F-actin localised at the MTOC (figure 4.6d). In the 
absence of chemoattractant, IL-5 priming induced little P-tubulin polymerisation, and F-
actin co-localisation was once again limited at the cell periphery and adjacent to the 
MTOC (figure 4.6e), as observed in control eosinophils (figure 4.6a). In the primed and 
chemoattractant polarised cell, F-actin co-localisation at the leading edge of the cell was 
consistent, but localisation in relation to the MTOC varied considerably (figure 4.6f). 
Although the degree to which various cells extended microtubular filaments towards the 
substratum varied, F-actin was consistently localised posterior to the limit of P-tubulin 
staining at the peripheral membrane. Subsequent problems encountered with the F-actin 
specific Texas Red phalloidin in double-staining localisation with other intracellular 
molecules may suggest that not all F-actin sites were being recognised. It is well 
documented that phalloidin binds poorly to sites of actin-binding protein co-localisation 
(Weiner et al., 1999), highlighting the need for a more extensive characterisation of the 
actin cytoskeleton using other non-phalloidin based actin-specific probes. However, in 
light of these observations, there is no doubt that adherent and chemotactic stimuli induce 
actin and microtubular cytoskeletal re-arrangement and partial co-localisation in migrating 
eosinophils. 
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Figure 4.6a-f. Co-localisation of F-actin and ~-tubulin in control, PMA, IL-5 
and eotaxin stimulated eosinophils 
Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (see section 2.2.1.2) were 
left to adhere for 30 minutes onto fibronectin coated transwell filters and (a) left un-
stimulated; (b) stimulated with PMA (10-7M) for 10 minutes; (c) with PMA (10-7M) for 10 
minutes followed by eotaxin (100ng/ml) for 10 minutes; (d) eotaxin for 10 minutes; (e) IL-5 
(1 Ong/ml) for 30 minutes; (f) IL-5 (1 Ong/ml) for 30 minutes followed by eotaxin (1 00ng/ml) 
for 10 minutes (section 3.2.3.2 and 4.2.1.2). Cells were fixed, permeabilised and stained 
with anti-P-tubulin and BODIPY-labelled secondary, followed by Texas Red® anti-
phalloidin (section 3.2.3.2 and 4.2.1.2). Stains were visualised using the Krypton/Argon 
laser of the Radiance 2000 confocal microscope (Biorad, Hempstead, UK). The images 
show the localisation of: (i) P-tubulin (green), (ii) F-actin (red) and (iii) merged to reveal 
regions of co-localisation (yellow). Controls of the BODIPY-labelled secondary were 
performed confirming specificity of binding to the primary antibody ( data not shown). 
Arrowheads denote leading edge formation, while thin white arrows indicate direction of 
migration. These images are representative of three separate experiments carried out in 
duplicate. Scale bar represents Sµm. 
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4.3.2 The role of the microtubular and actin cytoskeleton in CCR-3 
trafficking and internalisation 
4.3.2.1 Association of CCR-3 and the microtubular cytoskeleton 
In the previous chapter, the time-course of CCR-3 localisation was investigated in 
response to both priming (IL-5) and chemotactic (eotaxin) stimuli. I was interested in 
further characterising the intracellular mechanisms involved in CCR-3 trafficking and 
internalisation in response to these agonists, in particular, the involvement of the 
cytoskeleton and associated signalling proteins. Many previous studies have highlighted 
the role of the actin cytoskeleton in receptor endocytosis, internalisation and recycling 
(Salisbury et al., 1980; Hoffman et al., 1996; Zaslaver et al., 2001 ). However, the role of 
the microtubular network is still under considerable debate (Kapeller et al., 1993; 
Kharbanda et al., 1995; Zaslaver et al., 2001 ). 
Initial biochemical experiments indicated that CCR-3 was co-immunoprecipitated with ~-
tubulin in both control and eotaxin stimulated eosinophils (figure 4. 7), fuelling interest in 
characterising this association. lmmunohistochemical studies confirmed that CCR-3 co-
localises with the microtubular network both at the cell membrane and at distinct 
intracellular locations. In particular, CCR-3 was found adjacent to microtubules radiating 
from the MTOC and the "clear zone" around the MTOC itself, an area shown to be devoid 
of granules and containing the golgi complex (Koonce et al., 1984). In control eosinophils, 
in the absence of a complete microtubular network, CCR-3 is localised both at the 
peripheral membrane and associated with cytoplasmic spanning ~-tubulin (figure 4.8a), 
an association which is upregulated in IL-5 primed cells (figure 4.8c). In addition, priming 
induces some "clear zone" localisation of CCR-3, which is strongly upregulated under 
"non-physiological" adhesive conditions provided by high concentrations of PMA (figure 
4.8b). In the eotaxin polarised eosinophil, primed or un-primed, CCR-3 is co-localised 
with microtubular fibers in the leading pseudopodia (figure 4.8d - h), in particular at the 
ventral surface of the cell (figure 4.8dii and evi). Interestingly, in a cell altering its 
direction of migration, CCR-3 appears to traffic from the redundant leading pseudopod to 
the new leading edge via the microtubular framework (figure 4.8e). The lack of apparent 
co-localisation of CCR-3 with ~-tubulin in IL-5 primed cells, when compared to eotaxin 
stimulation alone, is most likely due to insufficient microtubular labelling. 
It appears that the fixation/lysis protocol utilised was not sufficient to maintain the integrity 
of the entire microtubular network in the highly motile cell (figure 4.8g and h), although, 
co-localisation was still apparent. Transmigrated eosinophils had lost their polarity, but 
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tight adherence to the under surface of the filter maintained microtubular polymerisation 
(figure 4.Bj and k). Once again, CCR-3 appeared to localise adjacent to the MTOC at the 
golgi complex, suggesting that most of the receptor pool was recycled back to the cell 
surface following internalisation. In addition, a distinct perinuclear ring was formed by 
microtubular fibers, another consistent site of CCR-3 and ~-tubulin co-localisation (figure j 
and kii inset). 
The next series of experiments were aimed at investigating the importance of cytoskeletal 
integrity in CCR-3 localisation and cellular function. Pre-treatment of eosinophils with the 
microtubular de-polymeriser nocodazole resulted in the aggregation of CCR-3 in distinct 
cytoplasmic aggregates (figure 4.9a-d). In treated control cells, the characteristic 
peripheral membrane localisation was absent (figure 4.9a), while in agonist stimulated 
cells, cell polarisation and CCR-3 trafficking were abolished (figure 4.9b-d). In the 
absence of an intact microtubular network, CCR-3 was unable to localise normally in 
response to external stimuli. FACS analysis of cell-surface expression of CCR-3 was 
used to confirm the link between the microtubular cytoskeleton and CCR-3 internalisation. 
In response to nocodazole CCR-3 cell-surface expression was reduced (figure 4.1 Ob and 
c) to the same extent as untreated control cells following long-term (60 minutes) agonist 
stimulation (figure 4.1 0a). Trafficking was limited by the abolishment of the polymerised 
microtubular cytoskeleton, but CCR-3 still appeared to internalise to a cytoplasmic 
compartment, as visualised by immunohistochemistry (figure 4.9), most likely in 
conjunction with the fragmented golgi complex (Iida H and Shibata Y, 1991; Cole et al., 
1996). 
4.3.2.2 Association of CCR-3 and the actin cytoskeleton 
FACS analysis of CCR-3 cell-surface expression was investigated following eosinophil 
treatment with the actin polymerisation inhibitor, cytocholasin D. As in nocodazole treated 
cells, CCR-3 cell-surface expression was reduced (figure 4.1 Oc) to the same extent as 
untreated control cells following long-term (60 minutes) agonist stimulation (figure 4.1 Oa). 
Another consistent observation was the ability of untreated (figure 4.1 Oa) and nocodazole 
treated (figure 4.1 Ob) cells to respond with increased CCR-3 expression at the cell-
surface following short-term (10 minute) eotaxin stimulation, while in cytocholasin D 
treated cells this elevation was abolished (figure 4.1 Oc). This suggests that the actin 
cytoskeleton plays a fundamental role in CCR-3 localisation at the peripheral membrane. 
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Figure 4.7. CCR-3 co-immunoprecipitates with ~-tubulin in control and 
eotaxin stimulated eosinophils: biochemical analysis 
Sorted IL-5 transgenic eosinophils were left unstimulated or incubated with eotaxin 
(1 00ng/ml) for 1 minute , then fractionated and immunoprecipitated with anti-CCR-3 
antibody (section 2.2.1 .4.1 and 4.2.3.1 ). Western blots were performed on 
immunoprecipitates with anti-P-tubulin (section 2.2.1.4.3 and 4.2.3.3). CCR-3 was found 
to co-immunoprecipitate with P-tubulin in the triton insoluble fraction of both control and 
eotaxin stimulated eosinophils. Specificity of the p-tubulin antibody was confirmed using 
wcl, exhibiting a single band of 50kd. This blot is representative of two separate 
experiments. 
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Figure 4.8a-c. Co-localisation of ~-tubulin and CCR-3 in control, PMA and IL-
5 stimulated eosinophils 
Freshly sorted peritoneal eosinophils from the IL-5 transgenic mice (see section 2.2.1.2) 
were left to adhere for 30 minutes onto fibronectin coated transwell filters and (a) left un-
stimulated; (b) stimulated with PMA (10-7M) for 10 minutes; (c) with IL-5 (10ng/ml) for 30 
minutes (section 3.2.3.2 and 4.2.1.2). Cells were fixed, permeabilised and stained with 
anti-CCR-3/Alexa 488 (section 3.2.3.3), followed by anti-~-tubulin and BODIPY-labelled 
secondary (section 4.2.1.2). Controls of the BODIPY-labelled secondary were performed 
confirming specificity of binding to the primary antibody (data not shown). Ventral sections 
were visualised using the Krypton/Argon laser of the Radiance 2000 confocal microscope 
(Biorad, Hempstead, UK). 
Images show the localisation of: (i) CCR-3 (green), (ii) ~-tubulin (red), (iii) merged to 
reveal regions of co-localisation (yellow). Insets for (c)iii include grayscale/inverted images 
for additional clarity. These images are representative of three separate experiments 
carried out in duplicate. Scale bar indicates 5µm. 
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Figure 4.8d and e. Co-localisation of p-tubulin and CCR-3 in eotaxin 
stimulated eosinophils 
Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (see section 2.2.1.2) were 
left to adhere for 30 minutes onto fibronectin coated transwell filters and stimulated with 
eotaxin (1 00ng/ml) for 1 0minutes (section 3.2.3.2 and 4.2.1.2). Cells were fixed , 
permeabilised and stained with anti-CCR-3/Alexa 488 (section 3.2.3.3) , followed by anti-~-
tubulin and BODIPY-labelled secondary (section 4.2.1.2). Sections were visualised using 
the Krypton/Argon laser of the Radiance 2000 confocal microscope (Biorad , Hempstead , 
UK). 
Images illustrated: (d) eotaxin stimulated eosinophil (i) dorsal and (ii) and ventral sections; 
insets highlight (i) polarising edge (ii) and MTOC region; ( e) comparison of the ventral 
surface of an unstimulated and stimulated eosinophil in response to eotaxin (i) CCR-3 
(green), (ii) ~-tubulin (red), (iii) merged image revealing regions of co-localisation (yellow) ; 
(iv) dorsal, (v) mid-section and (vi) and ventral surface of the same cells. Insets for vi) 
illustrate tubulin and CCR-3 localisation along a superseded pseudopod and the 
accumulation of these molecules at the new leading edge. Controls of the BODIPY-
labelled secondary were performed confirming specificity of binding to the primary 
antibody (data not shown). Arrowheads denoted leading edge while thin arrows indicate 
direction of migration. These images are representative of three separate experiments 
carried out in duplicate. Scale bar indicates 5µm. 
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Figure 4.8f-h. Co-localisation of ~-tubulin and CCR-3 in IL-5 primed and 
eotaxin stimulated eosinophils: short-term stimulation 
Freshly sorted peritoneal eosinophils from the IL-5 transgenic mouse (see section 2.2 .1.2) 
were left to adhere for 30 minutes onto fibronectin coated transwell filters and primed with 
IL-5 (1 Ong/ml) for 30 minutes followed by eotaxin (1 00ng/ml) for: (f) and (g) 10 minutes; 
and (h) 20 minutes (section 3.2.3.2 and 4.2.1.2). Cells were fixed, permeabilised and 
stained with anti-CCR-3/Alexa 488 (section 3.2.3.3), followed by anti-p-tubulin and 
BODIPY-labelled secondary (section 4.2.1.2). Sections were visualised using the 
Krypton/Argon laser of the Radiance 2000 confocal microscope (Biorad, Hempstead, UK). 
Images shown illustrate CCR-3 and P-tubulin localisation: (f and h) in polarised cells (i) 
dorsal (ii) mid, (iii) and ventral sections, separated into (iv) CCR-3 (green), (v) P-tubulin 
(red) and (iv) merged image indicating areas of co-localisation (yellow) ; (g) ventral section 
of polarised and migrating cell showing: (i) CCR-3 (green), (ii) b-tubulin (red) and (iii) 
merged image indicating areas of co-localisation (yellow). Controls of the BODIPY-
labelled secondary were performed confirming specificity of binding to the primary 
antibody (data not shown). Arrowheads denoted leading edge while thin arrows indicate 
direction of migration. These images are representative of three separate experiments 
carried out in duplicate. Scale bar indicates 5µm. 
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Figure 4.8i and j. Co-localisation of p-tubulin and CCR-3 in IL-5 primed and 
eotaxin stimulated eosinophils: long-term stimulation 
Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (see section 2.2.1.2) were 
left to adhere for 30 minutes onto fibronectin coated transwell filters and primed with IL-5 
(1 Ong/ml) for 30 minutes followed by eotaxin (1 00ng/ml) for 60minutes (section 3.2 .3.2 
and 4.2.1 .2). Cells were fixed, permeabilised and stained with anti-CCR-3/Alexa 488 
(section 3.2.3.3), followed by anti-~-tubulin and BODIPY-labelled secondary (section 
4.2.1 .2) . Ventral sections were visualised using the Krypton/Argon laser of the Radiance 
2000 confocal microscope (Biorad, Hempstead, UK). 
Images show the localisation of CCR-3 and ~-tubulin: U) in a fully migrated eosinophil 
(through the filter pores) (i) dorsal , (ii) mid and (iii) ventral surface separated into (iv) 
CCR-3 (green), (v) ~-tubulin (red) and (iv) merged image indicating areas of co-
localisation (yellow) . (k) fully migrated cells showing (i) dorsal and (ii) ventral surfaces; 
insets highlight MTOC region of fully migrated cell and CCR-3 at the perinuclear 
membrane. Sections supplemented with grayscale/inverted images for additional clarity. 
Controls of the BODIPY-labelled secondary were performed confirming specificity of 
binding to the primary antibody (data not shown). These images are representative of 
three separate experiments carried out in duplicate. Scale bar indicates 5µm . 
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Figure 4.9a-d. ~-tubulin and CCR-3 localisation in response to nocodazole 
treatment in control, IL-5 primed and eotaxin stimulated eosinophils 
Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (see section 2.2.1 .2) were 
incubated with nocodazole (10µm) for 30 minutes, prior to being left to adhere for 30 
minutes onto fibronectin coated transwell filters . Cells were: (a) left unstimulated; (b) 
primed with IL-5 (10ng/ml) for 30 minutes; (c) stimulated with eotaxin (100ng/ml) for 10 
minutes; (d) primed with IL-5 (1 Ong/ml) for 30 minutes followed by eotaxin (1 00ng/ml) for 
1 0minutes (section 3.2.3.2 and 4.2.1.2). Cells were fixed, permeabilised and stained with 
anti-CCR-3/Alexa 488, followed by anti-~-tubulin and BODIPY-labelled secondary (section 
4.2.1.2). Ventral sections were visualised using the Krypton/Argon laser of the Radiance 
2000 confocal microscope (Biorad, Hempstead, UK). 
Images show the localisation of: (i) CCR-3 (green), (ii) ~-tubulin (red), and (iii) CCR-3 and 
~-tubulin (co-localisation denoted by yellow). Controls of the BODIPY-labelled secondary 
were performed confirming specificity of binding to the primary antibody (data not shown) . 
These images are representative of three separate experiments carried out in duplicate. 
Scale bar indicates 5µm. 
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Figure 4.1 Oa-c. Characterisation of CCR-3 internalisation in control, IL-5 
primed and eotaxin stimulated eosinophils following nocodazole and 
cytocholasin D treatment 
Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (section 2.2.1 .2) were left 
(a) untreated or incubated with (b) nocodazole (10µm) or (c) cytocholasin D (1µm) for 30 
minutes prior to agonist addition, as specified (section 4.2.2) . Cells were stained with anti-
CCR-3/Alexa488 for the detection of cell-surface expression by FACS analysis (4 .2.2). 
CCR-3 internalisation was investigated in samples: (ii) untreated, unstimulated; (iii) 
untreated, IL-5 (30m) primed (a) or treated, unstimulated (b and c); (iv) IL-5 (30m) and 
eotaxin (10m); (v) IL-5 (30m) and eotaxin (30m); (vi) eotaxin (10m); (vii) eotaxin (30m); 
(viii) eotaxin (60m). These results are representative of two separate experiments run in 
triplicate. 
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Figure 4.11 a-c. Partial characterisation of F-actin and CCR-3 localisation in 
eosinophils: poor consistency in double-staining limits full characterisation 
Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (section 2.2.1.2) were left 
to adhere for 30 minutes onto fibronectin coated transwell filters. Cells were: (a) 
unstimulated or (b) primed with IL-5 (10ng/ml) for 30 minutes. Cells were fixed, 
permeabilised and stained with anti-CCR-3/Alexa 488, followed by Texas Red® anti-
phalloidin (section 4.2.1.2). Ventral sections were visualised using the Krypton/Argon laser 
of the Radiance 2000 confocal microscope (Biorad, Hempstead, UK). 
Images show the localisation of: (i) CCR-3 (green), (ii) F-actin (red), and (iii) CCR-3 and F-
actin (areas of co-localisation denoted by yellow). These images are representative of 
three separate experiments carried out in duplicate. Scale bar indicates Sµm. 
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lmmunohistochemical confirmation of F-actin and CCR-3 co-localisation was impeded by 
the poor consistency of double-staining with available antibodies. In future studies, a non-
phalloidin based F-actin probe should be used for this characterisation, limiting the 
possibility of actin-binding protein interference in F-actin labelling. Although some staining 
and co-localisation was evident in control and IL-5 stimulated cells (figure 4.11 ), F-actin 
was only partially labelled when compared to initial localisation experiments (figure 4.3). 
Future studies would aim to characterise F-actin/CCR-3 co-localisation in respect to the 
microtubular cytoskeleton and focal complex formation. 
4.3.3 CCR-3 associates with FAK in control and stimulated eosinophils 
- crosstalk between integrin and chemokine signalling 
In conjunction with CCR-3 localisation studies, I was interested in characterising the 
possible sites of crosstalk between integrin and chemokine generated intracellular signals. 
One previous study had shown intracellular association of human CCR-5 with FAK (Cicala 
et al., 1999). FAK, known to play a fundamental role in integrin mediated events 
(Schlaepfer DD and Hunter T, 1998; Schlaepfer et al., 1999) and focal complex dynamics 
(Parsons et al., 2000), was found to co-immunoprecipitate with CCR-3 in control 
eosinophils, a response which was upregulated in eotaxin stimulated cells (figure 4.12). 
This association was confirmed in immunohistochemical studies, showing that in control 
(figure 4.13a) and agonist stimulated cells (figure 4.13b and c ), FAK and CCR-3 were 
indeed co-localised at the peripheral membrane and focal complexes adjacent to the 
ventral surface. 
The distinct "tracking" of these intracellular aggregates prompted a brief investigation into 
FAK and ~-tubulin co-localisation. In control eosinophils, FAK did co-localise strongly with 
both monomeric and polymerised microtubules (figure 4.14a), radiating from and adjacent 
to the MTOC. These findings indicate that FAK may indeed play an integral role in CCR-
3 internalisation, a dynamic process involving microtubule and actin cytoskeletal 
remodelling. 
4.3.4 Caveolin expression in murine eosinophils - deciphering the path 
of CCR-3 internalisation and recycling. 
The acquisition of cell polarity relies on the correct localisation of signalling molecules 
involved in cell migration dynamics. Caveolae and their associated caveolin proteins may 
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play a crucial role in eosinophil signal transduction processes. Peripheral membrane 
bound caveolae are characterised by small invaginations on the surface of many cells and 
consist primarily of caveolin-1 protein. Electron micrographs of the eosinophil cell surface 
illustrate the presence of these indentations and associated intracellular vesicles (figure 
4.15a). lmmunohistochemical detection of caveolin-1 expression at the peripheral 
membrane did, indeed, confirm the potential role of caveolae in the aggregation of 
signalling molecules in response to chemotactic stimuli (figure 4.15b). Of particular 
interest was the localisation of caveolin-1 adjacent to the site of the golgi complex and 
MTOC (section 4.3.2.1 ), suggesting the association of this protein with the endocytotic 
trafficking of eosinophil signalling mediators (Parton et al., 1994; Schlegel et al., 2001; 
Pfeffer S, 2001 ). 
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Figure 4.12. CCR-3 co-immunoprecipitates with FAK in response to eotaxin 
(1 00ng/ml) stimulation 
Sorted IL-5 transgenic eosinophils were incubated with eotaxin (1 OOng/ml) for 0, 1 or 5 
minutes, then fractionated and immunoprecipitated with anti-FAK antibody (section 
2.2.1.4.1 and 4.2.3.1 ). Western blots were performed on immunoprecipitates with anti-
CCR-3 (section 2.2.1.4.3 and 4.2.3.3) and reprobed with anti-FAK antibody. 
This blot is representative of three separate experiments . 
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Figure 4.13a-c. FAK and CCR-3 localisation in control, IL-5 primed and 
eotaxin stimulated eosinophils 
Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (section 2.2.1.2) were left 
to adhere for 30 minutes onto fibronectin coated transwell filters. Cells were: ( a) left 
unstimulated; (b) stimulated with eotaxin (1 OOng/ml) for 10 minutes; or (c) primed with IL-
5 (1 Ong/ml) for 30 minutes followed by eotaxin stimulation (1 OOng/ml) for 1 Ominutes 
(section 3.2.3.2 and 4.2.1.2). Cells were fixed, permeabilised and stained with anti-CCR-
3/Alexa 488, followed by anti-FAK and Texas Red-labelled secondary (section 4.2.1.2). 
Ventral sections were visualised using the Krypton/Argon laser of the Radiance 2000 
confocal microscope (Biorad, Hempstead, UK). 
Images show the localisation of: (i) CCR-3 (green); (i) FAK (red); and (ii) merged to reveal 
regions of co-localisation (yellow). Controls of the Texas Red-labelled secondary were 
performed confirming specificity of binding to the primary antibody ( data not shown). 
Arrowheads denote leading edge while thin arrows indicate direction of migration. These 
images are representative of two separate experiments carried out in duplicate. Scale bar 
indicates 5µm. 
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Figure 4.14. FAK co-localisation with ~-tubulin in control eosinophils 
Freshly sorted peritoneal eosinophils from the IL-5 transgenic mouse (section 2.2.1.2) 
were left to adhere for 30 minutes onto fibronectin coated transwell filters. Cells were left 
unstimulated, fixed, permeabilised and stained with anti-FAK and BODIPY-labelled 
secondary, followed by either anti-~-tubulin and Texas Red-labelled secondary or Texas 
Red® anti-phalloidin (section 4.2.1.2). Ventral sections were visualised using the 
Krypton/Argon laser of the Radiance2000 confocal microscope (Biorad, Hempstead, UK). 
Images show the localisation of: (i) FAK (green); (ii) ~-tubulin (red); (iii) merged to reveal 
regions of co-localisation (yellow). Controls were produced for both BODIPY- and Texas 
Red-labelled secondary antibodies confirming specificity of binding to primary antibody 
(data not shown). These images are representative of two separate experiments carried 
out in duplicate. Scale bar indicates Sµm. 
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Figure 4.15. Caveolin expression in murine eosinophils - deciphering the 
path of CCR-3 internalisation and recycling. 
Caveolin localisation and expression was investigated by (a) transmission EM , (b) 
immunohistochemistry 
(a) Freshly sorted eosinophils were left to adhere on BSA coated polycarbonate coverslips 
for 30 minutes. Following adherence, cells were fixed with 2% gluteraldehyde and 
prepared for EM analysis (section 4.2.4). EM micrographs were taken on the Hitachi 
transmission electron microscope (H-7000; Hitachi, Japan). 
(b) Freshly sorted peritoneal eosinophils from IL-5 transgenic mice (section 2.2.1.2) were 
left to adhere for 30 minutes on fibronectin transwell filters. Cells were stimulated with 
eotaxin (1 00ng/ml) for 10 minutes, fixed, permeabilised and stained with anti-caveolin and 
BODIPY-conjugated secondary (section 4.2.1.2). Ventral sections were visualised using 
the Krypton/Argon laser of the Radiance 2000 confocal microscope (Biorad , Hempstead, 
UK). The image shows the localisation of caveolin-1 (green) supplemented with a 
grayscale/inverted image to enhance clarity . 
These Images are representative of three separate experiments carried out in duplicate. 
Scale bar indicates 5µm. 
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4.4 DISCUSSION 
Historically the actin and microtubular networks have been considered as two distinct 
cytoskeletal systems functioning independently. However, research in the last 1 O years 
has highlighted the co-operation of these filament systems in a variety of cellular 
processes (Gavin RH, 1997; Klymkowsky MW, 1999; Fuchs and Yang, 2000; Goode BL 
et al., 2000). The structural responses of a cell to chemoattractant stimuli rely on the 
interplay of these networks in providing the scaffold for the establishment of cell 
polarisation, focal adhesion formation, microdomain maintenance, and vesicle transport 
(Gavin RH, 1997; Goode et al., 2000). 
4.4.1 Actin and microtubule dynamics at the leading edge 
Initial characterisation of the actin and microtubular (MT) network of the eosinophil 
highlighted the specific requirements for rapid re-organisation of the cytoskeletal 
framework in such a highly motile cell. In comparison to the low-motile Swiss 3T3 
fibroblasts, the poly.merised actin network in the murine eosinophil was characterised by a 
tight dot-like formation (figure 4.3). F-actin appeared to co-localise with focal complexes, 
also referred to as podosomes, and distinguished from focal adhesions by their transient 
nature (Wolosewick JJ, 1984; Linder et al., 2000). This profile has been observed in other 
migrating invasive cells, such as the macrophage (Wolosewick JJ, 1984; DeFife et al., 
1999; Linder et al., 1999) and mast cell (Suzuki et al., 1998), in osteoclasts derived from 
the monocyte lineage (Zambonin-Zallone A, 1988; Teti et al., 1989), and in fibroblast cell-
lines transformed by Rous Sarcoma virus (RSV) or Fujinami avian sarcoma virus (FSV) 
(Tarone et al., 1985; Nakamura et al., 1993). In-vitro studies have found that the Wiskott-
Aldrich syndrome protein (WASP), the GTP-bound cdc42 (CDC42Hs) (Linder et al., 2000) 
and actin-binding protein paxillin (Suzuki et al., 1998) concentrate in the core of 
podosomes in primary human macrophages. WASP is essential for the formation of 
podosomes (Linder et al., 2000) through direct interaction with the paxillin bound (Salgia 
et al., 1995) SH2-SH3 adaptor Crkl (Oda et al., 2001) and, upon binding to CDC42Hs, 
also for their disappearance. Interestingly, expression of a constitutively-activated mutant 
of CDC42Hs in a Hela-derived cell-line induced a massive re-organisation of F-actin into 
cortical microspikes and podosome-like structures on the ventral face of the cells (Dutartre 
et al., 1996). It should be noted that podosomal formation has not been observed in all 
leukocyte populations, in particular they are absent in lymphocytes and lymphoblastic cell-
lines (Takubo T, 1997), reflecting the specific requirements of cell adhesion and motility of 
each cell. 
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The microtubular network is also highly dynamic in the munne eosinophil. Agonist 
stimulation, both adhesive and chemotactic, induces rapid tubulin polymerisation, 
producing a distinct "astral" formation of microtubules radiating from the MTOC (figure 
4.5). However, in the chemoattractant stimulated cells, microtubules extend rapidly 
towards the direction of stimulus (figure 4.5 and 4.6). Previous studies in fibroblasts 
have elucidated that in migrating cells, membrane protrusion via lamellipodia/filipodia 
formation is driven by actin polymerisation, whereas directional movement requires the 
direct targeting of microtubules to cortical actin sites (Kaverina et al., 1998). In addition, 
the depolymerisation of microtubules inhibits both cell polarisation and migration (Vasiliev 
J, 1991; Bershadsky et al., 1991 ). Microtubules have been postulated to "track" along 
actin cables towards the cortical actin foci, a process believed to be co-regulated by the 
actin motor myosin, the microtubule motors (kinesin and dynein) (Huang et al., 1999), and 
microtubule-associated cytoplasmic linker protein 170 (CLIP170) (Lantz and Miller, 1998; 
Perez et al., 1999). 
In chemoattractant stimulated eosinophils, F-actin polarised and co-localised with ~-
tubulin towards the leading edge (figure 4.3 and 4.6). Of particular interest was the 
observation that microtubule extension within the leading lamellipodia did co-localise with 
distinct F-actin "tracks" (figure 4.6f), observed in the initial characterisation of F-actin 
localisation (figure 4.3d). Interaction between these two cytoskeletal systems is mediated 
by the Rho-GTPases. The growth phase of microtubular extension within the leading 
lamellipodia locally activates Rac1 to drive actin polymerisation and further lamellipodia 
protrusion (Waterman-Storer et al., 1998). Rac1 and a nucleotide exchange factor 
activator of both Rac1 and Rho, GEF-H1, have been found to localise directly to 
microtubules (Ren et al., 1998). In preliminary studies, Rac1 did indeed localise to the 
leading edge in chemoattractant stimulated eosinophils (data not shown), indicating the 
potential role for this GTPase in mediating cytoskeletal rearrangement. In addition, 
microtubule depolymerisation directly activates Rho and downstream mediators, driving 
actin/myosin contractility, inducing focal adhesion formation and increasing substratum 
contact in the direction of migration (Ren et al., 1999). The dynamic interaction 
established between the actin and microtubular cytoskeletons provides a positive 
feedback loop to drive cell migration (Waterman-Storer and Salmon, 1999). 
4.4.2 The structural dynamics of intracellular trafficking 
The dynamic interplay of these two filament systems is also evident in the intracellular 
transport of vesicles and cellular organelles. Generally, microtubules are utilised for long-
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range transport of vesicles to endosomal compartments and the golgi complex, while actin 
filaments are essential in short-range transport, characteristic of membrane microdomain 
assembly (Langford GM, 1995). Co-operation exists to some extent at all stages of 
intracellular trafficking (Kuznetsov et al, 1992), a process regulated by the formation of 
"hetero-motor" complexes composed of both actin and microtubule motors (kinesin and 
myosin Vin this study) (Huang et al., 1999). 
lmmunohistochemical observations of ligand induced internalisation of CCR-3 (Chapter 3) 
suggested an integral role for both the actin and microtubule filament systems in the 
trafficking of this receptor. Initial biochemical studies into the role of the microtubular 
network in this process illustrated a direct association of CCR-3 with ~-tubulin (figure 4. 7), 
which was confirmed by a more thorough immunohistochemical investigation. In control 
cells, CCR-3 and ~-tubulin co-localised adjacent to the peripheral membrane (figure 4.8a). 
In some cells, CCR-3 was found to be partially internalised prior to exogenous eotaxin 
addition, suggesting a role ·for endogenous eotaxin (Nakajima et al., 1998) in basal 
homeostasis of the cell. Eotaxin stimulation induced leading edge co-localisation, 
followed by the distinct "tracking" of CCR-3 along microtubules from the leading 
pseudopod to a site adjacent to the MTOC, known to contain the golgi complex (figure 
4.8d-h). Although the traditional model of receptor resensitisation requires passage 
through the endosomal compartments of the cell (Sorkin A, 2000), some GPCR's traffic 
directly to the Golgi complex prior to recycling to the plasma membrane (Hein L et al., 
1994 ). CCR-3 association with the "clear zone" following the cessation of directed 
migration (figure 4.8i and j) suggests this may just be the case, while the perinuclear 
localisation of a small pool of this receptor may represent the endosomal/lysosomal 
associated fraction. 
Although investigation into the co-localisation of CCR-3 with the actin cytoskeleton was 
limited (figure 4.11 ), this association was illustrated by the co-localisation of FAK/CCR-3 
at actin-based focal complexes (figure 4.13), and will be discussed later in this Chapter. 
The interplay of these two filament systems was highlighted by the lack of CCR-3 
trafficking to the "clear zone" in both nocodazole and cytochalasin D treated cells (figure 
4.9). However, FACS analysis revealed that the receptor still internalised to a cytoplasmic 
compartment possibly in association with the newly fragmented golgi complex (Iida H and 
Shibata Y, 1991; Cole et al., 1996). 
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As previously mentioned (Chapter 3), microdomains play an integral role in both the 
formation of signalling complexes at the cell membrane and the intracellular trafficking of 
these mediators for recycling or degradation. Both clathrin-coated pits (Zhang et al., 
1996) and caveolae (Dupree et al., 1993) are intimately involved in the intracellular 
trafficking of GPCR's. In the case of chemokine receptors, receptor resensitisation and 
recycling is essential for the maintenance· of cell migration. Studies into the pathways 
utilised for CCR-5 receptor trafficking have identified the involvement of both clathrin-
coated pits and caveolae. A brief investigation into microdomain expression in 
eosinophils identified the caveolin localisation at the cell membrane (figure 4.15). EM 
analysis reveals distinct invaginations in association with adjacent vacuole formation 
along the entire plasma membrane. Further investigation using immunogold-labelling 
could be aimed at elucidating the expression of both clathrin-coated pits and caveolae, 
and the potential association of CCR-3 with these microdomain regions. 
4.4.3 Coupling focal adhesion and chemokine generated dynamics 
In association with the functional and structural responses of the eosinophil to 
chemoattractant stimuli, the potential crosstalk between integrin and chemokine activated 
pathways was investigated. Earlier work had demonstrated that the eosinophil adhered to 
substrate via the formation of actin-based focal complexes or podosomes, known to 
provide a transient scaffold for integrin mediated adhesion (Critchley DR, 2000). Ligand 
binding to an integrin receptor leads to clustering and the recruitment of actin filaments via 
the complex interplay of a variety of actin-binding proteins (paxillin, talin, vinculin, a-actinin 
and filamin), and the recruitment of downstream mediators including FAK (Lipfert et al. , 
1992). Studies in FAK-null mice exhibit enhanced focal contact formation and a defect in 
cell migration (Ilic et al., 1995), suggesting FAK plays an central role in integrin-mediated 
cell migration. Of particular interest in relation to chemokine generated signals was the 
observation, by Cicala and colleagues, that CCR-5 was found to directly associate with 
and phosphorylate FAK in HIV-1 envelope stimulated primary human lymphocytes (Cicala 
et al., 1999). Biochemical studies revealed that murine CCR-3 also directly associates 
with FAK upon ligand binding (figure 4.12), while immunohistochemistry confirmed the co-
localisation of CCR-3/FAK at the leading edge and focal complexes of the ventral surface 
(figure 4.13). Chemokine and cell adhesion receptor-mediated migration signals are 
thought to converge on common intracellular targets, such as FAK, to engage the cell 
migration machinery. The interplay of chemokine and integrin/adhesion molecule signals 
has been demonstrated previously in eosinophils. Eotaxin stimulation was found to 
upregulate Mac-1/ICAM-1 and VLA-4NCAM-1 associations (Jia et al., 1999), while 
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inducing VCAM-1 release of eosinophils, diverting integrin activity from beta1- to beta2-
integrins (Tachimoto et al., 2000). 
Structurally, the establishment of focal complexes and focal adhesions are essential for 
leukocyte migration. Since adhesion and focal complex formation preclude chemotaxis, 
integrin/extracellular matrix interactions must play an integral role in both the induction 
and maintenance of directed migration. Mechanical tension, through the interplay of the 
myosin motor and Rho GTPases, pulls the actin cytoskeleton against established 
adhesion sites, leading to the construction of focal complexes (Janmey PA, 1998), a 
process involving an intact microtubule network (Malek and lzumo, 1996). Once 
established, the upregulation in shear stress upregulates leukocyte migration relative to 
static conditions (Kitayama J, 2000; Luu T, 1999). In human eosinophils shear dependent 
transmigration through IL-4 stimulated endothelium resulted in the direct upregulation of 
eotaxin-3 production, and enhanced migration when compared to static conditions 
(Cuvelier and Patel, 2001 ). One of the main functional responses to shear stress is FAK 
activation, which has been shown to induce signalling via direct association with the Grb2 
adaptor protein, resulting in the downstream activation of MAP kinases and c-Jun NH2-
terminal kinase (JNK) (Li et al., 1997). There is no doubt that FAK lies at the crossroads 
of chemokine, integrin and extra-cellular matrix signalling, and further characterisation of 
its role in chemical and mechanical responses in the eosinophil are worth elucidating. Of 
particular interest is the functional role of CCR-3/FAK co-localisation, and the potential 
structural changes induced by this association. 
In this Chapter actin and microtubular cytoskeletal dynamics in the eosinophil were 
characterised. In particular, the co-localisation of these cytoskeletal networks in response 
to both priming (IL-5) and chemoattractant (eotaxin) stimulation were studied. 
Identification of the direct association of CCR-3 with the P-tubulin protein lead to the 
characterisation of receptor/microtubular interactions in agonist stimulated eosinophils. 
The microtubular network was shown to play an integral role in the internalisation and 
recycling of CCR-3. The association of FAK with CCR-3 confirmed the crosstalk of 
integrin based adhesion systems and chemokine-signalling pathways within the 
eosinophil. Co-localisation of FAK with the microtubular network further highlighted the 
interplay of functional and structural signals involved in eosinophil adhesion and motility. 
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CHAPTER 5: 
Inhibition of Eosinophil 
Migration 
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5.1 INTRODUCTION 
In the previous Chapters I have highlighted the importance of CCR-3 mediated signals in 
the directed migration of eosinophils. This Chapter focuses on the inhibition of eosinophil 
migration, both through the use of specific signalling inhibitors and by directly blocking 
CCR-3 signalling. 
Signalling inhibitors provide a useful tool for the characterisation of downstream second 
messengers induced by ligand-receptor interactions. In Chapter 1, the pertussis-sensitive 
nature of CCR-3-induced chemotaxis (Agrawal et al., 1992) was utilised to identify the role 
of Gia2 in CCR-3 mediated eosinophilic movement. In this Chapter, pertussis toxin was 
used as a negative-control of eosinophil migration, while the effect of wortmannin (inhibitor 
of phospholipid kinase signalling) and rapamycin (inhibitor of p70S6K signalling) on 
eotaxin/CCR-3 mediated chemotaxis was investigated. In-vitro evaluation of eosinophil 
chemotaxis required the development of a real-time fluorescence based assay employing 
Fluoroblok technology (section 5.2.2.2), thus enabling the continuous monitoring of cell 
migration in response to inhibitors and agonist. In conjunction with these in-vitro analyses, 
in-vivo migration was also evaluated in response to these signalling inhibitors. Due to the 
dynamic promiscuity of second messengers and resulting lack of specificity, the use of 
intracellular inhibitors to block eosinophil migration has limited clinical value. However, 
their use does provide insights into specific mechanisms that regulate migration. 
The development of a specific munne CCR-3 monoclonal antibody (19-4) enabled 
Coffman's group (DNAX, Palo Alto, CA, USA) to describe the first in-vivo depletion of 
eosinophils in response to parasitic infection (Grimaldi et al., 1999). I was interested in 
further characterising the potential use of this mAb in the ablation of eosinophilia in our 
murine model of allergic airways inflammation. In summary, purified CCR-3 mAb and 
anti-CCR-3 antibody ascites were found to be very effective in depleting eosinophil influx 
and reducing associated airways pathology. These results highlight the effectiveness of 
CCR-3 antagonists in the in-vivo depletion of airway eosinophils in the murine model, and 
the importance of chemotactic signals mediated by this receptor in the recruitment of 
these leukocytes to the site of allergen provocation. 
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5.2 MATERIALS AND METHODS 
FAGS sorting of peritoneal eosinophils 
Bronchoalveolar lavage 
Histological analysis of pulmonary tissue 
5.2.1 Mice 
Section 
Section 
Section 
2.1.1.2 
2.2.2.3 
2.2.2.4 
Male C57BL/6 IL-5 transgenic mice (originally obtained from Dr. Lindsay Dent, Uni. of 
Adelaide), were used in the in-vitro eosinophil migration/inhibition studies. These mice 
were also used as eosinophil donors in in-vivo migration/inhibition studies, while WT 
C57BL/6 mice were used as recipient mice. All mice were bred and maintained by the 
animal breeding establishment (ABE), JCSMR, ANU. Mice were treated in accordance 
with ANU animal experimentation guidelines. 
5.2.2 
5.2.2.1 
in-vitro inhibition of eosinophil migration 
CFDA labelling of eosinophils 
5mM stock of carboxyfluorescein diacetate was prepared (CFDA) (Molecular Probes, 
Oregon,USA) in DMSO and stored frozen at -20°C prior to use. FACS sorted eosinophils 
were washed twice in Hanks and resuspended to 108/ml in Hanks containing 5µm (in-vitro 
studies) or 1 0µm (in-vivo studies) CFDA, gently vortexed and covered with foil. Cells 
were incubated at 37°C for 30 minutes, upon which 5ml of PBS/0.1 %BSA (Sigma, MO, 
USA) was added. Cells were washed twice in PBS/0.1 % BSA (1500g for 5min), to 
remove unbound CFDA, covered with foil and left on ice. 
5.2.2.2 Transwell migration assay 
Eosinophils were labelled with CFDA as described in section 6.3.1. After washing, cells 
were resuspended in PBS to 2.5 x 106/ml. For intracellular signal inhibition studies cells 
were incubated with: no inhibitor; wortmannin (Sigma, MO, USA) at 1 0µg/ml for 30min; 
pertussis toxin (LIST Biologicals, CA, USA ) at 1 00µg/ml for 1.5 hrs; and rapamycin 
(Sigma-Aldrich, USA) at 1 µm for 1 hour. 
1 ml of RPMI media [2mM L-glutamine (Gibco), 10mM Hepes, 10mM non-essential amino 
acids (Gibco, NY, USA), 1 00µM 2-mercaptoethanol (Sigma, MO, USA), 5g D-glucose 
(Ajax), 1 mM sodium pyruvate (BDH, UK), 5ml penicillin/streptomycin (Gibco, NY, USA)] 
was added to each well of a 24 well (Nalgene Nunc, NJ, USA) plate and warmed to 37°C. 
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400µ1 of the media was removed and agonist added to the well and mixed. Agonist 
conditions used: no agonist; eotaxin (Peprotech, NJ, USA) at 1 00ng/ml. 
End-point assay using transwell filters: initial in-vitro studies were performed using 
traditional polycarbonate transwell filters (Corning Costar, MA, USA) coated with 50ug/ml 
fibronectin (Sigma, St. Louis, USA). 200µ1 of eosinophil suspension (5 x 105 cells) was 
added to each transwell and placed into the agonist containing plate. At the end point of 
the assay, trans-migrated cells were pipetted off the underside of the filter and the 
transwell removed. Migrated cell numbers were calculated by (1) CFDA fluorescence 
measured on the Cytofluor II plate reader (PerSeptive Biosystems, Framinghan, MA, 
USA) or (2) manually counting cells using the haemocytometer. 
Time-course assay using Fluoroblok insert: 200µ1 of eosinophil suspension (5 x 105 cells) 
was added to each Fluoroblok insert (BO Falcon, MA, USA) and placed into the . 
agonist containing plate. Cells were left to migrate for 3.5 hours at 37°C in a CO2 
incubator, with fluorescence measurements taken on the Cytofluor every 30 minutes. 
5.2.3 In-vivo inhibition of eosinophil migration 
5.2.3.1 In-vivo inhibition using intracellular signalling inhibitors 
Freshly sorted eosinophils were labelled with 1 0µm CFDA (section 5.2.2.1 ). Alternatively, 
GFP/IL-5 double transgenic eosinophils were used directly in this assay. After washing, 
cells were resuspended in PBS at 2.5 x 106/ml and incubated with: no agonist ; 
wortmannin (Sigma-Aldrich, USA) at 1 0µg/ml for 30min; pertussis toxin (LIST 
Biologicals,CA, USA) at 1 00µg/ml for 1.5 hrs; and rapamycin (Sigma-Aldrich, MO, USA) at 
1 µm for 1 hour. Following incubation, cells were washed 3 times in PBS (1,500g for 5min) 
to remove inhibitor and resuspended in saline at 5 x 106/ml. 200µ1 of treated cell 
suspension was injected into the tail vein of ova-sensitised receipient mice and ova-
sensitisation/antigen provocation was induced according to the following protocol: 
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Eosinophils sorted from peritoneal 
lavage using BD-FACSStar Plus 
• 
Incubated with CFDA for 30min at 37°C 
• 
Incubated with intracellular signalling inhibitors 
• 
Cells placed in upperchamber of Fluoroblok transwell 
(fibronectin coated), and allowed to settle 
• 
Semi-
permeable 
membrane 
~~~~~-t . 
1 mm 
In-vitro agonist stimulation - agonist added to lower well 
• 
Cells allowed to i igrate for 3hr 
Migrated cells counted using Cytofluor 
Fiaure 5.1 In-vitro inhibition of eosinoohil miaration 
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Day 
0 11 12 13 14 15 16 17 
OVAi.p P.B Inject PB Aero p Aero Sacrifice 
Donor Cells 3x30 8 3x30 Mice 
Aero 
3x30 
Aero - Saline or Ova aerosol provocation 
Peripheral blood (PB) smears (2.2.2.2), BALF cytospins (2.2 .2.3) and histological samples 
(5.2.3.1.1) were analysed on the confocal microscope (Leica TCS, Germany) for the 
detection of CFDA labelled and GFP-tagged eosinophils. 
5.2.3.1.1 Preparation of histological specimens for fluorescence microscopy 
In preparation for the embedding of lung tissue, a foil "cup" was formed, with the addition 
of 2 drops of OCT compound (Sakura, USA), and left on dry-ice. A longitudinal and 
transverse incision was made above the thoracic cavity to expose the ribcage and lungs 
carefully dissected out of the cavity. The large (left) lobe was excised and placed onto a 
fresh drop of OCT (placed on top of the previously frozen OCT), adding enough OCT to 
immerse the specimen. The specimen was then fully wrapped in foil and kept in the dark 
prior to sample preparation. The following day, longitudinal sections were cut by the 
Histology Unit (JCSMR), and mounted with glycerol onto glass slides. Specimens were 
visualised on the confocal microscope (Lei ca TCS, Germany). 
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5.2.3.2 In-vivo migration inhibition using CCR-3 (19-4) antibody treatment 
WT Male C57BL/6 were ova-sensitised and challenged according to the following model: 
Day 
Model for antibody experiment 
0 11 12 13 14 15 16 17 
OVAi.p P.B 1 Aero Aero Aero Sacrifice 
1mg 3x30 3x30 3x30 Mice 
1mg 19-4 I.P 
1 mg 19-41.P /200ul CCR-3 P.B P.B 
ascites /200ul CCR-3 
ascites 
Aero - Saline or Ova aerosol provocation 
On days 11 and 12, 1mg of CCR-3 (19-4) mAb in 200µ1 of saline or 200µ1 of CCR-3 
ascites were injected into the tail vein of recipient mice. Control mice were injected with 
200ul saline and analysed alongside CCR-3 (19-4) treated mice. 
5.2.3.2.1 Generation of CCR-3 antibody ascites 
Hybridoma cell-line specific for murine CCR-3 antibody (obtained from Dr Robert 
Coffman, DNAX Research Institute, USA) was grown in complete mouse lymphocyte 
culture media (MLC; made from a base of Dulbecco's modified eagle's medium [DMEM; 
Gibco BRL, NY, USA] supplemented with [final concentrations] 10% foetal calf serum, 
1 mM Na pyruvate, 1 0mM HEPES, 2mM glutamine, 50µg/ml penicillin, 50µg/ml 
streptomycin, 1 00µg/ml neomycin and 5 x 10-5 M mercaptoethanol) at 37°C, 5% CO2. 
Swiss nude mice were obtained from the specific pathogen-free (SPF) facility of the 
JCSMR, ANU. Mice were housed and treated in accordance with ANU guidelines for 
animal experimentation. Mice were injected i.p with 500µ1 pristane [2, 6, 10, 14-tetra-
methyl-pentadecane (Sigma, MO, USA)] one week prior to injection of hybridoma cells. 
On day 7, hybridoma cells were washed and incubated with fresh media for 5 hours 
before washing and resuspension of cells at 10 x 106/ml. Mice were injected with 2 x 106 
cells in saline, using a total volume of 200µ1. Mice were checked regularily for the 
formation of ascites. When ascites had developed in the peritoneal cavity (usually around 
3 weeks after injection), the mice were killed by cervical dislocation, before insertion of an 
18 gauge needle an ascites collection. Ascites were centrifuged at 500g for 5 minutes at 
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4°C to remove cells and debris, and the supernatant removed to a sterile tube. Ascites 
stored at 4°C prior to purification (within 2 days) or used unpurified the next day. 
5.2.3.2.2 Quantification of CCR-3 antibody ascites 
Collected ascites were quantified using an ELISA assay. Round-bottom ELISA plates 
(Nalgene Nunc, NJ, USA) were coated with goat anti-rat lgG (Southern Biotechnology 
Associates, Inc., Birmingham, USA) in NaCO3 buffer (pH 9.6) and incubated at 4°C 
overnight. Plates were washed in PBS/0.5% Tween and blocked with 4% skim milk 
powder in PBS/0.5% Tween for 1 hour at 37°C. Plates were then incubated with serial 
dilutions of ascites samples (intial dilution 1 :2000) and standard rat total lgG (Sigma, MO, 
USA) for 2 hours at 37°C. Rat immunoglobulins were detected with biotinylated goat anti-
rat total lgG (Southern Biotechnology Associates Inc., Birmingham, USA). Plates were 
washed in several changes of PBS/0.5% Tween before incubation with streptavidin-
conjugated alkaline phosphatase (Amersham International, Buckinghamshire, -UK) for 1 
hour at 37°C. Plates were washed again with PBS/Tween then incubated with alkaline 
phosphatase substrate solution for 15 minutes. Samples were read at 405nm with 
reference to 490nm on a microplate reader (BIO-TEK Instruments Inc., Winooski, VT). 
5.2.3.2.3 Purification of CCR-3 (19-4) antibody from ascites 
CCR-3 mAb was purified from ascites by hydrophobic charge induction chromatography 
(HCIC) using MEP HyperCel (BioSeptra, Cergy-Saint-Christophe, France) . Briefly, 
following overnight settling at 4°C, coagulated fat/fibrous tissue was removed and the 
remaining solute was filtered through 0.22µm filters (Millipore, Bedford, MA, USA). 2ml of 
MEP Hypercel slurry was transferred to a chromatography column and equilibrated with 
50mM Tris-HCI, pH8.0 (equilibration and packing buffer). The ascites was diluted with 
buffer, loaded carefully onto the column and washed with buffer until UV absorbance 
returned to baseline. Antibody was eluted with 50mM sodium citrate, pH 4.4, (Sigma, 
MO, USA) into packing buffer (pH 8.0) to avoid the denaturation of protein. 
5.2.3.2.4 Quantification of purified CCR-3 antibody 
See section 5.2.2.2. 
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5.3 RESULTS 
5.3.1 In-vitro inhibition of eosinophil migration 
The quantitation of eosinophil migration was initially performed using an in-vitro transwell 
chemotaxis assay (Partsch and Schwarzer, 1991; Schratzberger et al., 1996). Firstly, 
CFDA-labelled eosinophils were visualised under the confocal microscope (Leica LCS, 
Dassel, Germany), identifying localisation of the dye throughout the cytoplasmic 
compartment of the cell (figure 5.2a). Due to the light permeable nature of these 
traditional transwells, trans-migration could only be quantitated at the end-point of the 
assay, requiring manually intensive retrieval of cells. 
Control cells (no inhibitor and no agonist) displayed up to 7% eosinophil transmigration, 
induced by both endogenous eotaxin production and random migration of cells (figure 
5.2b). Exogenous eotaxin was used as a positive-control in these assays and produced a 
10% increase in eosinophil migration from control cells. Treatment of cells with the 
intracellular signalling inhibitors pertussis toxin, wortmannin and rapamycin prior to 
eotaxin stimulation (1 00ng/ml) induced a strong reduction in eosinophil migration, below 
that of control (no inhibitor and no agonist) cells. These trends were also reflected in the 
fluorescence measurements, which although not as quantitative as manual counts, gave a 
more consistent comparison of trans-migration in response to inhibition and agonist 
treatment. 
Modification of the chemotaxis protocol to incorporate the use of Fluoroblok filters enabled 
a time-course of eosinophil migration to be assessed. The unique light-opaque PET 
membrane of the Fluoroblok is specifically designed to absorb visible light, making it ideal 
for use in time-course migration assays. The greater efficiency of this automated protocol 
was highlighted by the general increase in eosinophil migration detected under all 
conditions by 3.5 hours (figure 5.2c compared to 5.3). Eosinophil migration in pertussis 
toxin treated cells was ablated to control (no inhibitor and no agonist) levels (figure 5.3), 
while wortmannin treated cells were still partially responsive to eotaxin induced 
chemotactic signals. However, in these experiments rapamycin treatment failed to 
produce any detectable inhibition to eosinophil migration and responses were equivalent 
to non-inhibited, eotaxin stimulated cells. The lack of response was correlated to the use 
of a "defective" batch of this drug, concluded from concurrent experiments on fibroblast 
migration (observations by Dr. Crouch and Dr. Serven, Molecular Signalling Laboratory). 
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a 
Figure 5.2a-c. In-vitro inhibition of eosinophil migration: transwell filter 
protocol 
Freshly sorted peritoneal eosinophils from the IL-5 transgenic mouse (section 2.2.1.2) 
were incubated with CFDA (5µm) for 30 minutes at 37°C (section 5.2.2.1 ), prior to re-
incubation with intracellular signalling inhibitors for times as indicated in section 5.2.2.2. 
Cell motility was assessed using the transwell migration assay (section 5.2.2.2). (a) 
Eosinophils labelled with CFDA were visualised using the Krypton/Argon laser of the Leica 
LCS confocal microscope (Dassel, Germany). Grayscale/inverted image is included for 
added clarity. (b and c) Migration of CFDA/inhibitor treated cells in response to eotaxin 
(1 00ng/ml) was compared with CFDA-labelled non-inhibited control and eotaxin 
stimulated cells using the transwell migration protocol, either by (b) manual quantitation of 
eosinophil migration or (c) fluorescence of migrated eosinophils measured using the 
Cytofluor II (PerSeptive Biosystems, Framingham, MA, USA). 
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Figure 5.3. In-vitro time-course of eosinophil migration: effect of 
intracellular signalling inhibitors 
FACS sorted peritoneal IL-5 transgenic eosinophils (section 2.2.1.2) were incubated with 
CFDA for 30 minutes at 37°C in Hanks solution. Cells were then re-incubated with 
various intracellular signalling inhibitors at 37°C in PBS: pertussis toxin (1 µm) for 1.5 
hours; wortmannin (1 0µg/ml) for 30 minutes; rapamycin (1 µg/ml) for 1 hour (section 
5.2.2.2). Using Fluoblok transwell filters, a 3.5 hour time-course of migration in response 
to eotaxin (1 00ng/ml) was measured on the Cytofluor II (PerSeptive Biosystems, 
Framinghan, MA, USA) and compared with untreated control and eotaxin stimulated 
eosinophils. This plot is representative of two separate experiments carried out in 
triplicate. 
Values represent mean+ SEM for 3 separate transwells. Significant differences are given 
in respect to the control (no inhibitor and no agonist) group: 1 * p<0.05, 1 ** p<0.001; and 
eotaxin stimulated (no inhibitor) group: 2* p<0.05, 2** p<0.001. 
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Further experiments will need to be undertaken to fully evaluate the role of the p70S6K 
pathway in eosinophil migration. The development of the Fluoroblok transmigration assay 
provided a reliable and efficient means of measuring real-time in-vitro chemotaxis in 
response to inhibitors and agonists. 
5.3.2 
5.3.2.1 
In-vivo inhibition of eosinophil migration 
Inhibition using intracellular signalling inhibitors 
In-vivo analysis of the inhibition of eosinophil migration was initially tested using the 
transfer of CFDA-labelled eosinophils into ova-sensitised mice, and monitoring the 
migration of labelled cells during the course of ova-aerosol provocation. However, several 
problems reduced the effectiveness of this protocol. The CFDA-label did not persist in 
eosinophils strongly "in-vivo" over the 6-days between transfer and lung excision. This 
problem was most prominent in the peripheral blood analysis where no "donor" cells could 
be positively identified, while in the BALF, only a limited number of CFDA-labelled 
eosinophils were visualised in control mice (figure 5.4a). These small numbers made 
FACS analysis of migrated cells unfeasible. The use of CFDA-labelled cells in in-vivo 
migration studies has mostly been characterised in lymphocytes (Brenan and Parish, 
1984). The persistence of labelling in these cells could be due to differences in the 
intracellular compartmentalisation of the dye in lymphocytes compared to eosinophils, 
however, this is yet to be characterised (discussions with Dr. Parish, Vascular and Cancer 
Biology Group, JCSMR). 
The development of the GFP/IL-5 double transgenic mouse (Matthaei and Hogan, 8MB, 
JCSMR) provided a possible model for "in-vivo" eosinophil transfer studies. Initial FACS 
analysis indicated GFP-tagging of eosinophils in this mouse, however, labelling was not 
strong enough to enable the visualisation of cell fluorescence (confocal or fluorescence 
microscope). 
5.3.2.2 Inhibition using CCR-3 (19-4) antibodies 
Inhibition of CCR-3 chemotactic signals was investigated with the use of the CCR-3 mAb 
(19-4 ). Initial studies were performed with two batches [(a) and (b )] of purified CCR-3 
mAb, 1 mg of which was injected into ova-sensitised mice on days 11 and 12, prior to ova-
aerosol provocation (section 5.2 .3.2). Peripheral blood levels were significantly lower in 
mice treated with either O/O+(a) [ova sensitised and aerosoled; mAb batch (a)] or O/O\b) 
when compared to OVA/OVA treated mice (figure 5.5a). Eosinophil numbers were up to 
30% lower in mAb treated mice (figure 5.5b), however, eosinophils still accumulated in 
the BALF when compared to SAL/SAL controls. Total cells were not significantly changed 
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a 
b 
Figure 5.4a and b. In-vivo eosinophil migration: effect of intracellular 
signalling inhibitors 
FACS sorted peritoneal IL-5 transgenic eosinophils (section 2.2.1.2) were incubated with 
CFDA for 30 minutes at 37°C in Hanks solution. Cells were then re-incubated with 
various intracellular signalling inhibitors at 37°C in PBS: pertussis toxin (1 µm) for 1.5 
hours; wortmannin (1 0µg/ml) for 30 minutes; and rapamycin (1 µg/ml) for 1 hour (section 
5.2.2.2). Ova-sensitised wild-type mice were i.v injected with 1 x 106 cells and ova-
aerosol provocated according to the protocol in section 5.2.3.1. Histological specimens, 
BALF cytospins and peripheral bloods were visualised using the Krypton/Argon laser of 
the Leica LCS (Dassel, Germany) confocal microscope. These images represent: (a) 
"donor" CFDA-labelled, control eosinophils in the BALF of ova-sensitised wild-type 
recipient; and (b) no CFDA-labelled treated with signalling inhibitors (representative for 
pertussis toxin, wortmannin and rapamycin treatments), are present in the recipient BALF. 
These images are representative of two separate experiments utilising 4 recipients per 
group. 
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Figure 5.5a -c. In-vivo eosinophil migration: inhibition using purified CCR-3 
mAb 
Wild-type C56BL/6 mice were exposed (i.p) to saline or OVA (1 0mg/ml) and challenged 
with an aerosol of saline or OVA (1 0mg/ml) (section 2.2.2.2). 1 mg of purified CCR-3 mab 
[lot 1 - o;o- (a) and lot 2 - 010- (b)] was i.v injected into ova-sensitised wild-type mice prior 
to ova-aerosol provocation according to the protocol in section 5.2.3.2. SAL/SAL (S/S) 
and OVA/OVA (0/0) groups were run in parallel for direct comparison with CCR-3 mAb 
treatment. (a) Time-course of peripheral bloods indicates a significant reduction in 
eosinophil numbers in 0/0+ (a) and 0/0+ (b) mice compared to 0/0 mice, however, not to 
S/S levels. (b) Eosinophil numbers were significantly reduced in 0/0+ (a) and 0/0+ (b) 
mice in the absence of total cell numbers in the BALF, (c) accounted for by a significant 
increase in the% of lymphocytes in the BALF. 
Values represent mean + SEM for groups of 4 mice. Significant differences are given in 
respect to the S/S treated group: * p<0.05, ** p,0.001; and 0 /0 group: 2* p<0.05, 2** 
p<0.001. 
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between the OVA/OVA treated groups, accounted for by a significant rise in the influx of 
lymphocytes into the airways (figure 5.5c). 
The effect of unpurified CCR-3 antibody ascites on the inhibition of eosinophil migration 
was also investigated. Two batches [(1) and (2)] of CCR-3 ascites were prepared, with 
batch (1) collected over 1 week and stored at 4°C and batch (2) used the day of 
extraction. As with purified antibody, peripheral blood levels were significantly lower in 
0/0+(1) [ova sensitised and aerosoled); batch (1 )] and 0/0\2) mice when compared to 
OVA/OVA treated mice, but still significantly higher than SAL/SAL treated mice (figure 
5.6a). Most striking was the dramatic reduction in both total cells and eosinophil numbers 
in the BALF following CCR-3 antibody ascites treatment (figure 5.6b ). Histological 
analysis confirmed a strong reduction in the influx of inflammatory cells, namely 
eosinophils, into the large airways of the lung and associated parenchyma (figure 5. 7a-d). 
Epithelial cell shedding and airways occlusion was also minimal compared to uninhibited 
OVA/OVA mice. 
The lack of morphological change was most apparent in 0/0\2) treated mice (figure 
5.7d), the histological profile of which was almost comparable to SAL/SAL controls (figure 
5.7a). Mucus production was also greatly reduced in CCR-3 antibody ascites treated 
mice, however, still prominent when compared to SAL/SAL controls (figure 5.8a-d). A 
comparison of the distal airways showed a reduction in eosinophil influx into the 
perivascular/peribronchiole space of 0/0+(1) and 0/0\2) compared to untreated 
OVA/OVA mice (figure 5.7e-h and 5.8e-h). No visual differences were apparent in the 
mucus production in treated and untreated OVA/OVA groups, all of which were only 
slightly elevated from the SAL/SAL mice. CCR-3 antibody ascites treatment had the most 
dramatic effect on reducing eosinophil influx and airways inflammation, and further "fine 
tuning" of CCR-3 antibody purification will be necessary to improve the specificity of this 
inhibitory response. 
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Figure 5.6a -c. In-vivo eosinophil migration: inhibition using CCR-3 antibody 
ascites 
Wild-type C56BL/6 mice were exposed (i.p) to saline or OVA (1 0mg/ml) and challenged 
with an aerosol of saline or OVA (1 0mg/ml) (section 2.2.2.2). 200ul of CCR-3 ascites [lot 1 
- 010- (1) and lot 2 - o;o- (2)] were i.v injected into ova-sensitised wild-type mice prior to 
ova-aerosol provocation according to the protocol in section 5.2.3.2. SAL/SAL (S/S) and 
OVA/OVA (0/0) groups were run in parallel for direct comparison with CCR-3 antibody 
ascites treatment. (a) Time-course of peripheral bloods indicates a significant reduction in 
eosinophil numbers in 0/0+ (1) and 0/0+ (2) mice compared to 0/0 mice, however, not to 
S/S levels. (b and c) Eosinophil numbers and total cells in the BALF were significantly 
reduced in 0/0+ (1) and 0/0+ (2) mice compared to 0/0 mice. 
Values represent mean + SEM for groups of 6 mice. Significant differences are given in 
respect to the S/S treated group: * p<0.05, ** p,0.001; and 0/0 group: 2* p<0.05, 
2**p<0.001. 
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Figure 5.7a - d. Histological analysis of CCR-3 antibody ascites treated mice 
following OVA/OVA provocation in a model of ova-sensitisation: large 
airways and associated parenchyma 
Wild-type C568L/6 mice were exposed (i.p) to OVA (1 0mg/ml) and challenged with an 
aerosol of OVA (1 0mg/ml) according to the protocol outlined in section 2.2.2.2. 200ul of 
CCR-3 antibody ascites [lot 1 - 010- (1) and lot 2 - 010- (2)] were i.v injected into ova-
sensitised wild-type mice prior to ova-aerosol provocation according to the protocol in 
section 5.2.3.2. SAL/SAL (S/S) and OVA/OVA (0/0) groups were run in parallel for direct 
comparison with CCR-3 antibody ascites treatment. On day 17, lungs were removed and 
fixed in 10% NSF before sectioning and staining with chromotrope. (a) S/S lungs were 
characterised by non-inflammed parenchyma, intact airway epithelium and no tissue 
eosinophilia . (b) Large numbers of inflammatory cells (mainly eosinophils) were localised 
in the peribronchial and perivascular regions of 0/0 treated lungs. Airways were 
characterised by extreme epithelial cell shedding and airways occlusion. (c) 010- (1) and 
(d) 010- (2) resulted in a visible decrease in eosinophil numbers in the peribronchial and 
perivascular regions compared to 0/0 mice. This inhibition is most distinct in 010- (2) 
treated mice, resulting in a profile comparable to S/S controls. 
Specimens illustrated: (a) S/S WT and inset; (b) 0/0 WT and inset.; (c) 010- (1) treated 
WT and inset; (d) 010- (2) treated WT and inset. Images are representative of each 
treatment group, comprised of 4 mice. 
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Figure 5.7e - h. Histological analysis of CCR-3 antibody ascites treated mice 
following OVA/OVA provocation in a model of ova-sensitisation: distal 
airways and parenchyma 
Wild-type C56BL/6 mice were exposed (i.p) to OVA (1 0mg/ml) and challenged with an 
aerosol of OVA (10mg/ml) according to the protocol outlined in section 2.2.2.2. 200ul of 
CCR-3 ascites [lot 1 - 010- (1) and lot 2 - 010- (2)] were i.v injected into ova-sensitised 
wild-type mice prior to ova-aerosol provocation according to the protocol in section 
5.2.3.2 . SAL/SAL (S/S) and OV NOVA (0/0) groups were run in parallel for direct 
comparison with CCR-3 ascites treatment. On day 17, lungs were removed and fixed in 
10% NBF before sectioning and staining with chromotrope . (e) SAL/SAL lungs were 
characterised by non-inflammed parenchyma, intact airway epithelium and no tissue 
eosinophilia. (f) Large numbers of inflammatory cells (mainly eosinophils) were localised 
in the peribronchial and perivascular regions of OVNOVA treated lungs. (g) 0 10 - (1) and 
(h) 010- (2) resulted in a visible decrease in eosinophil numbers in the peribronchial and 
perivascular regions compared to OV NOVA mice. 
Specimens illustrated: (e) SAL/SAL WT and inset; (f) OVNOVA WT and inset. ; (g) 0 /0 -
(1) treated WT and inset; (h) 010- (2) treated WT and inset. Images are representative of 
each treatment group, comprised of 4 mice. 
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Figure 5.8a - d. Mucus secretion in CCR-3 antibody ascites treated mice 
following OVA/OVA provocation in the short model of ova-sensitisation: 
large airways and associated parenchyma 
Wild-type C56BL/6 mice were exposed (i.p) to OVA (1 0mg/ml) and challenged with an 
aerosol of OVA (1 0mg/ml) according to the protocol outlined in section 2.2.2.2. 200ul of 
CCR-3 ascites [lot 1 - 010- (1) and lot 2 - 010- (2)] were i.v injected into ova-sensitised 
wild-type mice prior to ova-aerosol provocation according to the protocol in section 
5.2.3.2. SAL/SAL (S/S) and OVA/OVA (0/0) groups were run in parallel for direct 
comparison with CCR-3 ascites treatment. On day 17, lungs were removed and fixed in 
10% NBF before sectioning and staining with alcian blue-periodic acid Schiffs (ABS) to 
highlight mucus production. (a) No mucus secreting cells were visualised in S/S lungs. (b) 
0/0 treated lungs were characterised by strong mucus production in the airways (bright 
purple) , partially ablated following (c and d) 010- (1) and (d) 010- (2) treatment. 
Specimens illustrated: (a) S/S WT and inset; (b) 0/0 WT and inset; (c) 010- (1) treated 
WT and inset; (d) 010- (2) treated WT and inset. Images are representative of each 
treatment group, comprised of 4 mice. 
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Figure 5.8e - h. Mucus secretion in CCR-3 antibody ascites treated mice 
following OVA/OVA provocation in the short model of ova-sensitisation: 
distal airways and parenchyma 
Wild-type C56BL/6 mice were exposed (i.p) to OVA (1 0mg/ml) and challenged with an 
aerosol of OVA (10mg/ml) according to the protocol outlined in section 2.2.2 .2. 200ul of 
CCR-3 ascites [lot 1 - o;o- (1) and lot 2 - o;o- (2)] were i.v injected into ova-sensitised 
wild-type mice prior to ova-aerosol provocation according to the protocol in section 
5.2.3.2. SAL/SAL (S/S) and OVA/OVA (0/0) groups were run in parallel for direct 
comparison with CCR-3 ascites treatment. On day 17, lungs were removed and fixed in 
10% NBF before sectioning and staining with Alcian Blue-periodic acid Schiffs (ABS) to 
highlight mucus production. (a) No mucus secreting cells were visualised in S/S lungs. (b) 
0/0 treated lungs were characterised by some mucus production in the distal airways 
(bright purple), comparable to expression in (c and d) o;o- (1) and (d) o;o- (2) treated 
mice. 
Specimens illustrated: (a) S/S WT and inset; (b) 0/0 WT and inset.; (c) 010- (1) treated 
WT and inset; (d) o;o- (2) treated WT and inset. Images are representative of each 
treatment group, comprised of 4 mice. 
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5.4 DISCUSSION 
In this chapter a number of intracellular signalling inhibitors were used to investigate in-
vitro eosinophil migration, suggesting the utilisation of a number of signalling pathways in 
the directed migration of this cell . The Gi-protein specific inhibitor pertussis toxin was 
used as a negative control in these studies, and was shown to minimise eosinophil 
migration to levels below control cells (no inhibition/no agonist). This suggests migration 
in control cells was largely mediated by endogenous eotaxin (Nakajima et al., 1999) or 
other CCR-3 ligands. 
Inhibition of Pl3K mediated signals with the specific inhibitor wortmannin resulted in the 
partial abolishment of eotaxin instigated chemotaxis. This observation was confirmed in 
in-vivo studies where no inhibitor treated cells trafficked successfully to the sensitised 
airways. There is no doubt that the phospholipid cascade, through both Pl3K and 
Pl3,4,5K, plays an important role in the directed migration of eosinophils, however, other 
downstream mediators/cascades maintain cell chemotaxis following wortmannin 
inhibition. As previously mentioned (Chapter 3), Pl3K gamma-null mice display impaired 
chemotaxis, however, not all cell migration is ablated (Li et al., 2000; Hirsh et al., 2000). 
In-vivo studies incorporating the use of intranasal wortmannin administration in a guinea 
pig model, have shown a direct role for PI3K in allergen-induced eosinophil degranulation, 
but with little effect on the accumulation of this leukocyte in the BALF (Ezeamuzie et al., 
2001 ). However, intratracheal administration of Pl3K inhibitor at 1 hr prior and 24hr after 
allergen challenge in the rat model was found to suppress the late-phase influx of 
eosinophils into the airways (Tigani et al., 2001 ). Pl3K has also been shown to play a 
direct role in the IL-5-mediated chemokinetic release of eosinophils from the bone 
marrow, a process tightly regulated by a4 and ~2-integrins (Palframan et al., 1998). 
In-vitro studies have found that Pl3K inhibitors abolish the wave of extracellular calcium 
instigated by the activation of GPCRs (Kansra et al., 2001 ). In human eosinophils, 
intracellular calcium fluxes are a prerequisite for eosinophil chemotaxis and actin 
polymerization (Elsner et al., 1996). In other cells types, this mobilisation is instigated by 
the PLC/PKC (Wu et al., 1993; Li et al., 2000) and Pl3K (Qin et al., 2000; Siddiqui and 
English, 2000) pathways (Sawada et al., 2000). Wortmannin inhibition may partially 
ablate chemotaxis by the "running down" of intracellular calcium stores, while chemotaxis 
is still maintained by the PLC/PKC pathway via the associated intracellular Ca2+ flux and 
the activation of other downstream kinases. Pl3K has also been implicated in the 
activation of several MAPK's. Blockade of MAPK activation by PD98059 has been shown 
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to lead to a dramatic decrease in eotaxin-induced eosinophil rolling on endothelium and 
chemotaxis, consistent with the inhibition of actin polymerisation and rearrangement that 
is observed following treatment with this inhibitor (Boehme SA, 1999). Pl3K, in particular 
the p85a regulatory subunit of this kinase, is also integrally involved in receptor-
endocytosis (Li et al., 1995; Shpetner et al., 1996; Gaffet et al., 1997), integrin/FAK 
dynamics (Rankin et al., 1996; Nielsen et al., 1996) and the activation of the small 
GTPases Rae (Kotani et al., 1995) and Cdc42 (Jimenez et al., 2000), all potential sites at 
which eotaxin-induced signals are affected by wortmannin inhibition. 
Initial in-vitro and in-vivo results indicated the strong blockade of eosinophil chemotaxis by 
rapamycin. This bacterial-derived immunosuppressant, mostly characterised in terms of T-
cell activation and growth signals, has previously been observed to inhibit leukocyte 
migration in-vivo (Francischi et al., 1993; Poon et al., 1996; Tsuzuki et al., 1998). 
Rapamycin inhibited the migration of lymphocytes in an in-vitro chemotaxis assay 
(Tsuzuki et al., 1998), associated by the abrogation of the VLA-4NCAM-1 mediated 
pathway. Intramuscular injection of rapamycIn was shown to induce up to a 64% 
reduction in infiltrating eosinophils in a sephadex-induced sensitisation protocol 
(Francischi et al., 1993). This potent drug mediates signalling via the p70 ribosomal (s) 6 
kinase (p 70S6K) pathways by two mechanisms: the formation of complexes with the 
FK506 binding proteins (FKBPs), interacting with the mammalian target of rapamycin 
(mTOR) (Sabers et al., 1995), an immediate upstream mediator of p70S6K signalling 
pathway (Hara et al., 1998); or by the inhibition of Pl3K induced activation of p70S6K 
(Somwar et al., 1998). Interestingly, inhibition of mTOR by rapamycin significantly 
affects microtubule integrity and assembly (Choi et al., 200), a potential mechanism 
whereby this inhibitor may disrupt eotaxin induced polarisation and motility. The 
immunosuppressant effect of rapamycin could also be partially attributed to its ability to 
inhibit leukocyte infiltration (Abraham and Wiederrecht, 1996). 
The prevention of eosinophil recruitment by the blockade of the ligand/CCR-3 receptor 
interaction with neutralising antibodies may provide a novel therapy for the treatment of 
allergy, by acting upstream of many therapies currently being employed. Blocking CCR-3 
by antibody treatment has not been previously tested in allergy models. Following Ova-
sensitisation/Ova-provocation (OVA/OVA) in the murine model of allergic airways disease, 
the specific CCR-3mAb (19-4) was found to almost totally ablate eosinophil migration into 
the airways following allergen challenge and the pathophysiology associated with this 
eosinophilia was also greatly minimised. One of the main arguments against targeting the 
chemokine signalling system in therapeutic strategies has been the apparent redundancy 
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and overlapping in receptor-ligand interactions (Proudfoot et al., 2000). To date, 
members of the eotaxin family, the most potent eosinophil chemoattractants, have only 
been found to signal through CCR-3. The expression of this receptor on only a small 
subset of leukocytes, namely TH2 subsets, mast cells and basophils recruited 
inappropriately in response to allergen challenge, maintains the attraction of targeting this 
ligand-receptor complex in clinical intervention. A recent study on CCR-3 deficient mice 
confirmed the importance of this receptor in the recruitment of both eosinophils and mast 
cells to the allergic airway, with the majority of eosinophils being found arrested in the 
subendothelial space (Humbles et al., 2002). To be therapeutically useful, chemokine 
receptor antagonists need to be potent and selective, and the future development of 
humanised CCR-3 antibodies may provide significant advancement in the treatment of 
disease. 
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CHAPTER 6: 
General Discussion 
202 
6.1 INTRODUCTION 
Eosinophils are thought to play a key role in the induction and maintenance of atopic 
disease. Numerous clinical investigations and animal models of allergic inflammation 
highlight the strong correlation between eosinophilic infiltration and disease severity 
(Bradley et al., 1991; Oddera et al., 1996). Trafficking and activation of this leukocyte 
is a complex process, potentially regulated by many cytokines, chemokines, lipid 
mediators and small peptides. The migration process, although poorly understood, is 
modulated by the interplay of signals induced by; the surrounding extracellular 
matrix; local tissue/cell-associated adhesion molecule complexes; eosinophil-
associated integrin/focal adhesion complexes; and chemokine and cytokine 
signalling systems. The dynamic crosstalk between these diverse signalling 
systems results in the physical responses of eosinophil adhesion, polarisation and 
subsequent motility, all essential in the generation of directed migration. 
The most potent eosinophil chemoattractants characterised are the members of the 
eotaxin family of CC chemokines. Most importantly, the eotaxins have been found to 
signal exclusively through CCR-3, a member of the GPCR family, and the most 
predominantly expressed che111okine receptor on eosinophils. Additionally, the 
eosinophil-specific cytokine IL-5 is able to synergise with eotaxin/CCR-3-mediated 
chemotactic responses, resulting in the upregulation of eosinophil trafficking (Collins 
et al., 1995; Mould et al., 1997). 
The main focus of this thesis was to further elucidate intracellular mediators and 
pathways involved in CCR-3 signalling, and the potential crosstalk which exists 
between signals generated by this receptor, integrin/focal complex signalling and 
cytoskeletal rearrangement. The unique synergy, which exists between IL-5 and 
eotaxin generated signals, was also investigated in terms of the potential "priming" of 
eotaxin-mediated chemotactic responses. 
6.2 SUMMARY OF EXPERIMENTAL FINDINGS 
Signals generated through CCR-3 play a central role in the induction and 
maintenance of eosinophil chemotaxis to the site of allergic disease. The ability of 
cells to navigate through complex chemoattractant arrays relies on the ability of the 
cell to constantly remodel and extend the plasma membrane in the direction of the 
predominant chemotactic gradient. The role of structural (physical) polarisation 
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Figure 6.1. Eotaxin stimulation induces structural and functional 
polarisation, and internalisation of CCR-3 in the eosinophil. 
Stimulation of eosinophils with the potent chemoattractant, eotaxin, induces cell 
polarisation, and asymmetry of CCR-3 and IL-5R at the leading edge. Functional 
asymmetry within membrane microdomains suggests the need for establishing 
proximity of receptors and downstream signalling mediators in the instigation of 
eosinophil migration. Structural polarisation, through the dynamic rearrangement of 
the actin and microtubular cytoskeletons, plays an important role in the establishment 
and maintenance of functional asymmetry. Once desensitised, CCR-3 undergoes 
rapid internalisation via the microtubular network, a process most likely regulated by 
the cortical actin cytoskeleton and endocytotic vesicles associated with membrane 
microdomains. 
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of the chemotactically stimulated cell is well accepted, however, the requirement for 
functional (chemical) polarisation is still highly controversial. CCR-3 asymmetry at 
the leading edge in response to eotaxin, suggests there is a need for establishing 
proximity of receptors and downstream signalling mediators in the instigation of 
eosinophil migration through this chemokine receptor (Chapter 3). Not surprisingly, 
"priming" with IL-5 did not induce aggregation of its receptor, however, chemotactic 
stimuli did induce IL-5R polarisation. Asymmetric polarisation of signalling mediators 
may be a consequence of structural polarisation in the cell (Servant et al., 1999), 
enabling the aggregation of receptors and second-messengers in signalling 
complexes at the cell membrane. 
In other leukocytes, GPCR aggregation at the cell surface has been shown to occur 
within clathrin or caveolae-based microdomains (Kurzchalia and Parton, 1999). The 
expression of caveolin-1 on murine eosinophils, the isoform most closely associated 
with cell-surface caveolae, was confirmed by immunohistochemistry (Chapter 4). Of 
additional interest was the detection of mRNA expression of both caveolin-1 and 
caveolin-2 in BALF eosinophils, but not cells from the bone marrow pool. Further 
characterisation of caveolae/CCR-3 co-localisation would reveal whether the late 
expression of the caveolin isoforms reflects differential requirements for CCR-3 
aggregation in the eotaxin/receptor-mediated bone marrow release of eosinophils, as 
opposed to chemotactic signalling. 
G-proteins themselves are believed to play an integral role in the 
compartmentalisation of GPCRs within cellular microdomains (Kuschel et al., 1999), 
localisation which is essential for the efficient coupling of the receptor with down-
stream mediators (Ostrom et al., 2001 ). Ligand-induced association of CCR-3 with 
the Gia2-protein provides us with the first intracellular link in this chemokine-
regulated cascade (Chapter 2). The specific utilisation of Gia2, suggests that both 
the a- and ~y-subunits may potentially play an active role in second messenger 
activation and possibly in the recruitment of CCR-3 to specific microdomain 
compartments (Kuschel et al., 1999). 
Following functional polarisation, CCR-3 was found to rapidly internalise in response 
to prolonged eotaxin stimulation (Chapter 3). Eotaxin stimulation induced the tyrosine 
phosphorylation of the receptor itself (Chapter 3), confirming the need for receptor 
internalisation and resensitisation for the maintenance of cell chemotaxis (Zaslaver et 
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al., 2001 ). The strong association between functional and structural dynamics of the 
cell became apparent with the discovery of the direct association of CCR-3 with the 
microtubular cytoskeleton and the apparent co-localisation of both throughout the 
internalisation process (Chapter 4) . The microtubular system is highly dynamic in the 
murine eosinophil, forming a distinct "astral" array of microtubules radiating from the 
MTOC. Upon chemoattractant stimulus, microtubules extended rapidly towards the 
leading pseudopod, targeting directly to cortical actin sites (Kaverina et al., 1998). 
Although CCR-3 and actin association was not able to be fully characterised in this 
study, it is likely that internalisation and recycling of the receptor will involve the 
interplay of both the actin and microtubule cytoskeleton, a process potentially co-
regulated by "motors" from each cytoskeletal system (Huang et al., 1999). This co-
operation was partially highlighted by the lack of CCR-3 trafficking to the "clear zone" 
in conditions known to depolymerise both the microtubular (nocodazole) and actin 
(cytocholasin D) cytoskeletons. 
Following eotaxin stimulation, CCR-3 directly associated with microtubules at the 
leading edge, followed by the distinct "tracking" of desensitised receptor to the site of 
golgi complex localisation. Other GPCRs have also been observed to traffic in this 
manner. Bypassing traditional endosomal sites, GPCR may traffic directly to the golgi 
complex and be subsequently recycled to the plasma membrane (Hein et al., 1994). 
Potential insights were also made into the synergistic activity of IL-5 and eotaxin in 
both the spatial and temporal regulation of CCR-3. IL-5 "priming" was able to induce 
a more constant level of CCR-3 expression at the cell-surface. Receptor association 
with the insoluble fraction was consistently high, suggesting IL-5 may promote CCR-
3 association with a GPl-anchor at the cell-surface and upon receptor internalisation. 
GPl-anchored receptors are associated with both clathrin and caveolin-based 
microdomains and recycle their "load" rapidly between cell surface and the golgi 
complex (Nichols et al., 2001; Puri et al., 2001 ). The association of CCR-3 with a 
GPl-anchor at the cell membrane provides us with a potential model for the trafficking 
of the receptor to the golgi, in preparation for recycling back to the cell membrane. An 
extension of these observations would involve a more detailed characterisation of 
CCR-3 and microdomain-associated proteins, their role in the intracellular trafficking 
of CCR-3, and the integration of microtubule and actin-based filament sytems in the 
internalisation process. 
The potential crosstalk which exists between the chemokine and integrin signalling 
systems directly correlates with the functional and structural responses of the cell to 
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Figure 6.2. Signalling for eosinophil chemotaxis: chemokine receptor 
and integrin crosstalk. 
The potential crosstalk which exists between the chemokine and integrin signalling 
pathways correlates to the functional and structural responses of the eosinophil to 
chemotactic stimuli. The direct association of eotaxin stimulated CCR-3 with FAK, an 
integral protein involved in integrin signalling, at both the leading edge and at focal 
complexes provides a direct link between eosinophil adhesion and chemotaxis. The 
interplay of downstream second messengers, including the Ca2+ and phospholipid 
pathways, Rho GTPases and MAPK cascades plays a major role in maintaining the 
balance between cell migration and adhesion. Cell adhesion and focal complex 
formation precludes chemotaxis, and integrin/extracellular matrix interactions must 
play an integral role in both the instigation and maintenance of directed migration. 
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chemotactic stimuli. Actin localisation studies had confirmed that eosinophils adhere 
directly to substrate via focal complex or podosome formation (Chapter 4) , sites 
which provide the scaffold for integrin based signalling systems (Critchley DR, 2000). 
FAK is an integral protein involved in integrin signalling, and the direct association of 
CCR-3 with this kinase at both the leading edge and at ventrally located focal 
complexes provides a direct link between cell adhesion and migration signals 
(Chapter 4). Inhibition of intracellular signalling inhibitors confirmed the role of the 
Pl3K and p70S6K cascades in CCR-3 signalling (Chapter 5), further establishing a 
link between chemokine, cytoskeletal and integrin/FAK signalling pathways (Chapter 
4). Since cell adhesion and focal complex formation preclude chemotaxis, 
integrin/extracellular matrix interactions must play an integral role in both the 
instigation and maintenance of directed migration. "Shear stress" and the 
mechanical tension it provides is believed to play a major role in both the formation of 
focal complexes (Ingber et al., 1999) and in the upregulation of cell trafficking, a 
response dependant of FAK activation (Li et al., 1997). 
The prevention of eosinophil recruitment by the use of CCR-3 mab (19-4) provided 
insights into the effectiveness of CCR-3 blockades. The advantage of this particular 
chemokine receptor is its relative specificity and predominance of expression on the 
eosinophil, making it a strong candidate for antibody neutralisation (Proudfoot et al., 
2000). In our late-phase murine model of allergic airways disease, CCR-3mab was 
found to almost totally ablate eosinophil migration into the airways following allergen 
challenge and the pathophysiology normally associated with eosinophilia was greatly 
reduced. These results substantiate the potential of humanised CCR-3 antibodies to 
provide specific clinical intervention in allergic airways disease. 
In association with studies of CCR-3 signalling, characterisation of the Gz-1- mouse 
provided an important insight into the importance of G-protein mediated signals in 
airways responsiveness and innervation of the lung (Chapter 2). Gz-deficient mice 
from both the BalbC and C56BL/6 backgrounds displayed elevated airways 
responsiveness in response to ~-methacholine exposure. However, the importance 
of genetic variation in the analysis of experimental parameters was highlighted by the 
differences observed between Gz-1- mice of various backgrounds. Elevations in 
eosinophil numbers in the BALF of Ova-provocated C56BL/6 Gz+ were not found in 
the BalbC background , even though both groups displayed elevated airways 
responsiveness. The lack of a correlation between changes in BALF eosinophilia 
and elevated AHR levels confirmed previous reports suggesting eosinophils may be 
208 
dissociated from allergen-induced airways responsiveness (Corry et al. , 1996; 
Tourney et al., 2000). The functional promiscuity of G-protein family members in the 
generation of neurogenic signals (Gavett and Wills-Karp, 1993; Wong and Ross , 
1994) also suggests that Gz ablation would not result in the direct inhibition of 
smooth muscle relaxation. However, changes in neural pathway development and 
the resulting degradation of lung innervation (Kelleher et al., 1998) is worth further 
investigation in this model. In addition, elevated surfactant levels were found in the 
lungs of unsensitised Gz-1- mice. Elevations in SP-A and SP-O release have been 
observed in both human (Cheng et al., 2000) and murine (Haczku et al., 2001) 
allergic airways models. Future studies could further characterise the surfactants 
expressed, and whether this release is in direct response to the lack of Gz signals or 
a secondary physiological response. 
6.3 EOSINOPHIL CHEMOTAXIS: A SYNOPSIS 
Eosinophil chemotaxis is a complex process involving the integration of an intricate 
network of intracellular signalling pathways. The way in which cells can prioritise and 
combine these receptor-mediated signals and respond effectively and specifically to 
extracellular stimuli remains a focus of signal transduction research. In terms of the 
eosinophils' response to a chemotactic gradient, the functional crosstalk between 
both receptors and downstream mediators must in some way prioritise their 
responses by determining the outcome of both sequential and competing 
chemoattractant exposure. Investigations such as the ones carried out in this thesis 
will allow us to further elaborate these intricate networks and pave the way for future 
therapeutic strategies. 
In this thesis knowledge has been advanced in eosinophil biology, and in particular, 
the mechanism of eosinophil migration by establishing: (1) Gia2 as the Gi-protein 
involved in CCR-3 mediated signals; (2) the development of an eosinophil-specific 
immunohistochemical protocol for the detection and localisation of cell-surface and 
intracellular mediators; (3) CCR-3 and IL-5Ra asymmetry in the polarised eosinophil 
following eotaxin stimulation; (4) the potential of IL-5 priming to induce CCR-3 
aggregation/retention at the cell membrane, and hence a mechanism behind IL-5 and 
eotaxin synergy; (5) the expression and membrane localisation of caveolin-1 , an 
integral protein of membrane microdomains; (6) the association between FAK and 
CCR-3, and a potential site of cross-talk between integrin and chemokine signalling 
systems; (7) microtubular and actin cytoskeletal dynamics in response to eotaxin and 
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IL-5 stimulation; (8) the role of the microtubular cytoskeleton in CCR-3 internalisation 
and recycling , and the physical association of ~-tubulin with this receptor; (9) the 
potential role of Gz in airways responsiveness and lung innervation; (10) the role of 
the Pl3K and P70S6K pathways in chemotactic signalling through CCR-3; and (11) 
the effectiveness of CCR-3 antagonist in the ablation of eosinophil migration and 
recruitment in a murine model of allergic airways disease. 
In conclusion, CCR-3 plays a fundamental role in the induction and maintenance of 
eosinophil chemotaxis. Notably, the synergistic interaction between IL-5 and eotaxin 
generated signals suggest an important role for these agonists in the finetuning and 
upregulation of the eosinophil chemotactic response. The development of specific 
and reliable humanised antibodies against this receptor may provide a significant 
advance in the treatment of eosinophil derived pathophysiology in allergic disease. 
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